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Abstract 	
Fundamental to mammalian brain development is the integration of cell 
intrinsic and extrinsic signals that direct the proliferation and differentiation of 
neural stem cells. Precise expression of transcription factors together with other 
intracellular components instruct progenitor cell fate, whereas interaction with 
extracellular signaling factors refines this process. We have elucidated the 
composition of the cerebrospinal fluid that is the source of multiple extrinsic cues 
during brain development. The choroid plexus, a highly vascularized tissue 
located in each ventricle of the brain, actively secretes cerebrospinal fluid. By 
RNA sequencing, we obtained transcriptome data on the choroid plexi from 
lateral and fourth ventricles of the mouse brain and discovered that they include 
transcripts unique to each tissue. Transcription factor expression in the macaque 
 x 
and human choroid plexi suggests that positional identities of these tissues are 
conserved in the primate brain. Based on transcriptional results, we defined the 
choroid plexus secretome, a prediction of secreted factors from the choroid 
plexus. By quantitative mass spectrometry, we detected proteins secreted by 
each choroid plexus, and comparison of these proteomic results with 
transcriptional profiling suggests that choroid plexus transcriptomes contribute to 
availability of regionalized cerebrospinal fluid factors during development. 
In the second part of my dissertation research, I studied the role of DNA 
repair mechanisms in regulating neural stem cells. These studies focused on 
DNA LigaseIV, an essential component of DNA double-stranded break repair, 
during cerebral cortical development. Deficiency of LigaseIV activity caused by a 
missense mutation leads to LigaseIV syndrome, in which a key clinical feature is 
microcephaly. Using the Lig4 R278H mouse mutant, we found increased cell 
death in the developing cortex, contributing to reduced cortical thickness and 
cellularity in the anterior cerebral cortex. These results indicate that DNA 
LigaseIV is essential for proper cortical development. 
Together, these findings illustrate the complexity of regulatory 
mechanisms that guide brain development, requiring the integration of 
mechanisms from within and outside the cell. We have investigated two such 
mechanisms, extrinsic cues from regionalized cerebrospinal fluid and DNA 
LigaseIV. These results should provide greater insight into mechanisms of 
normal brain development and neuropathological states.    
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Chapter 1 
Introduction 	
  
 2 
The mammalian brain is arguably the most complex biological system 
known to man, with an estimated 100 billion neurons connecting through trillions 
of synapses in the human brain. Yet, despite the complexity and intricacies of the 
mature brain, it develops from a simple sheet of neural stem cells that folds to 
form a tube around which the entire brain and spinal cord develops. Neural stem 
cells along the anterior length of the neural tube proliferate and differentiate, 
giving rise to the neurons and glia of the mature brain. How these developmental 
events are regulated to produce one cohesive system and what the 
consequences are of insult during these developmental processes have been the 
questions asked by neuroscientists for generations. 
The focus of this dissertation is to elucidate the coordination of cell 
intrinsic and extrinsic mechanisms that regulate brain development, from genetic 
programs and intracellular events to extracellular signaling factors. The majority 
of the work is focused on understanding the regulation of cerebrospinal fluid 
(CSF) composition and the source of CSF, the choroid plexus (ChP) tissues, as 
these are key sources of extrinsic cues during brain development. I studied the 
transcriptional program of the lateral and fourth ventricle choroid plexi as one 
mechanism that regulates CSF composition during brain development. By RNA 
sequencing, I identified the molecular heterogeneity of ChP tissues across the 
ventricular system, which contributes to the regionalized availability of CSF 
factors. While I focus primarily on the factors that promote normal brain 
development, I also studied the role of DNA damage and the deleterious effects 
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of ineffective DNA repair mechanisms following Lig4 mutation in the developing 
cerebral cortex. 
In this chapter, I first introduce the cell intrinsic and extrinsic mechanisms 
that regulate development of the mammalian cerebral cortex and the 
coordination between these mechanisms. Next, I describe in greater detail the 
development of the ChP and the functions of CSF factors in regulating the 
developing and adult brain. Lastly, I introduce the role of DNA damage and repair 
mechanisms in the developing cerebral cortex and the clinical manifestations of 
DNA LigaseIV syndrome, in which a missense mutation in the LIG4 gene leads 
to an accumulation of DNA double-stranded breaks and apoptosis. 
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Part I. Coordination of cell intrinsic and extrinsic mechanisms in cerebral 
cortical development 
 
Fundamental to neural development is the integration of temporally and 
spatially restricted signals that control rapid changes across vast regions of the 
developing brain. During brain development, progenitor cells proliferate and 
differentiate to generate the neuronal and glial subtypes of the mature brain. The 
mechanisms regulating this developmental program are cell intrinsic, genetically 
encoded instructions and intracellular components, as well as cell extrinsic, 
extracellular diffusible factors. While cell intrinsic mechanisms specifying neural 
development have been the focus of much research, the contribution of extrinsic 
signals emanating from the meninges, vasculature, and CSF, has been 
demonstrated to also regulate and fine-tune the developmental process. 
Development of the cerebral cortex, the region of the brain responsible for 
higher order functions including attention, perception, and consciousness, has 
been particularly well characterized. Cortical development proceeds in an 
orderly, though intricate manner. As the neural tube closes, the fluid-filled space 
within the tube forms the brain’s ventricular system (Chau et al., 2015), while the 
cells lining the rostral neural tube, the region that will become the telencephalon, 
undergoes a massive proliferative program to expand into the mature, six-layered 
cortex. Progenitor cells in the dorsal telencephalon give rise to the excitatory, 
glutamatergic projection neurons that migrate radially from the proliferative zone 
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into the cortical plate (Molyneaux et al., 2007; Franco and Muller, 2013). Another 
progenitor population located in the ventral telencephalon produces inhibitory, 
GABAergic neurons that migrate tangentially and integrate with excitatory cells to 
form functional circuitry in the cortex (Welagen and Anderson, 2011). 
 
Progenitor types of the neocortex 
Several progenitor types in the dorsal telencephalon have been identified, 
including neuroepithelial cells (Huttner and Brand, 1997; Gotz and Huttner, 
2005), radial glial cells (Malatesta et al., 2000; Noctor et al., 2001; Noctor et al., 
2002), basal progenitors (also known as intermediate progenitors) (Haubensak et 
al., 2004; Noctor et al., 2004), short neural precursors (Gal et al., 2006; Stancik 
et al., 2010), and outer radial glial cells (Fietz et al., 2010; Wang et al., 2011). 
While these progenitor subtypes are best characterized in the mouse, recent 
work suggests that specific progenitor cell types are more abundant in the 
primate brain, potentially explaining the gyrification, or folding, of the cerebrum 
that greatly expands cortical surface area and correlates with higher cognitive 
function. 
Following neural tube closure, a layer of pseudostratified neuroepithelial 
cells lines the ventricular zone (VZ), the region immediately adjacent to the fluid-
filled ventricle which is defined as the apical surface of the developing cortex. 
These cells undergo primarily symmetric divisions to expand the progenitor pool 
and some asymmetric divisions to generate the earliest born neurons. By 
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embryonic day (E)9-10 in the mouse, these cells lose some of their epithelial 
characteristics to transition into radial glial cells (Noctor et al., 2002). Radial glia 
contact both the apical surface and extend a basal process to the pial surface, 
which serves as scaffolding for newly born neurons to migrate to the cortical 
plate (Rakic, 1972). Radial glia undergo asymmetric divisions to self-renew and 
also to produce a non-radial glial daughter cell (Noctor et al., 2001). Studies 
suggest that 10-20% of radial glial cells may generate neurons directly, though 
the majority of radial glia seems to produce another type of neural progenitor, 
known as the basal progenitor cell (Haubensak et al., 2004; Miyata et al., 2004; 
Noctor et al., 2004). Despite the molecular and morphological differences 
between neuroepithelial and radial glial cells, both types of progenitors 
demonstrate complex mitotic behavior known as interkinetic nuclear migration, in 
which the cell’s nuclear position changes depending on its phase of the cell cycle 
(Miyata et al., 2001; Noctor et al., 2001). Though the exact function of nuclear 
migration is unclear and may be involved with cell cycle progression, more recent 
studies suggest that the movement of the nucleus ensures proper integration of 
the daughter cells into the epithelium following mitosis (Kriegstein and Alvarez-
Buylla, 2009; Strzyz et al., 2015). 
Basal progenitors, unlike the apical progenitors from which they derive, 
are removed from the apical surface with their nuclei located in the subventricular 
zone (SVZ). Basal progenitors lack processes and tend to divide symmetrically in 
a terminal division to generate two daughter neurons (Noctor et al., 2004; Gal et 
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al., 2006; Noctor et al., 2008). However, some basal progenitors may undergo 
several additional rounds of symmetric divisions to generate more basal 
progenitors prior to final differentiation (Noctor et al., 2004; Wu et al., 2005). 
Another population of progenitor cells, distinct from apical and basal 
progenitors, is termed short neural precursors. These cells lack full-length 
processes that reach the pial surface, which are characteristic of radial glial cells, 
and they retract their shorter basal processes during cell division (Gal et al., 
2006). Short neural precursors are also molecularly distinct, as they express 
Pax6 but not Tbr2, a key marker of basal progenitors (Stancik et al., 2010). 
Lineage tracing studies demonstrate that short neural precursors are also distinct 
in their cell cycle kinetics and produce phenotypically distinct classes of neurons 
(Stancik et al., 2010). Defective production of short neural precursors seems to 
contribute to the neocortical pathology in Down syndrome (Tyler and Haydar, 
2013). 
Outer radial glial cells are radial glial-like progenitors located in the outer 
SVZ and extend a basal process to the pial surface. They are especially 
abundant in the primate brain and have been postulated to be responsible for 
generating the immense expansion of neocortical neurons in primates (Hansen 
et al., 2010; Lui et al., 2011; LaMonica et al., 2013). These cells have been 
observed to undergo interesting cellular behavior during mitosis, termed mitotic 
somal translocation, in which the nucleus translocates toward the cortical plate 
just prior to cytokinesis (Wang et al., 2011). Dysregulation of this nuclear 
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translocation may contribute cortical malformations in the human brain (Ostrem 
et al., 2014). 
While all of these progenitor cell types contribute to the cerebral cortex, for 
the remainder of this dissertation, we focus primarily on the functions of the 
apical progenitors (i.e. neuroepithelial and radial glial cells) as these cells are at 
the immediate VZ such that their apical surfaces are bathed in CSF. 
Furthermore, these cells have been shown to extend primarily cilia into this rich 
source of extrinsic signals (Cohen et al., 1988; Dubreuil et al., 2007; Lehtinen et 
al., 2011). As the earliest stem cells of the nervous system, the apical progenitors 
exert great influence on expanding the stem cell pool, and ultimately, on the size 
of the cerebral cortex. Alterations in the regulation and availability of cell intrinsic 
and extrinsic signals to apical progenitors may have significant impact on cortical 
development. 
 
Cell intrinsic mechanisms specify regional identity and cell fate 
Though the brain develops from a uniform sheet of pseudostratified neural 
stem cells, the dorsal and ventral telencephalon give rise to different types of 
neurons (excitatory versus inhibitory), while the anterior and posterior neural tube 
develop into different structures altogether (brain versus spinal cord). To 
generate such diversity in the system, the entire neural tube undergoes regional 
specification and patterning. Thereafter, the early mammalian brain is parsed into 
transient segmental units based on patterns of gene expression. These 
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structures are termed prosomeres in the forebrain, mesomeres in the midbrain, 
and rhomobomeres in the hindbrain. In the prosomeric model of forebrain 
development, the rostral neural tube is divided into transverse regions based on 
gradients of transcription factor expression (Puelles and Rubenstein, 1993). 
Likewise, the developing hindbrain is divided into equally spaced segments, 
which have been particularly well studied for their expression of Hox homeobox 
transcription factors that specify positional identity along the anterior-posterior 
axis (Durston et al., 2011; Philippidou and Dasen, 2013). Spatial and temporal 
misexpression of Hox genes leads to a change in the rhombomere’s identity 
(Marshall et al., 1992; Kessel, 1993; Durston et al., 2011). 
Transplantation studies support regional identity being largely cell intrinsic. 
Following transplantation of progenitor cells from their endogenous environment 
into a new environment, including culturing cerebellar progenitors in vitro or 
transplanting them into the embryonic forebrain, transplanted cells continue 
expressing markers of their region of origin and have limited differentiation 
capacity (Zappone et al., 2000; Hitoshi et al., 2002; Klein et al., 2005). Thus, 
there are mechanisms inherent to the cell that are retained despite passaging 
and introduction of new environmental cues.  
Transplantation studies have also been used to study progenitor lineage 
restriction in the cerebral cortex. Seminal studies in cortical development 
demonstrated that the birth date of neurons correlates with its laminar fate in the 
mature cortex, such that early born neurons arriving at the cortical plate first 
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become the lower layers of the cortex, while later born neurons migrate past to 
the more superficial layers of the cortex (Angevine and Sidman, 1961; Rakic, 
1974). Isochronic transplantation studies in ferrets, in which neural progenitor 
cells are harvested and transplanted into littermates at the same age, 
demonstrated that the laminar position of the transplanted neurons closely 
resembled that of the host (McConnell, 1985), supporting the hypothesis that 
neurons are committed to their fate early in development. When cortical 
progenitors were cultured in vitro, the daughter neurons generated through 
sequential cell divisions preserved their temporal specification, becoming more 
restricted in their differentiation capacity with each subsequent division (Shen et 
al., 2006). While these findings support intrinsic specification of neuronal cell 
fate, more work is needed to determine the mechanism by which this temporal 
order is established. Two models have been proposed in which either a common 
progenitor changes over time to produce different subtypes of neurons in a 
defined temporal order, or several progenitor types may be present and are 
either intrinsically programmed or extrinsically signaled to produce a specific type 
of neuron at a specific time (Franco et al., 2012; Franco and Muller, 2013; Guo et 
al., 2013).   
Studies have identified numerous transcription factors expressed in a 
spatially and temporally restricted manner that direct cortical development. This 
includes the transcription factors Emx2 and Pax6, whose loss of expression 
leads to ventralization of the entire neocortex (Muzio et al., 2002; Kimura et al., 
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2005). In addition to being distinct from the ventral forebrain, neocortical 
progenitors are also distinct from the dorsal midline, which develops into the 
choroid plexus and hippocampus. It was demonstrated that the neocortex 
expresses the transcription factor Lhx2 in a graded manner, which represses 
dorsal midline fate. Loss of Lhx2 expression leads to expansion of midline 
structures at the expense of progenitors with neocortical identity (Monuki et al., 
2001).  Interestingly, a recent study demonstrated that oscillations in transcription 
factor expression also regulate cell identity (Imayoshi et al., 2013). 
While transcription factor expression is essential for specifying neuronal 
cell fate, other cellular components controlling mitotic spindle orientation and cell 
polarity also influence the behavior of neural progenitors. Symmetrical divisions 
in progenitors lead to expansion of the stem cell pool, while asymmetrical 
divisions lead to differentiation into either a different type of progenitor or terminal 
differentiation into a postmitotic neuron. It was observed that the cleavage 
orientation of the cell is telling of the type of division, where vertical cleavage 
planes perpendicular to the ventricular surface produce two daughter 
progenitors, while horizontal cleavage planes parallel to the ventricular surface 
produce one apical progenitor that remains as an apical progenitor and the other 
daughter cell differentiates into a neuron (Chenn and McConnell, 1995; Lizarraga 
et al., 2010). It was reasoned that the cleavage orientation may lead to 
differential inheritance of cellular components between daughter cells, including 
complex of proteins at the apical surface (Kim et al., 2010b; Lehtinen and Walsh, 
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2011) and cytoplasmic regulators of cell fate, including Numb protein (Rhyu et 
al., 1994) and Notch (Chenn and McConnell, 1995). 
 
Cell extrinsic signals refine regional identities and cell fate 
Despite the widely established roles of cell intrinsic mechanisms in 
specifying progenitor and neuronal subtypes, cell extrinsic signals play an 
important role in shaping and refining this process (LaMantia et al., 1993; Hunter 
and Hatten, 1995). From early brain development, extrinsic signals are required 
for induction of the telencephalon from the neural tube, triggering the 
downstream expression of specific transcription factors. The anterior neural ridge 
secretes fibroblast growth factor 8 (FGF8), which induces expression of the 
transcription factor Foxg1 in all future cortical progenitors, even before the 
telencephalon is morphologically apparent (Shimamura and Rubenstein, 1997; 
Fukuchi-Shimogori and Grove, 2001; Monuki and Walsh, 2001). Many other 
extrinsic factors have been described that are necessary to pattern the 
mammalian forebrain (Grove and Monuki, 2013). While transplantation studies 
discussed previously demonstrate that regional and neuronal identities are 
intrinsically programmed, other key studies suggest plasticity in cell fate, which 
can be shifted based on the extracellular context. When progenitors for early 
born neurons were transplanted heterochronically into an older environment, 
some of the neurons generated had changed their fate and settled into a different 
laminar position (McConnell, 1988). 
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 Throughout neurogenesis, there is simultaneous development of several 
sources of extrinsic signals, including the meninges, vasculature, and choroid 
plexus. These structures, though non-neural, play an important role in instructing 
neurogenesis that has long been neglected. Here, we discuss a few of the 
signals emanating from these sources, though more work is needed to 
understand the entire extracellular milieu available during brain development.  
 
Meningeal sources of extrinsic signals 
The meninges cover the outer surface of the brain, developing from the 
mesenchyme that surrounds the neural tube. In the mouse, the earliest 
meningeal cells are apparent at embryonic day (E)9-10 (McLone and Bondareff, 
1975). While radial glial progenitors have their cell body close to the ventricular 
zone, their basal processes extend to the pial surface and attach to the meninges 
(Radakovits et al., 2009). Detachment of basal processes leads to apoptosis of 
radial glia and reduced cortical size, suggesting that the meninges play an 
important role in progenitor cell survival. Several factors have been identified to 
be secreted from the meninges, including the chemoattractant Cxcl12 (Borrell 
and Marin, 2006) and the vitamin A derivative, retinoic acid (Siegenthaler et al., 
2009). Defective meningeal formation in Foxc1 mutants leads to lateral 
expansion of the forebrain but decreased neuronal production. Through a series 
of co-culture rescue experiments, it was determined that decreased supply of 
meningeal-derived retinoic acid to underlying progenitors leads to decreased 
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production of deep (Ctip2+) and upper (Brn2+) layer neurons, as retinoic acid 
normally promotes cell cycle exit (Siegenthaler et al., 2009). However, other 
studies suggest that the defects seen in Foxc1 mutants are instead caused by 
defective skull formation, and the role of retinoic acid in neuronal differentiation is 
limited to the ventral forebrain and hindbrain (Chatzi et al., 2011; Chatzi et al., 
2013). Nevertheless, the meninges are in close apposition with the cerebral 
cortex throughout development and represent another rich source of signals. 
 
Vascular sources of extrinsic signals 
Vasculature in the brain develops through angiogenesis, whereby 
endothelial cells of existing blood vessels proliferate.  Interestingly, blood vessels 
in the telencephalon develop in a ventral to dorsal gradient regulated by the 
expression of specific homeobox transcription factors in the endothelium, a 
process which occurs in concert with neuronal development (Vasudevan et al., 
2008). Tight junctions between endothelial cells form the blood-brain barrier, 
which is functional during development, such that there is no direct passage of 
blood-borne factors into the CNS (Ben-Zvi et al., 2014). Endothelial cells 
themselves are a rich source of diffusible factors to the developing brain. In co-
cultures of endothelial cells with neural stem cells, endothelial-derived signals 
promote stem cell renewal and induce expression of Notch signaling activation 
(Shen et al., 2004). The vascular niche is also implicated in regulating the adult 
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stem cell niche, as proliferating cells in the SVZ are in close apposition with 
vasculature (Tavazoie et al., 2008; Kokovay et al., 2010). 
 
Cerebrospinal fluid as source of extrinsic signals 
The CSF has historically been considered a fluid cushion and a means to 
remove metabolic waste from accumulating in the brain. However, CSF is also a 
rich source of growth factors and other signaling molecules, metabolites, and 
microRNAs (Parada et al., 2006; Zappaterra et al., 2007; Lehtinen and Walsh, 
2011; Feliciano et al., 2014). CSF protein concentration is dynamic over the 
course of development (Zappaterra et al., 2007; Lehtinen et al., 2011), and in 
particular, insulin-like growth factor 2 (IGF2), has been shown to signal through 
IGF receptor 1β, localized to the apical surface of progenitor cells by apical 
complex proteins, to regulate progenitor proliferation and brain size. Igf2 deficient 
mice have reduced cortical surface area and thickness by reduction of upper 
layer Cux1+ cells (Lehtinen et al., 2011). Likewise, signaling molecules in the 
CSF including Fibroblast growth factor 2 in the midbrain (Martin et al., 2006) and 
Sonic hedgehog (Shh) in the hindbrain (Huang et al., 2009c; Huang et al., 2010) 
have been shown to regulate brain development. The development and functions 
of the ChP-CSF system are described in greater detail in Part II of the 
Introduction. 
 
 
 16 
Coordination of cell intrinsic and extrinsic signals in cortical development 
Throughout embryonic brain development, the progenitor cells of the 
forebrain are exposed to signals emanating from within and outside the cell. 
While transcription factors and cell polarity determinants regulate progenitor 
lineage restriction, progenitors also express cell surface receptors that sense the 
external environment. For example, the apical complex proteins restrict cell fate 
by limiting cell fate determinants to one region of the cell, thereby allowing 
postmitotic daughter cells to differentially inherit these determinants. The apical 
complex protein Pals1 regulates cell fate and survival through the mTOR 
pathway (Kim et al., 2010b), yet Pals1 also functions to enrich cell surface 
receptors along the apical region of cortical progenitors (Lehtinen et al., 2011). 
Studies have also demonstrated that extrinsic signals secreted by newly 
born neurons may signal back to progenitor cells to regulate the cleavage plane 
of their neighbors (Poggi et al., 2005; Siegrist and Doe, 2006). Indeed, neurons 
are a source of local signals as well, as Cajal-Retzius cells, the earliest born 
neurons of the brain, secrete the extracellular matrix protein reelin (D'Arcangelo 
et al., 1997). Reeler mice, which have a mutation in the Reelin gene, show 
disrupted neuronal positioning in an inverted order (Ogawa et al., 1995), and 
radial glial fibers show disrupted orientation (Nomura et al., 2008). However, the 
exact cellular and molecular mechanisms of reelin signaling are still unclear 
(Sekine et al., 2014).  
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The interplay of cell intrinsic and extrinsic signals is further exemplified by 
disrupting the canonical Wnt/β-catenin signaling pathway. β-catenin functions as 
a component of adherens junctions and transducer of Wnt signaling by 
interactions with the T cell factor/lymphoid enhancer binding factor (TCF/LEF) 
within the nucleus. Following abrogation of normal Wnt/β-catenin signaling by 
expression of constitutively active β-catenin in all neural progenitors, progenitors 
remain within the cell cycle rather than differentiating, leading to a massive 
horizontal expansion of the cortex and convoluted folding resembling gyri and 
sulci (Chenn and Walsh, 2002). Likewise, studies of another component of the 
adherens junction, αE-catenin, demonstrate the cooperation of intrinsic and 
extrinsic mechanisms. Deletion of αE-catenin from apical junction complexes 
leads to increased proliferation through activation of the hedgehog signaling 
pathway (Lien et al., 2006). These results suggest that during normal 
development, as cell density of neural precursors increases and more adherens 
junctions occupy the cell surface, there would be a feedback mechanism to 
reduce hedgehog signaling and decrease proliferation. 
 
 
Conclusions 
 Proper development of the mammalian brain requires the coordination 
signals. While cell intrinsic mechanisms provide many of the instructions during 
development that dictate progenitor cell fate, the wealth of extrinsic cues 
emanating from the meninges, vasculature, CSF, as well as newly born neurons, 
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provide an added regulatory mechanism for tighter control of brain development. 
Despite the recent observations that have identified key diffusible signals in 
regulating the developmental process, much work is still needed to understand 
how they contribute to normal brain development.  
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Part II. Development and functions of the choroid plexus-cerebrospinal 
fluid system 
 
 
This literature review is published in: Lun MP, Monuki ES, and Lehtinen MK 
(2015). Development and functions of the choroid plexus-cerebrospinal fluid 
system. Nature Reviews Neuroscience 16 (8):445-57. 
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Summary 
 
The ChP is the principal source of CSF, which has accepted roles as a 
fluid cushion and a sink for nervous system waste in vertebrates. Various animal 
models have provided insights into how the ChP–CSF system develops and 
matures. In addition, recent studies have uncovered new, active roles for this 
dynamic system in the regulation of neural stem cells, critical periods and the 
overall health of the nervous system. Together, these findings have brought 
about a paradigm shift in our understanding of brain development and health, 
and have stimulated new initiatives for the treatment of neurological disease. 
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Introduction 
The ChP is a secretory tissue responsible for producing CSF in the 
vertebrate brain. CSF flows from the lateral to the third ventricle via the 
interventricular foramina (also known as the foramen of Monro), and then through 
the cerebral aqueduct to the fourth ventricle (Figure 1.1). Subsequently, the CSF 
flows down the central canal of the spinal cord or circulates in the subarachnoid 
space, where it is resorbed by arachnoid villi and granulations (Lehtinen and 
Walsh, 2011; Damkier et al., 2013) either by classical lymphatics in sinonasal 
tissues that underlie the cribriform plate (Mollanji et al., 2002; Johnston et al., 
2005; Koh et al., 2006), or by the recently described meningeal-dural sinus 
lymphatics (Louveau et al., 2015) back into the systemic circulation or regional 
and cervical lymph nodes.  
The ChP–CSF system is crucial for the development and maintenance of 
the CNS (Redzic et al., 2005; Johanson et al., 2008; Lehtinen et al., 2013). 
Despite the widely disparate complexity of the CNS across species, the ChP is 
an evolutionarily conserved structure that is present in lower vertebrates to 
humans (Netsky and Shuangshoti, 1975; Brocklehurst, 1979). Indeed, the 
function of the ChP appears to be conserved across species, as the ChP has 
been documented to secrete analogous signals, including growth factors, in 
various systems (Parada et al., 2006; Zappaterra et al., 2007).  
Landmark studies have demonstrated that appropriate ChP function is 
imperative for the formation  and  integrity  of  the  CNS:  too  little  CSF  severely 
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Figure 1.1. The choroid plexus-cerebrospinal fluid system. 
The choroid plexus (ChP) consists of epithelial cells that surround a core of 
capillaries and connective tissue. The epithelial cells are joined by tight junctions, 
which form the blood–cerebrospinal fluid (CSF) barrier. The ChP is located in 
each ventricle in the brain and is regarded as the principal source of CSF, 
secreting up to 500ml of CSF per day in the adult human brain. CSF flows from 
the lateral to the third ventricle through the interventricular foramina, and from the 
third to the fourth ventricle through the cerebral aqueduct. CSF can then enter 
the central canal of the spinal cord or the subarachnoid space, where 
microscopic arachnoid villi and macroscopic arachnoid granulations (granulations 
are present in humans and other large mammals), together with lymphatics 
present in the cribriform plate-olfactory region (Mollanji et al., 2002; Johnston et 
al., 2005; Koh et al., 2006) or lining the meninges–dural sinuses (Louveau et al., 
2015), resorb CSF into the systemic circulation or into regional and cervical 
lymph nodes. The ChP is organized into an outer layer of cuboidal epithelial cells 
surrounding a core of fenestrated capillaries and other stromal cell types. 
Functioning as the blood–CSF barrier, the ChP is also a gateway for immune cell 
entry into the CNS (Box 1). 
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impairs   brain   growth, as CSF pressure is necessary for normal brain 
development (Desmond and Jacobson, 1977), whereas excess CSF − owing to   
overproduction, obstructed flow or limited resorption of CSF — can lead to 
hydrocephalus (Oi, 2011; Damkier et al., 2013). Excessive subarachnoid CSF 
may be an early marker of autism spectrum disorder (Shen et al., 2013). 
However, despite the potential for the ChP–CSF system to regulate the CNS in a 
global manner, it remains one of the most understudied areas of neurobiology. 
Indeed, although the discovery that the ChP is responsible for CSF secretion was 
made over a century ago, the development and regulation of the ChP–CSF 
system are only beginning to be understood.  
In this article, we first explore the early work elucidating the structure of 
the ChP and organization of its cell types. We next delve into the cell-intrinsic 
and -extrinsic molecular mechanisms that guide the specification of ChP cells 
and their proliferation into a highly structured organ. Last, we explore the impact 
of recent findings relating to the ChP, specifically its participation in regulating 
neural stem cells of the embryonic and adult brain. Note that we include a brief 
discussion of the potential for ChP-targeted therapies in rejuvenating and 
repairing the CNS, as recent findings highlight these emerging possibilities. 
However, we refer the reader to several recent reviews on the ChP in aging, 
disease and injury, and transport mechanisms in CSF production (Emerich et al., 
2005; Redzic et al., 2005; Zheng and Chodobski, 2005; Johanson et al., 2008; 
Wolburg and Paulus, 2010; Zappaterra and Lehtinen, 2012; Damkier et al., 
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2013). Together, this information should promote further investigation into the 
regulation of the ChP and its secreted factors, and the capacity to harness the 
potential of the ChP to repair the aged and diseased brain.  
 
Location and structure  
The ChP is a highly vascularized tissue that is located within each 
ventricle of the brain (Figure 1.1). It develops from several locations along the 
dorsal axis of the neural tube. After neural tube closure, the hindbrain ChP of the 
fourth ventricle is the first to appear, followed by the synchronous development of 
the telencephalic ChP in each lateral ventricle and, finally, the diencephalic ChP 
of the third ventricle (Kappers, 1955; Dziegielewska et al., 2001; Currle et al., 
2005). The diencephalic ChP is the last to appear, but histological analyses of 
human brain tissues suggest it completes differentiation earlier than the other 
ChPs (Netsky and Shuangshoti, 1975). Although the telencephalic ChP and 
diencephalic ChP initially emerge as distinct entities, the diencephalic tissue 
bifurcates during development, sending a branch through the intraventricular 
foramina and ultimately fusing into one continuous tissue with the telencephalic 
ChP (Kappers, 1955; Netsky and Shuangshoti, 1975; Dziegielewska et al., 2001; 
Currle et al., 2005). The ChP is found in chordates above amphioxus (lancelet), 
and the order of ChP development seems to be conserved across species, 
despite enormous differences in gestational length (Dziegielewska et al., 2001). 
However, although the gross appearance of the hindbrain ChP is similar among 
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species, the appearance of the telencephalic ChP and diencephalic ChP varies 
considerably (Netsky and Shuangshoti, 1975). Much progress in the field stems 
from experiments performed in species as diverse as the spiny dogfish shark, 
sheep and marsupials, the latter of which confer the experimental benefit of 
having mostly postnatal development of the brain and thus the ChP (Liddelow et 
al., 2010). However, harnessing newer technologies, including mouse genetics 
and proteomics, has enabled tremendous progress in our understanding of the 
development and specification of the ChP. Therefore, most ages referred to in 
this review relate to mouse development.  
The structure of the ChP reflects its secretory role. It consists of a 
monolayer of cuboidal epithelial cells that surrounds a stromal core of capillaries 
and connective tissue. Adjacent ChP epithelial cells are joined together by tight 
junctions to form the blood–CSF barrier that prevents paracellular free passage 
of molecules from the systemic circulation into the CSF. Together with adherens 
junctions, the tight junctions also ensure the apico-basal polarity of membrane 
proteins (for example, transporters) that are critical for normal epithelial cell 
function (Damkier et al., 2013). The identification of junctional, enzymatic and 
transporter proteins in the embryonic ChP suggests that barrier functions are 
present in the developing brain (Liddelow et al., 2012; Kratzer et al., 2013). 
Experiments using injectable tracers suggest that these barrier functions are 
intact early in ChP development (Ek et al., 2003; Ek et al., 2006; Johansson et 
al., 2006). However, transcriptome studies have also revealed dynamic 
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expression of transporters, indicating that the blood–CSF barrier changes during 
the course of development and provides differential neuroprotection or regulation 
of CSF production in the embryonic versus the mature brain (Kratzer et al., 
2013).  
Depending on the location, the ChP receives its blood supply from either 
the anterior or posterior circulation. The anterior choroidal artery, which branches 
from the internal carotid or middle cerebral artery, supplies the telencephalic 
ChP. The posterior choroidal artery, which branches from the posterior cerebral 
artery, feeds the telencephalic as well as the diencephalic choroid plexi. Finally, 
the anterior and posterior inferior cerebellar arteries, which originate from the 
basilar and vertebral arteries, supply the hindbrain ChP (Damkier et al., 2013). 
Blood flow and CSF secretion are thought to be regulated in part by sympathetic 
and parasympathetic innervations (Lindvall and Owman, 1981; Vogh and 
Godman, 1985; Ellis et al., 2000; Damkier et al., 2013). Unlike the endothelium in 
the brain’s parenchyma, capillaries of the ChP are fenestrated. These endothelial 
fenestrae are connected by thin membranous diaphragms that are permeable to 
small molecules and water, thus enabling the rapid delivery of water via the blood 
to epithelial cells for CSF production. Solutes may cross from the blood into the 
stromal space by diffusion across endothelial fenestrae or by vesicular transport 
(Redzic and Segal, 2004). As with capillaries in other tissues, pericytes are found 
in the ChP and wrap around the endothelial cells. Finally, the ChP harbors 
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various immune cells (Box 1) and is considered a gateway for immune cell entry 
into the CNS (Ransohoff and Engelhardt, 2012).  
 
Lineage specification and progenitors  
Studies of the molecular mechanisms that guide ChP development have 
typically focused on either the hindbrain or the telencephalic region. The 
diencephalic ChP has frequently been omitted, perhaps due to its relatively 
smaller size and/or more challenging dissection. It consists of three parts, and 
historically, the nomenclature for these parts has varied considerably. We refer to 
the work of Netsky and Shuangshoti (Netsky and Shuangshoti, 1975) in calling 
these three parts as the velum transversum (the anterior portion of the third 
ventricle), and the dorsal and ventral diencephalic plexus. Recent gene 
expression studies in rodent and primate tissues show that the hindbrain ChP 
and telencephalic ChP are spatially heterogeneous, and that their positional 
identities reflect their developmental origins along the rostral-caudal axis of the 
developing nervous system (Lun et al., 2015b). Nevertheless, the limited number 
of ultrastructural studies that have been performed on the ChPs from all four 
ventricles suggest that they all undergo identical developmental stages and the 
mature ChP epithelia are morphologically indistinguishable (el-Gammal, 1981, 
1983; Ek et al., 2003).  
Evidence from murine and avian systems indicate that ChP cell fate 
decisions are made early in development. In the murine brain, ChP specification 
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occurs between E8.5 and E9.5 (Thomas and Dziadek, 1993), 2–3 days before 
overt differentiation is evident. Indeed, engraftment studies between chicken and 
quail show that ChP fate is determined up to 3 days before the anatomical 
appearance of the ChP (Wilting and Christ, 1989). Developmentally regulated 
proliferation in the hindbrain ChP is thought to be complete by the end of 
embryonic development (Hunter and Dymecki, 2007; Huang et al., 2009c); 
however, it is not known whether proliferation in the telencephalic ChP and 
diencephalic ChP follows a similar developmental time course. As mature ChP 
epithelial cells are post-mitotic, the rate of ongoing proliferation in the ChP 
diminishes dramatically in the adult brain (Liddelow et al., 2010). Nevertheless, 
there is evidence for proliferative cells in the adult ChP in rodents and in human 
patients following acute injury (Li et al., 2002; Barkho and Monuki, 2015) and in 
cancer (Safaee et al., 2013a, Box 2).  
ChP epithelium is derived from neuroepithelial cells, which are the 
multipotent stem cells of the nervous system, whereas the stromal component of 
the ChP is thought to be derived from head mesenchymal cells (Wilting and 
Christ, 1989). Specification of ChP epithelium from neuroepithelial cells seems to 
require the repression of neural cell fate. The antagonistic expression of Hes1, 
Hes3 and Hes5, which encode basic helix–loop–helix (bHLH) transcription 
factors, versus neurogenin-2 (Ngn2; also known as Neurog2), leads to the 
specification of ChP epithelium versus Cajal-Retzius cells, respectively (Imayoshi 
et al., 2008). The inactivation of Hes1, Hes3 and Hes5 leads to a failure in the 
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development of telencephalic ChP and hindbrain ChP, potentially through 
abrogation of bone morphogenetic protein (BMP) signaling (Hebert et al., 2002; 
Imayoshi et al., 2008). In the absence of Hes expression, upregulation of the 
proneural Ngn2 inhibits ChP specification, instead increasing the production of 
Cajal-Retzius cells from the dorsal midline of the telencephalon (Imayoshi et al., 
2008).  
Similar observations have been made for other transcription factors that 
function to maintain ChP epithelial cell fate. LIM-homeobox protein LMX1A is 
expressed in the hindbrain rhombic lip and telencephalic cortical hem and 
functions in the normal specification of the roof plate (Chizhikov et al., 2010). In 
Lmx1a-/- Dreher mice, the hindbrain roof plate does not form, leading to a failure 
of hindbrain ChP development (Millonig et al., 2000). In addition, LMX1A can 
also regulate later cell-fate decisions, preventing ChP-specified cells from 
acquiring the fates of neighboring cells (Chizhikov et al., 2010). LMX1A, in 
conjunction with BMP signaling, may repress LIM-homeodomain transcription 
factor 2 (Lhx2) expression in the dorsal midline, thus excluding Lhx2 from the 
cortical hem and telencephalic ChP. By contrast, LHX2 is expressed in the 
cerebral cortex in a graded manner, and loss of Lhx2 expression in this region 
converts the cortex into expanded cortical hem and ChP (Monuki et al., 2001).  
Other transcription factors have been implicated in the repression of ChP 
cell fate and regulation of ChP maintenance and survival. For example, 
overexpression of EMX2 in chicks suppresses telencephalic ChP development, 
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which is consistent with the normal absence of EMX2 from ChP progenitors (von 
Frowein et al., 2006). However, deletion of Otx2 at E9 in mice leads to failure of 
the development of all ChPs, but its deletion at E15 affects only development of 
the hindbrain ChP, suggesting that OTX2 has multiple, temporally regulated 
functions in the ChP (Johansson et al., 2013). Additional markers of the 
presumptive ChP region include tropomyosins, which are actin regulatory 
proteins that demarcate the sites of ChP formation at least 2 days before its 
appearance (Nicholson-Flynn et al., 1996). Tropomyosin-expressing 
neuroepithelial cells and microtubule-associated protein 2-expressing 
neuroepithelial cells, which are destined to become neurons, are mutually 
exclusive, suggesting that neuroepithelial cells with ChP cell fate are segregated 
by E15 in rats. Tropomyosin expression is concentrated in cells forming the 
segmental boundaries between prosomeres, rhombomeres and other 
neuroepithelial regions undergoing evagination, suggesting that tropomyosins 
may function to modulate cell shape and motility (Nicholson-Flynn et al., 1996).  
 
Hindbrain choroid plexus progenitors 
The hindbrain ChP is the first to develop: it emerges as bilateral crests 
from the roof of the hindbrain that connect at the midline by E14.5 in mice 
(Huang et al., 2009c). The primary progenitor domain for the hindbrain ChP is the 
rhombic lip, which is a germinal matrix that initially appears as a thin strip of cells 
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along the dorsal midline of the neural tube following neural tube closure and that 
flares out and expands as the neural tube bends.  
The rhombic lip can be subdivided into upper and lower structures 
(Awatramani et al., 2003; Landsberg et al., 2005; Hunter and Dymecki, 2007) 
(Figure 1.2). The upper rhombic lip contributes largely to cerebellar 
development, but the lower rhombic lip, which is located between the medulla 
and the developing ChP, generates a diverse set of cell types, including the 
epithelial cells of the hindbrain ChP. Rhombic lip progenitor cells display graded 
Wnt1 expression, and it is the cells expressing high levels of Wnt1 that give rise 
to the hindbrain roof plate epithelium (hRPe), a transient pseudostratified 
epithelium that covers the roof of the fourth ventricle (Awatramani et al., 2003; 
Hunter and Dymecki, 2007).  
Early studies suggested a model in which ChP development followed a 
linear progression of differentiation. Rhombic lip progenitors were thought to 
produce a non-mitotic population of hRPe cells, which then underwent a series of 
stereotyped morphological changes (stages I–IV; see below and Figure 1.3), 
without the addition of more cells, to ultimately transform into the mature 
hindbrain ChP epithelium (Kappers, 1955; Sturrock, 1979; Wilting and Christ, 
1989; Thomas and Dziadek, 1993; Dziegielewska et al., 2001). Although 
epithelial transformation is an important aspect of ChP development, recent 
studies  have  elucidated  molecularly  and temporally distinct fields of cells in the  
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Figure 1.2. Progenitor domains of the hindbrain and telencephalic choroid 
plexi. 
(A) Hindbrain choroid plexus (ChP) development begins at about embryonic day 
9.5 (E9.5) and peaks between ~E11 and E12. The left panel shows a sagittal 
view of mouse embryo at E11.5; the dashed line represents idealized field of 
view for the middle panel, which shows a dorsal view of the neural tube. The 
rhombic lip neuroepithelium surrounds three fields of hindbrain roof plate 
epithelium. Field 1 (yellow) contains cells that do not express transthyretin (Ttr) 
or potassium voltage-gated channel subfamily E member 2 (Kcne2), whereas 
field 2 (blue) contains caudally derived (from rhombomeres 2 to 8) Ttr- and 
Kcne2-positive cells and field 3 (green) contains rostrally derived (from 
rhombomere 1) Ttr- and Kcne2-positive cells (Hunter and Dymecki, 2007). The 
right panel depicts the dorsal view of a proliferating ChP, as it emerges from the 
lateral edges of the fourth ventricle and grows medially to complete its 
development by E14. Sonic hedgehog (SHH) that is secreted by hindbrain ChP 
epithelial cells (pink) signals to underlying pericytes (Nielsen and Dymecki, 2010)  
(green) to regulate vascular outgrowth (red) while also signalling to hindbrain 
ChP progenitors (black) adjacent to the lower rhombic lip to induce further 
progenitor proliferation (Huang et al., 2009c) (inset). (B) Development of 
telencephalic ChP follows that of the hindbrain ChP. The left panel shows a 
sagittal view of a mouse embryo at E12.5, in which the dashed line represents 
the idealized coronal section that is shown in the right panel. The right panel 
depicts a telencephalic ChP developing bilaterally at the invaginated dorsal 
midline of the neural tube. Telencephalic ChP formation requires signals from the 
dorsal midline, including bone morphogenetic proteins and WNTs originating 
from the cortical hem. Disruption of the dorsal midline is frequently associated 
with either ChP over proliferation or failure of the ChP to form. 
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Figure 1.3. Morphological stages of the developing choroid plexus 
epithelium. 
The choroid plexus (ChP) of each ventricle has the same morphology and is 
organized into a layer of cuboidal epithelium surrounding a core of vasculature 
and other stromal cells. The maturation of epithelial cells includes four 
stereotypical stages. The ChP epithelial cells first appear to be pseudostratified 
with centrally located nuclei in stage 1 and little to no villous elaboration. This is 
followed by a transition to a columnar epithelium with apically located nuclei in 
stage 2, and the tissue becomes convoluted into sparse primary villi. In stage 3, 
the epithelial cells flatten to become more cuboidal in shape, nuclei are centrally 
or apically located, and primary villi in the tissue become more abundant. Last, in 
stage 4, nuclei become more basally located, which is thought to be caused by 
the apical enrichment of transport machinery and microvilli, and villi are more 
complex with multiple fronds. Junctions and adhesion molecules are found 
between adjacent cells, allowing the mature ChP to function as the blood-
cerebrospinal fluid (CSF) barrier by restricting the passage of solutes from the 
systemic circulation into the CSF.  
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lower rhombic lip and hRPe that contribute to hindbrain ChP development 
(Awatramani et al., 2003; Hunter and Dymecki, 2007).  
Fate-mapping studies have revealed that the hRPe consists of three 
molecularly distinct fields of cells, which emerge at different developmental times 
and have unique organizational and proliferative programs (Hunter and Dymecki, 
2007). Field 1 cells populate the dorsal midline from E8 to E9.5. They express 
Wnt1 and are mitotic until about E10.5, but are not thought to contribute to ChP 
epithelium. By contrast, field 2 and field 3 cells form more laterally at E9.5, 
express Wnt1 and growth differentiation factor 7 (Gdf7), are post-mitotic, and 
contribute to hindbrain ChP epithelium. Field 2 cells derive from rhombomeres 2–
8, whereas field 3 cells derive from rhombomere 1. Field 2 cells express markers 
of mature ChP epithelial cells including transthyretin and the potassium voltage-
gated channel subfamily E member 2 (Kcne2) as early as E9.5, whereas the 
expression of these genes is delayed in field 3 cells until E12.5 (Hunter and 
Dymecki, 2007). The mechanisms that regulate the appearance of these 
patterned, segmented fields of cells are not known. The hRPe is transient in 
development and ceases to contribute to the hindbrain ChP by ~E12.5. 
Intriguingly, further genetic analyses have shown that, from E12.5 to E14.5, the 
lower rhombic lip can directly contribute to the hindbrain ChP, when the hRPe no 
longer exists (Hunter and Dymecki, 2007). As the temporal interval for hindbrain 
ChP production continues well past E14.5, these findings have spurred further 
investigation into the source of hindbrain ChP progenitor cells.  
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Taking advantage of mouse genetic approaches to selectively target sonic 
hedgehog protein (SHH) expression in hindbrain ChP epithelial cells using Wnt1-
Cre mice, recent studies have identified a third progenitor cell domain for the 
hindbrain ChP that is positioned between the anterior edge of the lower rhombic 
lip and the differentiated hindbrain ChP (Huang et al., 2009c). This persisting 
mitotic region, which consists of LMX1A- and GLI1-expressing ChP progenitor 
cells, produces ChP epithelial cells from E12.5 to the late stages of mouse 
embryonic development. These progenitor cells proliferate in response to SHH 
exposure, which is expressed by the hindbrain ChP epithelial cells. Thus, these 
findings suggest the existence of an autoregulatory loop in which mature ChP 
epithelial cells produce SHH, which stimulates the proliferation of adjacent ChP 
epithelial cells. As these progenitor cells become post-mitotic, they progressively 
integrate into the adjacent ChP epithelium (Huang et al., 2009c).  
Genetic fate-mapping studies not only have revealed that the roof plate 
isthe source of progenitors for the hindbrain ChP but also have demonstrated 
that there is molecular heterogeneity in the roof plate epithelium, which may 
persist in the mature ChP (Awatramani et al., 2003). Genetic lineage studies 
have verified that the hindbrain ChP receives contributions from rhombomeres 1 
to 8 (Awatramani et al., 2003; Landsberg et al., 2005; Chizhikov et al., 2006; 
Hunter and Dymecki, 2007). Furthermore, fate-mapping studies have illustrated 
that the embryonic roof plate, unlike the floor plate, develops in a segmental, 
lineage-restricted fashion from Wnt1-expressing neuroepithelial cells of discrete 
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rhombomeric coordinates (Awatramani et al., 2003). This genetic approach 
demonstrates that Wnt1-expressing cells from rhombomere 2 (Hoxa2 lineage) 
and rhombomeres 3 and 5 (Egr2 lineage) from distinct axial regions do not 
intermingle in the mature ChP. This segregation of lineages in the mature ChP 
may provide a basis for distinct functional domains within the mature hindbrain 
ChP with regards to CSF production and other functions. Consistent with this 
model, the regionalization of SHH-expressing cells that is observed in the 
developing hindbrain ChP may persist in adulthood (Awatramani et al., 2003), 
and even neighboring cells differ in their expression of γ-protocadherin, a cell 
adhesion molecule that is found on the apical surface of ChP epithelium and that 
might have a role in CSF production (Lobas et al., 2012). There have been 
suggestions that ChPs differ in their metabolic rates and adrenergic activity 
(Quay, 1966; Nathanson, 1980). However, the functional significance of a 
molecularly segregated ChP remains to be explored.  
Little is known regarding secreted signaling factors that regulate the 
proliferation of ChP progenitor zones. However, in addition to SHH mentioned 
above (Huang et al., 2009c), the Notch signaling pathway is able to stimulate 
hindbrain ChP epithelial proliferation (Hunter and Dymecki, 2007). Notch ligands 
are expressed by the developing mammalian ChP (Irvin et al., 2004). In the 
zebrafish mutant mibtfi91, disruption in Notch signaling leads to formation of a 
misplaced and diminutive hindbrain ChP (Garcia-Lecea et al., 2008). However, 
investigation of Notch signaling in zebrafish ChP development has also 
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suggested that knockdown of Notch signaling in notch1b, deltaA and deltaD 
mutants leads to expansion of the hindbrain ChP (Bill et al., 2008). These 
differential effects of Notch on ChP development may arise because Notch 
influences the entirety of the rhombic lip or directly affects ChP progenitors 
(Huang et al., 2009c). Intriguingly, the activated NOTCH3 receptor is also 
implicated as an oncoprotein in human ChP tumors (Dang et al., 2006; Pierfelice 
et al., 2011; Safaee et al., 2013a, Box 2).  
 
Telencephalic choroid plexus progenitors 
The telencephalic ChP emerges between the medial wall of each telencephalic 
vesicle (Figure 1.2). The telencephalic ChP develops simultaneously on both 
sides of the medial wall such that each lateral ventricle has its own ChP tissue. It 
undergoes a distal to proximal maturation process in which proliferative cells at 
the root of the plexus are progressively added to the growing tissue that extends 
into the ventricle (Knudsen, 1964; Tennyson and Pappas, 1964; Liddelow et al., 
2010). Bromodeoxyuridine (BrdU) injection studies performed in the marsupial 
Monodelphis domestica (gray short-tailed opossum) show that newly postmitotic 
epithelial cells gradually incorporate into the growing ChP tissue along the dorsal 
stalk of the plexus (Liddelow et al., 2010). In these studies, neither BrdU-positive 
progenitors nor newly postmitotic cells were observed in the ventral region of the 
ChP. In conjunction with proliferative activity, the neuroepithelium comprising the 
midline choroid plaque also undergoes cell death, such that this region thins 
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during the course of development in mice (Furuta et al., 1997; Currle et al., 
2005).  
The dorsal midline is a well-established patterning and signaling center, 
which provides a source of BMPs that is critical for telencephalic ChP formation. 
It is thought that high levels of BMPs are required to induce ChP formation 
(Furuta et al., 1997; Monuki et al., 2001; Watanabe et al., 2012) and that BMPs 
might control telencephalic ChP morphogenesis by regulating the balance 
between cell proliferation and cell death to produce an epithelial monolayer 
(Furuta et al., 1997). By in situ hybridization, co-expression of Bmp2, Bmp4, 
Bmp5, Bmp6, and Bmp7 correlates with sites of ChP differentiation and with 
expression of the gene encoding forkhead box protein J1, a transcription factor 
involved in ciliogenesis (Furuta et al., 1997; Cheng et al., 2006). Misexpression 
of the constitutively active BMP receptor type 1A (BMPR1A) leads to expansion 
of an epithelium that resembles the telencephalic ChP epithelium at the expense 
of cortical neuroepithelium (Panchision et al., 2001), whereas inactivation of 
BMPR1A leads to defective specification of telencephalic ChP epithelium (Hebert 
et al., 2002; Fernandes et al., 2007). A high level of BMP expression also 
represses LHX2, a suppressor of ChP epithelial and cortical hem fates (Monuki 
et al., 2001). The sufficiency of BMP signaling in ChP induction has been 
demonstrated by the differentiation of mouse and human embryonic stem cells 
into ChP epithelial cells using BMP4 (Watanabe et al., 2012).  
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The telencephalic ChP in humans has anterior and posterior domains 
(Bailey, 1915), and fate-mapping studies taking advantage of Gdf7-Cre mice 
suggest that the anterior–posterior substructure is likely to be conserved across 
species (Currle et al., 2005). The anterior telencephalic ChP can be identified by 
its descent from the Gdf7 lineage, whereas the larger posterior domain is devoid 
of Gdf7-lineage cells (Currle et al., 2005). The boundary between the anterior 
and posterior domains of the mouse telencephalic ChP is not morphologically 
discernible. However, another distinguishing feature between these two domains 
is that the anterior domain shows evidence for developmentally regulated 
apoptosis at E10.5 and E11.5, whereas the posterior domain lacks TUNEL-
positive cells (Currle et al., 2005). Early Gdf7-mediated ablations achieved by 
driving diphtheria toxin A (DTA) expression from the Gdf7 promoter (Gdf7-DTA 
mice) led to a failure of the entire telencephalic ChP to develop, suggesting that 
development of the anterior domain of the telencephalic ChP precedes and is 
necessary for the development of the posterior domain. In these experiments, 
BMP levels were also attenuated, supporting the model that the roof plate is 
required to induce high levels of BMP signaling, which in turn induces posterior 
telencephalic ChP formation (Currle et al., 2005).  
The cortical hem, a WNT-rich transient dorsal midline structure (Grove et 
al., 1998; Shimogori et al., 2004; Louvi et al., 2007), is located between the 
developing ChP and hippocampus, and is thus positioned to provide inductive 
signals to both neighboring areas (Figure 1.2). Defects in the cortical hem may 
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compromise proper development of the ChP or hippocampus. In the zinc finger 
Gli3 mouse mutant extra-toesJ (XtJ), downregulation of Wnt expression in the 
cortical hem is accompanied by the absence of the telencephalic ChP, but the 
development of the hindbrain ChP remains unaffected (Franz, 1994; Grove et al., 
1998; Theil et al., 1999). Disruption of Gli3 expression in the XtJ mutant probably 
contributes to the failure of the telencephalic ChP to develop, as GLI3 expressed 
in ChP mesenchyme may coordinate epithelial and mesenchymal interactions 
(Grove et al., 1998). Likewise, mice lacking Dmrta2 (doublesex and mab-3 
related transcription factor A2) have poorly developed cortical hem and 
telencephalic ChP structures, which probably result from DMRTA2 regulation of 
development through WNT–β-catenin signaling (Konno et al., 2012). By contrast, 
expansion of the cortical hem may lead to an enlarged telencephalic ChP, as 
loss of Lhx2 expression in the cortex is associated with an expansion of both the 
cortical hem and ChP (Porter et al., 1997; Monuki et al., 2001).  
 
ChP epithelial cell maturation 
Upon differentiation, ChP epithelial cells transition through a series of 
stereotyped developmental stages (Figure 1.3). Based on cellular morphology 
(Kappers, 1955; Dziegielewska et al., 2001), stage 1 is defined by a sheet of 
pseudostratified epithelial cells. In stage 2, these cells transition into a simple, 
high columnar epithelium, and in stage 3, they achieve a flattened (cuboidal) 
epithelial cell shape. In most species examined, stage 3 can be followed by stage 
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4, depending on whether the epithelial cells have a high glycogen (energy 
source) content and apical or centrally positioned nuclei (in which case they 
remain at stage 3), or a lower glycogen content and basally positioned nuclei (in 
which case they progress to stage 4) (Tennyson and Pappas, 1964; Shuangshoti 
and Netsky, 1966; Netsky and Shuangshoti, 1975). Transition through these 
distinct stages is accompanied by structural changes such as the polarization 
and formation of microvilli and cilia along the apical surface, as well as changes 
in cellular content, including an increase in the number of mitochondria and 
maturation of the endoplasmic reticulum (Dohrmann, 1970; Sturrock, 1979). 
Owing to their narrow width (~50 nm), microvilli are generally free of organelles. 
However, microvilli have been estimated to increase the surface area of E16 rat 
epithelial cells, leading to a total apical surface area of 75cm2 for the rat 
telencephalic ChP; similarly, in humans, the ChP surface area is increased to 
200cm2 (Keep and Jones, 1990). The increase in apical ChP surface area 
parallels its increased ability to produce CSF. Indeed, the machinery and 
enzymes required for CSF secretion are enriched in this brush border (Quinton et 
al., 1973), suggesting that if the microvilli were damaged or ablated, CSF 
production by ChP epithelial cells would substantially decrease. Eventually with 
advanced age, microvilli decrease in size as does the production of CSF 
(Sturrock, 1988; Serot et al., 2001; Zheng and Chodobski, 2005). The vast 
majority of ChP epithelial cells are multi-ciliated (9+2 microtubule configuration), 
with tufts of cilia ranging from 4–8 cilia per cell in rats to 50 cilia per cell in 
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salamander (Netsky and Shuangshoti, 1975). Motile cilia are thought to 
contribute to CSF flow, and structural defects induced by chemical or genetic 
means can contribute to hydrocephalus (Banizs et al., 2005; Banizs et al., 2007; 
Narita et al., 2010; Swiderski et al., 2012). However, epithelial cells extending 
one primary cilium (9+0 configuration) into the CSF can also be observed in the 
ChP. Although the functional significance of mono-ciliated epithelial cells remains 
to be elucidated, they have been proposed to play roles in osmosensation and/or 
chemosensation (Damkier et al., 2013).  
 
Epithelial–mesenchymal interactions  
Despite cell-intrinsic mechanisms that may underlie the specification of 
ChP epithelium, extrinsic signaling through cell–cell interactions between ChP 
epithelial cells and mesenchymal cells is also necessary for both epithelial and 
stromal development. When grafted to the body wall, tissues containing the ChP 
anlagen are capable of maturing into tissues histologically indistinguishable from 
true ChP (Wilting and Christ, 1989). The epithelium forms with appropriate apico-
basal polarity, microvilli architecture, and tight junctions between adjacent cells. 
The underlying stroma, which develops from the body wall of the host rather than 
from the grafted tissue, develops fenestrated capillaries, which are not typically 
found in the body wall (Wilting and Christ, 1989). However, the molecular 
mechanisms underlying the coordinated development of ChP epithelium and 
underlying vasculature are only beginning to be understood.  
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Vascularization of the choroid plexus 
During ChP development, actively proliferating epithelial sheets envelop 
the underlying mesenchyme and abundant vascular supply, which raises the 
question of how the co-development of these cell types of different embryological 
origin is coordinated. Live-imaging of zebrafish has shown that the ChP 
epithelium makes close contact with vascular cells very early in development 
(Garcia-Lecea et al., 2008). Signaling factors expressed at the roof plate-
neuroepithelium boundary may induce vascular differentiation in the ChP (Broom 
et al., 2012). However, factors from the ChP epithelium have also been shown to 
regulate vascular outgrowth (Figure 1.2). In particular, Shh, which encodes a 
protein known to induce angiogenesis in other tissue types, is expressed by 
hindbrain ChP epithelial cells, and patched 1 (Ptc1), which encodes its receptor, 
is highly enriched in the ChP mesenchyme (Nielsen and Dymecki, 2010). Ptc1-
expressing cells were identified to be chondroitin sulfate proteoglycan 4 (CSPG4; 
also known as NG2)-expressing pericytes, which are vascular support cells that 
are capable of responding to ChP-derived SHH and transducing this signal to 
regulate vascular outgrowth and surface area. However, other yet-to-be identified 
mechanisms control the vessel diameter and capillary fenestrations, as these 
parameters were normal following manipulations in SHH signaling. Indeed, the 
exact developmental time course of ChP vasculature is not well understood. 
Fenestrae have not been observed in E14.5 mice (Nielsen and Dymecki, 2010). 
In rats, in addition to increased epithelial apical surface density, low numbers of 
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fenestrae can be observed at E16, and they increase progressively in number 
per unit length of ChP vessel perimeter up to postnatal day 30 (Keep and Jones, 
1990). These observations suggest that there is crosstalk between the 
developing epithelium, stroma and vasculature. Indeed, SHH that is secreted by 
ChP epithelial cells seems to regulate ChP epithelial production via vascular 
outgrowth (Nielsen and Dymecki, 2010) as well as by directly signaling to ChP 
epithelial progenitors (Huang et al., 2009c).  
 
Functions of the ChP–CSF system 
The ChP has long been appreciated as the principal source of CSF 
(Dandy and Blackfan, 1913; Cushing, 1914; Dandy, 1919), and ChP epithelial 
cells acquire their secretory, transport and barrier functions shortly after 
differentiation (Ek et al., 2003; Johansson et al., 2005; Ek et al., 2006; Johansson 
et al., 2006; Liddelow et al., 2009; Ek et al., 2010; Liddelow et al., 2012). Ion 
transporters at the basal and apical surfaces of ChP epithelial cells transport ions 
into CSF, and water supplied by blood is transported apically through aquaporins 
down an osmotic gradient (Brown et al., 2004; Damkier et al., 2013). Transporter 
expression varies dynamically with age (Liddelow et al., 2012; Kratzer et al., 
2013). Evidence in rats suggests that CSF secretion and CSF fluid volume 
increase dramatically during the second postnatal week and reach mature adult 
levels before complete maturation of the brain (Bass and Lundborg, 1973). 
Transport across the epithelium extends beyond ions to many factors, including 
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proteins, nutrients and metabolic precursors (Liddelow et al., 2009; Liddelow et 
al., 2011). Myo-inositol represents one osmolyte and precursor for many 
signaling molecules, which is actively transported across the ChP epithelium by 
sodium/myo-inositol transporter 1, the activity of which is regulated by potassium 
channel subunits KCNE2 and KCNQ1 (Abbott et al., 2014). Important insight into 
how transport across the ChP epithelium influences brain function comes from 
Kcne2-deficient mice, which are susceptible to stress and seizures, and have low 
levels of myo-inositol in the CSF. Dose-dependent CSF-supplementation of 
myoinositol in Kcne2-deficient mice reverses their behavioral phenotypes (Abbott 
et al., 2014). The role of CSF myoinositol in psychiatric disease remains to be 
elucidated; however, these findings demonstrate that transport across the ChP 
epithelium can have far-reaching consequences on brain function.  
ChP epithelial cells also express and secrete their own proteins into the 
CSF. The total CSF protein content varies with age such that it peaks near birth 
in rodents (Dziegielewska et al., 1980; Lehtinen et al., 2011; Lun et al., 2015b). In 
other species with longer gestational periods, CSF protein content peaks in 
utero, suggesting that CSF protein changes are due to fundamental changes in 
the brain rather than birth (Ek et al., 2005). Transthyretin, a thyroid hormone 
carrier routinely used as a marker of ChP epithelium, is expressed by ChP 
epithelial cells shortly after their appearance and is present in embryonic CSF 
(Dziegielewska et al., 2001; Redzic et al., 2005; Hunter and Dymecki, 2007). 
Although some factors are directly secreted into the CSF, others are ferried via 
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interactions with binding proteins or encapsulated in exosomes. Extracellular 
vesicles originating from the ChP transport important proteins for brain 
development such as folate receptor-α (Grapp et al., 2013), as well as non-
coding RNAs, including microRNAs that regulate neural stem cells via 
modulation of the insulin-like growth factor (IGF) signaling pathway in an age-
dependent manner (Feliciano et al., 2014; Tietje et al., 2014). Ultimately, the CSF 
is a rich source of proteins, lipids, hormones, cholesterol, glucose, microRNAs 
and many other molecules and metabolites that affect a wide range of CNS 
functions (Dziegielewska et al., 2001; Parada et al., 2006; Zappaterra et al., 
2007; Lehtinen and Walsh, 2011; Feliciano et al., 2014). ChP functions are 
dynamic from development into adulthood, as protein secretion into CSF and 
ciliary motility continue to mature (Dziegielewska et al., 2001; Nonami et al., 
2013). 
In the developing cerebral cortex, cortical progenitor cells line the 
ventricular surface, extending a primary cilium directly into the CSF. The primary 
cilia, as well as their adjacent apical domains, harbor receptors poised to receive 
signals emanating from the CSF (Louvi and Grove, 2011). Indeed, pure 
embryonic CSF, without the addition of exogenous growth-promoting signals, 
promotes the development and growth of cortical progenitor cells in an age-
dependent manner (Lehtinen et al., 2011; Zappaterra et al., 2013). For instance, 
embryonic CSF stimulates young stem cells that are cultured as neurospheres or 
in tissue explants to divide vigorously. By contrast, the same stem cells bathed in 
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older CSF, including adult CSF, undergo limited cell division. These results are 
consistent with findings that many protein signals in the CSF fluctuate with age. 
Some of the proliferative effects of embryonic CSF can be attributed to ChP-
secreted IGF2 and signaling through the IGF1 receptor at the ventricular surface 
(Lehtinen et al., 2011; Higginbotham et al., 2013; Yeh et al., 2013; Feliciano et 
al., 2014). However, as mentioned above, the CSF is home to many signaling 
molecules with important roles in development (for example, fibroblast growth 
factors (Martin et al., 2006), SHH (Dziegielewska et al., 1980; Huang et al., 
2010), retinoic acid (Yamamoto et al., 1996; Chang et al., 2015), leukemia 
inhibitory factor (Gregg and Weiss, 2005; Hatta et al., 2006), semaphorin3B 
(Arbeille et al., 2015) and others (Lehtinen and Walsh, 2011). Thus, the 
construction of the mammalian brain depends upon the appropriate interactions 
of multiple signaling activities delivered to neural stem cells via the CSF.  
Intriguingly in vivo, lateral and fourth ventricle CSF shows distinct protein 
signatures (Cavanagh et al., 1983; Zappaterra et al., 2007; Lun et al., 2015b), 
which are suggestive of regionalized protein gradients across the ventricular 
system (Figure 1.4). Gene expression analyses performed in intact ChP as well 
as purified ChP epithelial cells from TTR::RFP mice (a random integration 
transgenic mouse line that expresses monomeric red fluorescent protein 1 from a 
transthyretin minigene) have revealed that the telencephalic and hindbrain ChP 
are spatially heterogeneous, with distinct gene expression domains that mark 
positional  identity  and  encode  regionalized secretomes (Lun et al., 2015b). For  
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Figure 1.4. Telencephalic and hindbrain choroid plexi are transcriptionally 
and functionally distinct tissues.  
Gene expression profiling of mouse and primate telencephalic choroid plexus 
(ChP) and hindbrain ChP reveal that, despite being morphologically similar, 
these tissues are transcriptionally heterogeneous (Lun et al., 2015b). The ChPs 
maintain distinct positional identities reminiscent of their axial tissues of origin. 
The telencephalic ChP has higher expression levels of Emx2, Otx1 and Six3, 
which are markers of the telencephalon, whereas the hindbrain ChP has higher 
expression levels of Hoxa2, En2 and Meis1, genes that are critical for patterning 
the hindbrain. Further analysis of the ChP secretome reveals that these tissues 
are functionally distinct in their expression and secretion of signalling factors into 
the cerebrospinal fluid (CSF) (Lun et al., 2015b). In particular, the telencephalic 
ChP secretes more cystatin C (CSTC), cathepsin B (CTSB) and cathepsin D 
(CTSD), whereas the hindbrain ChP secretes more sonic hedgehog (SHH), 
proenkephalin (PENK) and extracellular superoxide dismutase (EC-SOD). 
Protein expression domains have been observed within each ChP (for example, 
EC-SOD (Lun et al., 2015b) and SHH (Awatramani et al., 2003) protein 
domains), which is suggestive of protein gradients within each ventricle. These 
findings indicate that the molecular heterogeneity of the telencephalic versus the 
hindbrain ChP contributes to establishing a regionalized CSF and support a 
model of protein gradients throughout the ventricular system. IGF2, insulin-like 
growth factor 2.  
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example, the telencephalic ChP is enriched for markers of the posterior half of 
the telencephalon (Puelles and Rubenstein, 1993)  including Emx2, Otx1, and 
Six3, whereas the hindbrain ChP is enriched for Hox genes (for example, Hoxa 
and Hoxb), which is consistent with previous studies (Awatramani et al., 2003; 
Philippidou and Dasen, 2013), as well as En2 and Meis1 (Lun et al., 2015b). 
Proteomic analyses demonstrate that this differential gene expression 
functionally translates to the differential secretion of nearly 200 proteins by the 
telencephalic and hindbrain ChP (Lun et al., 2015b). For example, the 
telencephalic ChP secretes higher amounts of cystatin C and cathepsin D, 
whereas the hindbrain ChP secretes higher amounts of SHH, which is consistent 
with previous studies (Huang et al., 2009c), as well as proenkephalin and 
extracellular superoxide dismutase (EC-SOD). Regionalized ChP protein 
secretion occurs in an age-dependent manner, such that embryonic ChP shows 
robust regionalization of gene and protein expression, which decreases in 
adulthood, in a gene-specific manner (Lun et al., 2015b). Spatial domains with 
distinct protein expression profiles were also observed within each ChP (for 
example, there is much higher expression of EC-SOD ventrally than dorsally 
within the hindbrain ChP), suggesting the production of local protein gradients 
within a ventricle. The regionalized gene expression domains marking identity as 
well as its secretome (for example, SHH is both a selective marker for hindbrain 
ChP as well as a component of its secretome) are conserved in the mouse, 
macaque, and human brain (Lun et al., 2015b). Although hindbrain ChP-secreted 
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SHH has roles in instructing hindbrain ChP (Huang et al., 2009c; Nielsen and 
Dymecki, 2010) and cerebellar development (Huang et al., 2010), it remains to 
be determined whether the regional ChP-secretomes, in aggregate, also have 
broader roles in instructing regional brain development.  
The ChP–CSF system is also emerging as a key component in the 
regulation of adult neurogenesis in both the ventricular-subventricular zone (V-
SVZ) that is located adjacent to the lateral ventricles and the subgranular zone of 
the hippocampus. The landscape along the V-SVZ is organized into pinwheels, 
where the neural stem cells (B cells or astrocytes) form the core of the pinwheels 
and are surrounded by rosettes of multi-ciliated ependymal cells (Mirzadeh et al., 
2008). The neural stem cells span the length of the V-SVZ, with a primary cilium 
that extends into the CSF and a basal domain that contacts the vascular plexus 
(Doetsch et al., 1999; Fuentealba et al., 2012). As adult neurogenesis proceeds, 
neural stem cells give rise to immature precursors (type C cells or transit 
amplifying cells), which ultimately generate neuroblasts (type A cells). The 
architecture of this germinal niche, and the unique polarity of the B cells, are 
thought to function as key determinants of adult neurogenesis, allowing for 
instructive extrinsic cues to arrive from both apical as well as basal domains.  
Both embryonic and adult CSF can support adult neural stem cells that 
are cultured as neurospheres (Lehtinen et al., 2011), and these favorable effects 
of CSF are partly mediated by a combination of factors that are dynamically 
distributed in the CSF. The maintenance of adult V-SVZ architecture is crucial for 
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its continued production of neural stem cells (Mirzadeh et al., 2008). Recent 
studies have proposed one mechanism by which CSF-distributed factors may 
support the viability of this niche. ChP-secreted interleukin-1β binds to 
interleukin-1 receptors on the surface of type B neural stem cells, regulating the 
expression of vascular cell adhesion molecule 1 (VCAM1), a cell surface 
sialoglycoprotein and a member of the immunoglobulin superfamily (Kokovay et 
al., 2012). VCAM1 then promotes adhesion to the neural stem cell niche and 
maintains niche architecture by activating NADPH oxidase 2-mediated redox 
homeostasis. Inhibition of VCAM1 stimulates quiescent type B cells to swiftly 
proliferate and advance through the cell lineage to type A neuroblasts (Kokovay 
et al., 2012). An added layer of regulation to this model comes from endothelial 
sources of neurotrophin 3 (NT3), a neurotrophic factor with a prominent role in 
promoting survival. NT3 was suggested to be required for the quiescence and 
long-term maintenance of adult stem cells (Delgado et al., 2014). Originating 
from either the brain’s vasculature or the ChP capillaries, NT3 acts as a 
cytostatic factor by stimulating the phosphorylation of nitric oxide synthase and 
production of nitric oxide in B cells (Delgado et al., 2014). Upon B cell 
differentiation into neuroblasts, SLIT in the CSF can serve as a chemorepulsive 
cue that guides neuroblasts along the rostral migratory stream to the olfactory 
bulb (Sawamoto et al., 2006).  
The role of ChP–CSF signaling in adult hippocampal neurogenesis and 
cognitive function has also been explored in experiments that uncovered a type 1 
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interferon (IFN)-dependent gene expression profile in aged ChP (Baruch et al., 
2014). Heterochronic parabiosis, an approach in which young and old mice are 
surgically connected to share a blood supply (Conboy et al., 2005; Villeda et al., 
2011; Katsimpardi et al., 2014), was used to test whether the aged gene 
expression profile was due to signaling events triggered at the apical, ventricular 
side of the ChP (that is, events triggered by factors delivered by the CSF), or at 
the basal side of the ChP (that is, events triggered by factors delivered through 
the systemic circulation) (Baruch et al., 2014). The results suggest that signaling 
events occurring at the apical and basal aspects of the ChP may modulate ChP 
function. Although the aged circulation did not induce expression of type I IFN-
dependent genes in young ChP, it did stimulate the expression of type II IFN-
dependent genes including Ccl11, which encodes a chemokine associated with 
impaired plasticity. By contrast, CCL11 expression in old ChP was not mitigated 
by young circulation, suggesting that a complex array of brain as well as 
systemic signals regulate ChP gene expression. CSF from older animals induced 
a type I IFN-dependent gene response in cultured ChP cells. In mouse 
behavioral experiments, blocking type I IFN signaling in the aged brain improved 
cognitive function and hippocampal neurogenesis (Baruch et al., 2014).  
ChP–CSF based signaling has broad effects on the brain, extending 
beyond neurogenesis to the regulation of critical periods. For example, ChP 
epithelial cells synthesize and secrete the homeodomain transcription factor 
OTX2. OTX2 is likely to be distributed by the CSF throughout the brain and is 
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taken up by parvalbumin-positive GABAergic interneurons in the forebrain, where 
it is thought to regulate interneuron maturation, and consequently the timing for 
the critical period of plasticity for binocular vision (Sugiyama et al., 2008). 
Genetic disruption of OTX2 expression in the ChP impairs the function of these 
forebrain circuits, enabling the reopening of binocular plasticity in primary visual 
cortex such that vision is restored in amblyopic mice (Spatazza et al., 2013). In 
addition to the regulation of critical periods, CSF-based signaling is important in 
the early phase of sensory map formation. The reduction of CSF serotonin levels 
at birth, which can be accelerated by preterm birth, has an important role in 
initiating the formation of barrel fields and eye-specific segregation of the visual 
system (Toda et al., 2013).  
 
Summary and perspectives 
In summary, the ChP–CSF system actively coordinates the development 
and health of the CNS. Although progress has been made in understanding the 
specification and origins of the ChP tissues, many questions remain unresolved. 
First, ChP epithelial cells secrete hundreds of factors into the CSF, but the 
regulation of gene transcription and protein translation, and the degree to which 
conventional versus unconventional mechanisms of protein secretion (Nickel and 
Rabouille, 2009) are engaged by the ChP remain poorly understood. Second, the 
identification of conserved, spatial heterogeneity across ChP and the secretion of 
regionalized ChP proteomes (Lun et al., 2015b) suggest the presence of protein 
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gradients across the cerebroventricular system. As the CSF delivers important 
health- and growth-promoting signals for the developing nervous system, these 
findings raise questions regarding the utility and functional consequences of a 
regionalized CSF. Third, the model that systemic signals regulate ChP (Baruch et 
al., 2014), together with findings that CSF composition and mixing with the 
interstitial fluid maintain the health of the brain via convective flux more generally 
than previously believed (Iliff et al., 2012; Iliff et al., 2013; Xie et al., 2013b, Box 
3), raise tantalizing hypotheses for the myriad ways by which CNS health can be 
regulated. Collectively, pairing actively evolving technologies with available 
models, including recently developed fluorescent ChP zebrafish lines (Henson et 
al., 2014), should accelerate steps towards further elucidating the biology of the 
ChP–CSF system as well as advancing future therapies, including the 
transplantation of engineered ChP epithelial cells.  
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Box 1. Immune cells in the choroid plexus 
The ChP is home to various immune cells, including ChP macrophages, 
dendritic cells and Kolmer’s epiplexus cells, and also provides a port of entry for 
immune cells into the CNS. Macrophages and dendritic cells are located primarily 
in the ChP stroma, whereas Kolmer’s epiplexus cells reside along the apical, 
ventricular side of the ChP epithelium, where they probably function as local 
antigen-presenting cells to lymphocytes (Ransohoff and Engelhardt, 2012). ChP 
macrophages are thought to derive from the hematopoietic stem cell-derived 
myeloid cells that are produced at mouse embryonic day 10.5 (E10.5) in the 
aorta–gonad–mesonephros region or by E12.5 in the fetal liver (Prinz and Priller, 
2014). Although immune cell function in the developing ChP has not been 
extensively investigated to date, the ChP may serve as a port for microglia to 
enter first the cerebrospinal fluid (CSF) and then the brain at the ventricular 
surface. In the human fetal brain, ionized calcium-binding adaptor molecule 1 
(IBA1)-expressing microglia are found in close proximity to the developing ChP 
as early as 5.5 gestational weeks (Monier et al., 2006). Once in the developing 
brain, microglia regulate several important processes, including cortical 
progenitor cell numbers, neuronal plasticity and circuit function (Pont-Lezica et 
al., 2011; Tremblay et al., 2011; Cunningham et al., 2013). 
Although the mechanisms regulating immune cell passage across the 
developing ChP are not well understood, it is a task that probably involves the 
tight regulation of numerous intercellular signaling events, as has been shown for 
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adult tissues. For example, in the adult ChP, infiltrating immune cells first migrate 
from the blood across the fenestrated endothelium into the stromal space. They 
then move along the basolateral surface of the ChP epithelium, from where they 
gain passage across the epithelium into the CSF-filled ventricles (Ransohoff and 
Engelhardt, 2012). Indeed, recent studies show that the ChP expresses adhesion 
molecules and chemokines including intercellular adhesion molecule 1 and 
interferons, which facilitate the transepithelial passage of leukocytes into the CSF 
(Steffen et al., 1996; Kunis et al., 2013; Shechter et al., 2013a; Shechter et al., 
2013b; Schwartz and Baruch, 2014). Secreted signals distributed in the CSF (for 
example, interleukin-13, interleukin-10 and transforming growth factor-β) then 
serve as instructive cues to attract macrophages to sites of injury, such as the 
spinal cord (Shechter et al., 2013b). In the developing brain, the sources and 
signals that instruct immune cells to cross the ChP and enable them to identify 
target sites of action remain to be elucidated. 
Historically, the CNS has been considered immune privileged. The 
immune cell content of healthy CSF is estimated to consist of approximately 90% 
T cells, 5% B cells, 5% monocytes and <1% dendritic cells (Ransohoff and 
Engelhardt, 2012). We now know that immune cells in the CSF patrol the CNS, 
antigens in the CNS can trigger adaptive immune responses, and unbridled 
immune responses in the CNS can develop into chronic immunopathological 
conditions such as multiple sclerosis. An improved understanding of the 
mechanisms underlying immune-ChP interactions in the developing and mature 
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brain should enable the development of new therapies for a wide range of 
nervous system disorders. 
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Box 2. Pathologies of human choroid plexus 
 
Although not particularly well studied, human ChP pathologies are not 
uncommon. During development, ChP pathologies include cysts (see figure), 
hemorrhages, diffuse villous hyperplasia and tumors. ChP cysts are common the 
developing fetus (estimated 1-2% incidence) but generally resolve on their own. 
These cysts occur with increased frequency in trisomies, particularly trisomy 18 
(33–50% incidence), and in certain syndromes, such as Aicardi syndrome (see 
the figure). When a ChP cyst is seen in the absence of other trisomy-associated 
stigmata, the risk of trisomy for pregnant women under 35 years of age is 
extremely low (Demasio et al., 2002). ChP hemorrhages (see the figure) tend to 
occur in term rather than premature infants (>35 weeks gestation) (Greenfield et 
al., 2008). Although these can be seen in otherwise uncomplicated term 
deliveries (Tavani et al., 2003), ChP hemorrhages are often associated with 
perinatal stress or hypoxia-ischemia, in addition to factors such as trauma and 
anticoagulation therapy. Vascular malformations can also cause ChP 
hemorrhage (van Rybroek and Moore, 1990). In infants and children, 
microorganisms (for example, bacteria in neonatal meningitis) can use the ChP 
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for primary colonization and CNS entry via the CSF and ventricular system 
(Greenfield et al., 2008). 
Abnormal ChP proliferative lesions take the form of diffuse villous 
hyperplasia, benign papillomas and malignant carcinomas. Although ChP tumors 
represent less than 1% of brain tumors overall, they represent 2–4% of brain 
tumors in children and 10–20% of tumors in the first year of life. ChP carcinomas 
(see the figure) are seen mainly in the lateral ventricles of children (mostly 
between 2–4 years of age) (Naeini et al., 2009), whereas adult ChP tumors are 
most often papillomas of the fourth ventricle. ChP papillomas and carcinomas 
(Tong et al., 2015) have relatively complex cytogenetic abnormalities (multiple 
chromosome gains and losses) but display different cytogenetic patterns, 
suggesting distinct pathways in the pathogenesis of papillomas versus 
carcinomas. Diffuse villous hyperplasia and ChP tumors can lead to 
hydrocephalus because of CSF overproduction, which can be treated by 
cauterization or resection (Hirano et al., 1994; Fujimura et al., 2004; Smith et al., 
2007). Other tumors seen in the ChP include meningiomas, lipomas, 
xanthogranulomas and rare metastases. Although meningiomas (which arise 
from meningeal arachnoidal cells) occur commonly on the surface of the brain, 
they can also occur in the ChP, presumably arising from tela choroidea, where 
meningeal cells abut the ventricular lining. 
ChP pathology is increasingly implicated in cognitive and 
neurodegenerative disorders as well. Unlike blood, which has three major carrier-
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distributor proteins for thyroid hormone, the CNS has only one major thyroid 
hormone carrier-distributor: namely, ChP-derived transthyretin. Accordingly, CNS 
deficiencies in thyroid hormone – which are linked to abnormal brain 
development, adult dementia, depression, and other cognitive problems (Davis et 
al., 2003; Davis and Tremont, 2007) − can be due to systemic hypothyroidism or 
ChP transthyretin defects. The ChP is also central to at least three different 
mechanisms for clearing amyloid-β (Aβ) peptides, which are implicated in the 
pathophysiology of Alzheimer disease (AD): CSF-mediated Aβ clearance, direct 
Aβ absorption, and Aβ chaperone and protease production. AD is associated 
with accelerated atrophy of the ChP (Serot et al., 2001; Emerich et al., 2005; 
Fleming et al., 2009), which plausibly leads to decreased Aβ clearance via these 
three mechanisms. This possibility has led multiple groups to suggest a causal 
role for ChP atrophy in AD (Silverberg et al., 2003; Maurizi, 2010). Notably, 
accelerated ChP atrophy has also been described in stroke, multiple sclerosis, 
schizophrenia and other CNS diseases, raising the possibility that accelerated 
ChP atrophy exacerbates multiple CNS diseases (Serot et al., 2001; Emerich et 
al., 2005). Viral-mediated gene delivery to the ChP (Haskell et al., 2003; Haddad 
et al., 2013) and ChP epithelial cell generation from human embryonic stem cells 
(Watanabe et al., 2012) provide hope for ChP-targeted therapies and drug 
screens to combat ChP pathologies and to enable ChP-CSF-based delivery of 
therapeutic compounds throughout the CNS. 
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Box 3. Cerebrospinal fluid exchange and flux 
In addition to distributing secreted signals throughout the ventricular 
system, the cerebrospinal fluid (CSF) has an important role in clearing the brain 
of toxins and waste. Recent work using two-photon imaging in mice through a 
cranial window, which allows for imaging of the superficial cerebral cortex, led to 
a model in which a tripartite clearance mechanism contributes to clearing waste 
in the brain. Named the ‘glymphatic’ system, aquaporin 4 channels on astrocytic 
end feet first facilitate the para-arterial CSF influx into the brain’s parenchyma 
(Iliff et al., 2012). This convective flux of CSF and interstitial fluid (ISF), with the 
aid of arterial pulsatility (Iliff et al., 2013), then flushes parenchymal waste via an 
intercellular trans-astrocytic path into the paravenous space for eventual 
clearance into the systemic circulation. Radiolabel tracer studies estimate that 
40–80% of proteins and solutes in the extracellular space of superficial cortex 
may be removed in this manner, with the clearance of amyloid-β being one of the 
most intriguing noted to date. In these studies, the ISF space was estimated to 
increase by more than 60% during natural sleep or anaesthesia (Xie et al., 
2013b). These findings suggest new potential roles for sleep and CSF fluid 
mechanics in the maintenance of brain health. However, many questions remain 
to be addressed in future studies (Hladky and Barrand, 2014).  
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Part III. DNA damage and repair in development of the cerebral cortex 	
 
Complexity of the mature brain arises from an intricate program of 
proliferation and differentiation of neural progenitors. During early brain 
development, the neuroepithelial cells lining the neural tube are the multipotent 
stem cells of the nervous system that give rise to the subsequent neurons of the 
mature brain. These postmitotic neurons then remain in place for the duration of 
the organism’s life. Thus, the fidelity of DNA replication in progenitors and the 
maintenance and repair of DNA in postmitotic neurons are of utmost importance 
as deficiency in either of these processes lead to cell cycle arrest and/or 
apoptosis. If, however, a cell with DNA damage bypasses cell cycle checkpoints, 
the transmission of DNA mutation to daughter cells is replicated exponentially 
and leads to oncogenesis (McKinnon, 2009). Nevertheless, DNA breakage may 
occur as a physiological consequence of neuronal function (Madabhushi et al., 
2015), yet failure to repair DNA breaks can also have deleterious consequences 
on the brain (McKinnon, 2009). What, then, are the molecular and cellular 
mechanisms that prevent otherwise catastrophic events following genomic 
instability in the brain, including neurodevelopmental and degenerative diseases 
and cancer? 
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DNA damage during neural development 
 As neural stem cells undergo multiple cycles of proliferation, DNA 
replication error is the major contributor of DNA damage during development. 
DNA appears to be most vulnerable to damage during S phase of the cell cycle, 
when DNA is replicated (Aguilera and Gomez-Gonzalez, 2008). While early 
neuroprogenitors cycle rapidly, S phase of the cell cycle is extended, perhaps 
allowing for greater DNA damage surveillance (McKinnon, 2009). As neuronal 
differentiation begins, S phase in neuroprogenitors progressively shortens, 
reducing the time for DNA surveillance. Thus, progenitor cells may exhibit 
differential tolerance to DNA damage over the course of neurogenesis (Lee et al., 
2012). As proliferation gives way to neuronal maturation, increased metabolic 
demands lead to the accumulation of reactive oxygen species and other 
byproducts of metabolism, which can cause DNA breakage (McKinnon, 2009). 
Other environmental factors, including ultraviolet and ionizing radiation, also 
contribute to DNA damage. In the short term, DNA damage leads to cell cycle 
arrest or interference of transcription and DNA replication. However, long-term 
consequences include apoptosis, cellular senescence, and cancer (Hoeijmakers, 
2001).  
DNA breakage is also a physiological event. During production of B and T 
lymphocytes, the process of V(D)J recombination requires double-strand breaks 
(DSBs) in DNA to generate the wide diversity of B cell immunoglobulins and T 
cell receptors necessary for a functional immune system (Schatz and Ji, 2011). 
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In the brain, it was recently reported that neuronal activity triggers DSBs in 
promoter regions of early-response genes, including Fos, Npas4, and Egr1 
(Madabhushi et al., 2015). Early-response genes are defined by their 
characteristic robust increase in expression, on the timescale of minutes, 
following neuronal stimulation. Typically transcription factors, early-response 
genes trigger expression of late-response genes to regulate synaptogenesis, and 
ultimately, learning and memory (West and Greenberg, 2011). It was determined 
that DSBs in promoter regions of early-response genes were specifically 
generated by topoisomerase IIβ, likely freeing the promoter from topological 
constraints to enhance expression (Madabhushi et al., 2015). These findings 
provide interesting correlates to investigate in DNA repair disorders, including 
insufficient repair of DNA DSBs. 
 
DNA damage repair mechanisms and deficiencies 
Following DNA damage, several mechanisms are available to respond to 
and repair the damage. Highly conserved across species, four main mechanisms 
are employed by mammalian cells: nucleotide-excision repair, base-excision 
repair, homologous recombination, and non-homologous end joining (NHEJ). 
Interestingly, no one mechanism can repair every kind of DNA damage. Here, we 
focus on NHEJ, which functions to repair DSBs in proliferating and differentiated 
cells (McKinnon, 2009). In NHEJ, the first step of DSB repair requires signaling 
for cell cycle arrest, thus allowing for repair pathways to proceed. DSBs induce 
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phosphorylation of histone H2AX, which triggers the assembly of numerous 
proteins, including p53 binding protein 1 (53BP1), at the site of the breakage 
(Paull et al., 2000). The formation of the phosphorylated form of histone H2AX 
(called γH2AX) and 53BP1 foci in the nucleus correlates well with DSBs and is 
used as a marker of DSB generation (Gatz et al., 2011). DSBs activate the p53 
cell cycle checkpoint pathway, which triggers neuronal apoptosis if DSBs are 
unrepaired (Frank et al., 2000). Through the NHEJ pathway, Ku70/80 proteins 
are recruited to the DSB, along with recruitment of the catalytic subunit of the 
DNA-dependent protein kinase (DNA-PKC). DNA-PKC can autophosphorylate 
and also function as an endonuclease to cleave DNA 5’ and 3’ overhangs. As the 
last step, the LigaseIV/XRCC4 complex is recruited to ligate the DNA ends, a 
reaction which is catalyzed by the LigaseIV enzyme. 
 
 
LigaseIV syndrome: Molecular basis and clinical presentation 
 LigaseIV (LIG4) syndrome is a human disorder caused by hypomorphic 
mutations in the LIG4 gene, which encodes an essential component of the NHEJ 
DNA repair mechanism. Patients typically present with immunodeficiency, growth 
retardation, bird-like facial features, and microcephaly (Chistiakov et al., 2009). 
No patient with biallelic null mutations have been reported, and Lig4 knockout 
mice are embryonic lethal (Barnes et al., 1998; Frank et al., 1998; Frank et al., 
2000), suggesting that complete loss of Lig4 is incompatible with life. 
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LIG4 deficiency is an extremely rare, autosomal recessive disorder, with 
only sixteen cases having been reported in the literature (IJspeert et al., 2013). 
The first case report in the literature described a patient with extreme 
radiosensitivity who later developed acute lymphoblastic leukemia (Riballo et al., 
1999). A missense mutation (833G>A) in LIG4 was determined to be the 
underlying cause. This mutation causes an arginine to histidine substitution at 
amino acid 278 (R278H) within the LIG4 active site, thus reducing enzymatic 
activity (Riballo et al., 1999). LIG4 syndrome (OMIM 606593) was later defined, 
describing the clinical features as well as the cellular phenotype of four additional 
patients with LIG4 deficiency (O'Driscoll et al., 2001). In a review of all sixteen 
case reports, patients were characterized into five subcategories based on the 
spectrum of clinical features (IJspeert et al., 2013). The variable severity of the 
disorder seems to correlate with the level of residual LIG4 activity (Girard et al., 
2004; Rucci et al., 2010). Mutations near the active site reduce enzymatic activity 
rather than protein expression, while mutations in the XRCC4-binding domain 
seems to cause more deleterious effects, as this region is necessary for LIG4 
stability (Bryans et al., 1999; Chistiakov et al., 2009).  
While the clinical features of LIG4 syndrome largely resemble other DNA 
repair disorders, such as Nijmegen breakage syndrome and ataxia 
telangiectasia, the cellular phenotype of LIG4 deficiency is distinct. Cells from 
LIG4-deficient patients undergo cell cycle arrest following radiation exposure, 
indicating that these cells are regulated by normal cell cycle checkpoints 
 67 
(O'Driscoll et al., 2001). Since cell cycle checkpoints are intact, and cells undergo 
apoptosis, it is unclear whether there is an increased rate of malignancy in LIG4 
syndrome. 
Microcephaly in LIG4 deficiency is well established. The small brain 
phenotype is present at birth and non-progressive, suggesting that the pathology 
arises and is limited to the window of neural development. While several mouse 
models have been produced to recapitulate the human genetics of this disorder, 
the neurodevelopmental defects are still understudied. Widespread apoptosis 
has been observed in the CNS of several Lig4 null and deficient mouse models, 
as well as in mice deficient in other components of NHEJ pathway, suggesting 
that the cell death phenotype is likely a consequence of the inability to repair 
DSBs (Frank et al., 2000). Interestingly, the embryonic lethality and neuronal 
apoptosis observed in Lig4 knockout mice was rescued via p53 deficiency (Frank 
et al., 2000). However, the lymphocyte development and radiosensitivity are not 
rescued in the Lig4/p53 double mutant, suggesting that the neuronal apoptosis 
and impaired lymphogenesis arise from different mechanisms (Frank et al., 
2000).  
 Thus far, one study has been performed to investigate the mechanism of 
neural progenitor apoptosis in Lig4 deficiency using the Lig4Y288C mouse, which 
carries a homozygous, hypomorphic mutation (Nijnik et al., 2007; Gatz et al., 
2011). In line with previous reports in the Lig4 null mouse, E14.5 Lig4Y288C mice 
have increased apoptosis throughout the cortex (Barnes et al., 1998; Frank et al., 
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2000; Gatz et al., 2011). With the additional insult of ionizing radiation, it was 
observed that apoptotic cells were enriched in the intermediate zone/cortical 
plate in Lig4Y288C embryos, compared to enrichment of apoptosis at the 
ventricular zone of controls. Thus, it appears that while cells incur DNA damage 
at the VZ/SVZ, they progress through mitosis and migrate into the intermediate 
zone, where they undergo apoptosis in Lig4Y288C mice (Gatz et al.). 
 
Conclusions 
 LIG4 syndrome is rare disorder arising from mutations in the LIG4 gene, 
leading to defective DNA repair. The severity of clinical features is associated 
with the residual ligase activity. However, the syndrome is often linked to a small 
brain phenotype, or microcephaly, likely owing to apoptotic responses during 
development of the CNS. Investigation into the defective neurodevelopmental 
program in this syndrome will provide greater insight into genomic stability as an 
intrinsic mechanism in directing cortical development.   
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Chapter 2 
Materials and Methods 
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Animals 
Chapter 3 
Timed pregnant CD-1 dams were obtained from Charles River Laboratories. 
mT/mG/Foxj1Cre+/− mice were obtained through heterozygous breedings 
(Muzumdar et al., 2007; Zhang et al., 2007). Ttr::RFP mice were obtained 
through heterozygous breeding of C57BL/6J x CBA/J mice outbred onto CD-1 
mice (Kwon and Hadjantonakis, 2009). All animal experimentation was 
performed under protocols approved by the IACUCs of Boston Children’s 
Hospital (BCH) and UC Irvine. Tissues were collected from both male and female 
embryos. 
Chapter 4 
Lig4R278H mice were obtained through heterozygous breedings (Rucci et al., 
2010). For embryonic mice, the day of plug is embryonic day 0.5, and for 
postnatal mice, the day of birth is postnatal day 0. Wild-type, heterozygous, and 
knockin mice were collected from each litter. 
 
Fluorescence-activated cell sorting 
Ttr::RFP embryos were checked for genotype under a fluorescence microscope. 
Ttr::RFP-negative littermates were collected and processed in parallel to set the 
signal threshold for the RFP gate. tChP and hChP tissues were dissected and 
collected separately, and digested in type II collagenase (Life Technologies) in 
HBSS for 15–20 minutes with occasional tapping followed by TrypLE Express 
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(Life Technologies) for 15–20 minutes. Dissociated cells were filtered through a 
40µm mesh strainer. Fluorescence-activated cell sorting (FACS) was performed 
with dead-cell exclusion by the green LIVE/DEAD Fixable Stain Kit (Life 
Technologies). We excluded debris and dead cells by side-scatter area and 
forward-scatter area, and single-cell selection by forward-scatter height and 
forward-scatter area before analyzing for RFP expression. RFP-positive cells 
comprised ~30–50% and ~15–20% of all single cells in the tChP and hChP, 
respectively; post-sort purity was >92%. 
 
RNA sequencing and analysis 
Each sequenced sample comprised tissue or cells isolated from the tChP or 
hChP of E18.5 mouse embryos and pooled across a single litter. Total RNA was 
isolated from whole ChP or FACS-purified ChP epithelial cells by using the 
RNeasy Micro Kit (Qiagen) and converted to cDNA and preamplified using the 
Ovation RNAseq System V2 (NuGEN) following the manufacturer’s protocol. 
cDNA was converted to Illumina paired-end sequencing libraries following the 
standard protocol (TruSeq v2) and sequenced on a Illumina HiSeq 2000 
instrument to a depth of ~20–60 million pass-filter reads per library, after 
standard quality control filters. RNAseq data have been deposited in the NCBI 
Gene Expression Omnibus database (GEO; www.ncbi.nlm.nih.gov/geo) with the 
GEO series accession number GSE66312. The 50 base paired-end reads were 
mapped to the UCSC mm9 mouse reference genome and “known genes” 
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transcriptome using TopHat v2, and fragments per kilobase per million reads 
(FPKM) values were estimated using cufflinks v2 (Trapnell et al., 2012). We then 
used the HTSeq and DESeq software packages to perform library normalization, 
principal component analysis (PCA), and differential expression testing (Anders 
and Huber, 2010; Anders et al., 2013). Because the tChP and hChP samples 
came from the same biological replicates, differential expression was modeled as 
either a paired-sample single-factor design or a multifactor design contrasting 
both region (tChP vs hChP) and cell type (whole ChP vs purified epithelial cells). 
Hierarchical clustering and heatmap generation were performed in R on the 
library-normalized, variance-stabilized read counts from DESeq, using Pearson 
correlation and complete linkage. For heatmap display purposes, genes were 
scaled across conditions to have a mean of zero and 1 standard deviation. 
Genes selected for hierarchical clustering had a false discovery rate (FDR; 
Benjamini-Hochberg adjusted p value) <0.05. Gene Ontology term enrichment 
analysis was done with DAVID v6.7 (Huang et al., 2009a, b) comparing tChP- 
and hChP-enriched genes with a minimum twofold expression difference 
(FDR<0.05) to the full mouse transcriptome. The statistic reported for the 
annotation clusters, the enrichment score, is the geometric mean of the 
enrichment p values for the annotation terms in each cluster, in -log10 scale. 
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Macaque and human brain samples 
Tissue samples for molecular analyses were available through the following 
sources: (1) Rhesus macaque samples were collected from fresh brain 
specimens or brain slabs preserved in RNAlater from the Sestan Laboratory at 
Yale University, (2) human samples were obtained from frozen brain specimens 
from the Sestan Laboratory at Yale University, and (3) human samples were 
obtained under an IRB approved protocol at BCH. Samples were processed as 
follows: fresh macaque brains were chilled on ice for 15–30 minutes before 
sectioning. Brains were placed ventral side up onto a chilled aluminum plate (1 
cm thick) on ice. ChP samples were collected from both lateral and fourth 
ventricles. Samples were snap frozen in isopentane (JT Baker)/dry ice at -30 to   
-40°C and stored at -80°C. Fresh frozen human samples (from Yale University) 
were microscopically inspected, and ChP samples were dissected from lateral 
and fourth ventricles using a dental drill (AnyXing, 300D) and a Lindemann Bone 
Cutter H162A.11.016 or diamond disk saw (Dental Burs; r=11 mm) on a 1-cm-
thick aluminum plate over dry ice. Dissected tissue samples were stored at -80°C 
before further processing. Human tissue specimens from BCH were reviewed by 
a neuropathologist (H.G.W.L.), and nonidentifying information was recorded for 
each specimen. Tissue sections were stained with hematoxylin and eosin (H&E) 
according to standard methods. RNA was extracted using miRNeasy Micro kit 
(Qiagen), reverse transcribed (Promega), and subjected to qRT-PCR using 
Taqman probes purchased from Life Technologies (see Table 3.2). All tissues 
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were handled in accordance with ethical guidelines and regulations for the 
research use of human brain tissue set forth by the NIH 
(http://bioethics.od.nih.gov/humantissue.html). All fresh nonhuman primate 
samples were collected in accordance with a protocol approved by Yale 
University’s Committee on Animal Research and NIH guidelines. 
 
RNA extraction and reverse transcription 
Mouse choroid plexi were pooled from 2-3 embryos, collected into 500µL TRIzol 
reagent (Life Technologies), and stored at -80°C. To extract RNA, samples were 
homogenized by triturating 3 times with 1mL insulin syringes, followed by 
addition of 1/5 volume chloroform. Samples were vortexed, incubated on ice for 
15 minutes, and centrifuged at 4°C for 15 minutes. The top phase was 
transferred to a new tube, followed by addition of equal volume isopropanol and 
1µL glycogen (20 mg/mL), and incubated on ice for 15 minutes. After 
centrifugation at 4°C for 15 minutes, the supernatant was removed, and the pellet 
was washed with 70% ethanol. After drying, the pellet was resuspended in 17µL 
nuclease-free water (Life Technologies). Concentration was measured by 
Nanodrop spectrophotometer (Thermo Fisher) and normalized to 1µg RNA in 
15µL. DNA was removed using TURBO DNase (Ambion) following 
manufacturer’s protocol. Reverse transcription was performed in 40µL total 
reaction using ImProm-II Reverse Transcription System (Promega). 
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Quantitative PCR 
Expression of genes in mouse, macaque, and human tissues (except HOXA2) 
were measured by Taqman qPCR. Taqman Universal PCR Master Mix, gene 
expression probes, and internal control 18S control probe were purchased from 
Life Technologies. Taqman probe catalog numbers are provided in Table 3.2. 
10µL total volume reactions were run in duplicate on a StepOne Plus instrument 
(Applied Biosystems) with the program: 95°C for 20 seconds, followed by 95°C 
for 1 second and 60°C for 20 seconds for 40 cycles. Expression of HOXA2 in 
macaque and human tissues were measured by SYBR-green qPCR using the 
following forward (F) and reverse (R) primer probes: HOXA2 (F): 
GAAGAAGGCGGCCAAGAAAA; HOXA2 (R): GCTGTGTGTTGGTGTAAGCA; 
GAPDH (F): ACAACTTTGGTATCGTGGAAGG; GAPDH (R): GCCATCACGCC-
ACAGTTTC. Ten µL total volume reactions were run in duplicate with the 
program: 95°C for 2 minutes, followed by 95°C for 15 seconds and 60°C for 60 
seconds for 40 cycles. All qPCR studies were performed using at least three 
biological replicates, and statistical analyses were performed using two-tailed t 
tests. Results are reported as mean ± SEM. 
 
Microarrays 
Whole tChP and hChP were isolated from three biological replicates (pooled 
litters) and total RNA was isolated using the TRIzol reagent (Life Technologies), 
followed by DNA cleanup using the Turbo DNA-free Kit (Life Technologies). 
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Polyadenylated mRNA was purified and cDNA was generated and in vitro 
transcribed according to Illumina’s protocols. The amplified, biotin-labeled cRNA 
was hybridized to the Illumina MouseWG-6 v2.0 Expression BeadChip array. 
Microarray data were analyzed using the Partek Genomics Suite software and 
crossreferenced to the RNAseq data in Excel. 
 
Mass spectrometry 
Protein (30 µg) from either native CSF, collected as described previously 
(Zappaterra et al., 2013), or ChP-conditioned medium, was reduced in 0.1 M 
DTT and filtered twice with a 30 kDa spin filter (Millipore). Samples were 
alkylated, washed, and digested overnight with 2 µg trypsin (Promega) at 37°C. 
Digested proteins were eluted, acidified, desalted, and dried. Each sample was 
reconstituted and analyzed by a nanoLC system (Eksigent) equipped with LC-
chip system (cHiPLCnanoflex, Eksigent) coupled online to a Q-Exactive mass 
spectrometer (Thermo Scientific). Peptides were separated by a linear gradient 
with a gradient length of 180 minutes. Before submitting for database search, the 
Thermo “raw” files were converted into the Mascot generic format (MGF-files) 
using the ProteoWizard software tool. All tandem mass spectrometry (MS/MS) 
data were analyzed using Mascot (v2.3.01, Matrix Science). The Mascot 
searches were performed using a concatenated mouse protein sequence 
database (UNIPROT.MOUSE, downloaded June 2014). Protein sequence 
database was searched with tryptic cleavage specificity, a fragment ion mass 
 77 
tolerance of 20 mµ and a parent ion tolerance of 10 ppm. Scaffold (version 
Scaffold_4.2.1, Proteome Software) was used to validate MS/MS-based peptide 
and protein identifications, resulting in an overall peptide and protein FDR of 1%. 
The subsequent output gave protein IDs with spectral counts corresponding to 
unique peptides identified for the protein per sample. Proteins were accepted as 
present if identified in any of the biological replicates. 
 
Choroid plexus-conditioned medium 
tChP and hChP were dissected, cultured in neurobasal medium (Life 
Technologies) supplemented with penicillin-streptomycin and glutamine, 10 µl 
medium per ventricle of ChP for 24 hours in 96-well plates. Media was then 
centrifuged at 10,000xg at 4°C for 10 minutes, and stored at -80°C. 
 
Antibodies 
The following antibodies were purchased: Aquaporin-1 (Millipore AB2219, 1:500; 
Santa Cruz Biotechnology sc-32737, 1:100), Cystatin C (Millipore ABC20, 1:500), 
ECSOD (Millipore 07-704, IHC 1:100, WB 1:500), EMX2 (Santa Cruz 
Biotechnology sc-28221, 1:100), GFP (Abcam ab13970, 1:500), HOXA2 (Sigma-
Aldrich HPA029774, 1:100), MEIS1 (Abcam ab19867, 1:1500), OTX1 (Abcam 
ab25985, 1:100), PECAM1 (BD Pharmingen 550274, 1:200), Proenkephalin 
(Thermo Scientific PA5-25783, IHC 1:100, WB 1:500), Transthyretin (Dako A002, 
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IHC 1:100, WB 1:500), HRP-conjugated Transferrin (Immunology Consultants 
Laboratory RX-25P-1, 1:500). 
 
Immunostaining 
Paraffin sections (5 µm) of brains were dehydrated, and antigen retrieval was 
performed using Antigen Unmasking Solution (Vector Laboratories). Sections 
were blocked and permeabilized (0.04% Tween-20 in PBS, 5% serum), followed 
by primary antibody incubation overnight at 4°C. Cryosections (14 µm) of brains 
were blocked, permeabilized, and incubated with antibodies (0.4% Triton-X in 
PBS, 5% serum). After washing, slides were incubated with fluorescent 
secondary antibodies (Alexa Fluor, Life Technologies) and counterstained with 
Hoechst 33258. 
 
Western blot and quantification 
Protein concentration from choroid plexus conditioned media samples were 
quantified using Pierce BCA Protein Assay Kit (Thermo Fisher). Equal total 
protein was loaded per lane on 10% polyacrylamide gels and transferred onto 
nitrocellulose membranes (Biorad). Membranes were blocked for 1 hour at room 
temperature (5% dry milk in TBST), and incubated with primary antibody 
overnight at 4°C (antibodies diluted in 3% bovine serum albumin in TBST). 
Membranes were washed 3x with TBST, and incubated with HRP-conjugated 
secondary antibody for 1 hour at room temperature (antibody diluted in 1% 
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bovine serum albumin in TBST). After washing, membranes were incubated with 
Clarity Western ECL Substrate (Biorad), and signal was captured on Bio-Rad 
chemidoc. For signal intensity quantification, images were converted to 8 bit files. 
Intensities were quantified using ImageJ, and relative intensities were calculated 
based on the loading control from the same blot. Statistical analysis was 
performed on the relative intensities using two-tailed t test. Results are reported 
as mean ± SEM. 
 
ELISA 
Shh concentrations in ChP-conditioned medium were measured using the Mouse 
Shh N-Terminus Quantikine ELISA kit (R&D Systems) per the manufacturer’s 
instructions. tChP- and hChP-conditioned media were measured by BCA protein 
assay kit (Pierce), and samples with equal total protein were assayed by ELISA. 
 
Biochemical assay 
Relative SOD activity was measured in diluted rat CSF samples (1:10) using the 
Superoxide Dismutase Assay Kit (Cayman Chemical) according to the 
manufacturer’s instructions. 
 
E14.5 BrdU pulse and staining 
Timed-pregnant females at E13.5 were injected intraperitoneally with BrdU 
(50mg/kg) and sacrificed 24 hours later. Embryos were fixed in 4% 
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paraformaldehyde for 2 hours at room temperature followed by sucrose gradient 
and embedding in O.C.T. Brains were sectioned at 5µm thickness. For cell 
proliferation assay, slides were steamed for 15 minutes with 100mM sodium 
citrate with 0.05% Tween-20. Sections were then stained by standard protocol 
using anti-Ki67 (BD Pharmingen 550609, 1:50) and anti-BrdU (AbD BU1/75 
ICR1, 1:200). To analyze for cell death, sections were stained with anti-cleaved 
caspase 3 (Cell Signaling 9661, 1:100) and anti-Tuj1 (Covance MMS-435P, 
1:200). Nuclei were counterstained with Hoechst. Cell counts were quantified 
from 4 consecutive sections from both hemispheres and statistical analysis was 
performed comparing averaged counts from each brain. 
 
P8 Cux1 and Ctip2 staining 
Pups were cryoanesthetized for 10 minutes on ice and intracardially perfused 
with 15mL of 4% paraformaldehyde at 0.8 mL/min. Brains were dissected and 
post-fixed in 4% paraformaldehyde for 30 minutes, followed by sucrose gradient, 
and embedding in O.C.T. Brains were sectioned at 14µm thickness. Antigen 
retrieval was performed prior to staining (HistoVT One), and stained by standard 
protocol using anti-Cux1 (Santa Cruz sc-13024, 1:200) and anti-Ctip2 (Abcam 
ab18465, 1:200). Nuclei were counterstained with Hoechst. Cux1+ and Ctip2+ 
cells were quantified in 200µm-wide dorso-lateral regions of the cortex in 3 
consecutive sections using ImageJ. Statistical analysis was performed by 
comparing the averaged counts from the 3 sections of each sample.  
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Chapter 3 
Results Part I 
Spatially Heterogeneous Choroid Plexus Transcriptomes Encode 
Positional Identity and Contribute to Regional CSF Production 
 
 
 
This work is published in: Melody P. Lun, Matthew B. Johnson, Kevin G. 
Broadbelt, Momoko Watanabe, Young-jin Kang, Kevin F. Chau, Mark W. 
Springel, Alexandra Malesz, André M.M. Sousa, Mihovil Pletikos, Tais Adelita, 
Monica L. Calicchio, Yong Zhang, Michael J. Holtzman, Hart G.W. Lidov, Nenad 
Sestan, Hanno Steen, Edwin S. Monuki, and Maria K. Lehtinen (2015). Spatially 
heterogeneous choroid plexus transcriptomes encode positional identity and 
contribute to regional CSF production. Journal of Neuroscience 35(12):4903-16.  
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Summary 
A sheet of choroid plexus epithelial cells extends into each cerebral 
ventricle and secretes signaling factors into the CSF. To evaluate whether 
differences in the CSF proteome across ventricles arise, in part, from regional 
differences in choroid plexus gene expression, we defined the transcriptome of 
lateral ventricle (telencephalic) versus fourth ventricle (hindbrain) choroid plexus. 
We find that positional identities of mouse, macaque, and human choroid plexi 
derive from gene expression domains that parallel their axial tissues of origin. We 
then show that molecular heterogeneity between telencephalic and hindbrain 
choroid plexi contributes to region-specific, age-dependent protein secretion in 
vitro. Transcriptome analysis of FACS-purified choroid plexus epithelial cells also 
predicts their cell-type-specific secretome. Spatial domains with distinct protein 
expression profiles were observed within each choroid plexus. We propose that 
regional differences between choroid plexi contribute to dynamic signaling 
gradients across the mammalian cerebroventricular system.  
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Introduction 
The choroid plexus-CSF (ChP-CSF) system is essential for the 
development and maintenance of the vertebrate brain (Johanson et al., 2008; 
Lowery and Sive, 2009; Lehtinen and Walsh, 2011; Lehtinen et al., 2013). ChP-
distributed factors actively regulate proliferation and survival of neural stem cells 
(Huang et al., 2009c; Lehtinen et al., 2011). However, little is known about the 
regulation of the CSF proteome and whether regionalization across choroid plexi 
contributes to differential protein secretion. 
The choroid plexi, located in each brain ventricle, consist of epithelial cells 
enveloping a stromal, fenestrated capillary network (Sturrock, 1979; Wilting and 
Christ, 1989). ChP epithelial cells secrete CSF, and tight junctions between cells 
form the blood-CSF barrier, preventing diffusion of systemic signals into CSF 
(Damkier et al., 2013). The choroid plexi differentiate from the roof plate (Currle 
et al., 2005; Emerich et al., 2005) and can be identified by early papillarity by 
mouse embryonic day (E)11–E12 (Sturrock, 1979). The hindbrain 
(myelencephalic) ChP (hChP) of the fourth ventricle forms first, followed by the 
bilateral development of the telencephalic ChP (tChP) of the lateral ventricles, 
and finally, the diencephalic ChP of the third ventricle (Kappers, 1955; 
Dziegielewska et al., 2001; Currle et al., 2005). Cell lineages originating from the 
hindbrain roof plate contribute to the hChP (Awatramani et al., 2003; Currle et al., 
2005; Hunter and Dymecki, 2007). However, it is not known whether derivation of 
tChP versus hChP from separate lineages defines their positional identity, 
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leading to ChP tissues that are functionally distinct in their protein secretion or 
receptivity. The possibility that each ChP produces a regionalized CSF would 
enable a powerful means to deliver region-specific signals to distinct populations 
of neural stem cells.  
Although CSF flow directed from the lateral toward the fourth ventricle 
allows mixing of CSF, previous studies have suggested that CSF composition is 
regionalized between ventricles (Cavanagh et al., 1983; Zappaterra et al., 2007). 
Recent gene expression studies provide insight into the general ChP secretome, 
but these studies have relied on intact, in toto tChP and have not investigated 
tissue regionalization (Marques et al., 2011; Liddelow et al., 2012; Liddelow et 
al., 2013). Although epithelial cells represent the predominant cell type in the 
ChP (Keep and Jones, 1990), the ChP is vascularized, and vascular cells 
represent important sources of secreted signals in the nervous system (Palmer et 
al., 2000; Tavazoie et al., 2008; Kokovay et al., 2010; Delgado et al., 2014). 
Parsing the various ChP cell types, the regionalized secretomes of tChP versus 
hChP, and ultimately their contribution to the CSF proteome, would impart 
greater insight to the availability of extrinsic signals during brain development.  
We demonstrate that the positional identities of the telencephalic and 
hindbrain choroid plexi derive from anterior-posterior gene expression domains 
that parallel their axial tissues of origin in the rodent and primate brain. We define 
the embryonic ChP secretome by assaying FACS-purified ChP epithelial cells 
alongside in toto ChP, and uncover molecular heterogeneity between choroid 
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plexi that contributes to regional ChP protein secretion in an age-dependent 
manner, coupling the choroid plexi to the production of signal gradients across 
the ventricular system. 
 
 
Results 
Transcriptome analysis of whole-choroid plexi and purified choroid plexus 
epithelial cells 
Because ChP-secreted signals may be a source of regionalized CSF in 
the lateral and fourth ventricles (Figures 3.1A,B), we performed next-generation 
RNA sequencing (RNAseq) analyses of telencephalic and hindbrain choroid plexi 
to identify transcriptional signatures that define positional heterogeneity between 
these tissues. First, RNAseq of whole tChP and hChP was performed at E18.5 in 
mice (Figure 3.1C), when proliferation of the choroid plexi nears completion 
(Hunter and Dymecki, 2007), peak CSF protein concentration is observed 
(Lehtinen et al., 2011), and the ventricular system nears maturation, with distinct 
ventricular compartments and flow (Johanson et al., 2008). Second, because 
whole ChP consists of epithelial, vascular, and mesenchymal cells (Figure 3.1A), 
transcriptome profiling of the bulk ChP is likely to miss smaller but significant cell-
type-specific expression characteristics. Therefore, we performed parallel 
RNAseq of purified ChP epithelial cells (CPEC), the cells responsible for CSF 
secretion, isolated from Transthyretin::RFP (Ttr::RFP) transgenic mice (Kwon 
and Hadjantonakis, 2009) by FACS (Figure 3.1D). Of note, Ttr::RFP  
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Figure 3.1. Next-generation mRNA sequencing reveals regional 
heterogeneity between telencephalic and hindbrain choroid plexi.  
(A) Left, H&E staining of sagittal E12.5 mouse brain. Right, H&E staining of 
sagittal E18.5 mouse brain and hChP (inset). Patency of lateral ventricle (LV), 
third ventricle (3V), and fourth ventricle (4V) changes dramatically with 
development, and the Aqueduct of Sylvius (Aq) constricts prior to birth. Blue 
arrows indicate tChP and hChP. Scale bar, 2 mm. High-magnification of hChP in 
E18.5 (inset) shows ChP structure with epithelial cells enveloping a core of 
vascular and mesenchymal cells. (B) Silver stain of LV and 4V CSF, E18.5 
mouse. Although some proteins are present at similar levels in the CSF of both 
ventricles (black arrowhead), others are more enriched in the CSF of the LV (red 
arrowhead) or of the 4V (blue arrowhead), suggesting regional differences in 
CSF protein composition between ventricles despite potential mixing between 
compartments due to CSF flow. (C) Whole tChP and hChP were dissected from 
wild-type and Ttr::RFP transgenic mice at E18.5. Scale bar, 2 mm. (D) ChP from 
Ttr::RFP mice were dissociated and FACS-sorted to purify the CPECs. Left, 
Sagittal view of tChP and hChP (inset) from E18.5 Ttr::RFP transgenic mouse. 
Sections were immunostained with anti-AQP1 (green) and Hoechst (blue), and 
imaged along with native RFP (red). Right, Representative FACS plot showing 
the purification of RFP+ CPEC. (E, F) RNA was isolated from either whole ChP or 
purified CPEC from two biological replicates of each (embryonic litters) and 
processed for RNA sequencing. (E) Euclidean distance matrix and clustering 
dendrogram indicating the correlation across all eight samples. (F) PCA of gene 
expression estimates, with circles representing tChP and triangles representing 
hChP, and ellipses indicating the 99% confidence interval for the SE of the 
centroid for each region. Both PCA and clustering indicate that a large proportion 
of variance (42%) is attributed to tissue type (whole ChP vs purified CPEC), 
whereas a smaller but highly significant proportion of variance (22%) is due to 
regional gene expression differences between tChP and hChP, with both effects 
strongly outweighing the variability between biological replicates. 
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(Figure 3.1 continued)   
 88 
expression is mosaic across ChP epithelial cells (Figure 3.1D). However, this 
mosaic expression, which becomes increasingly sparse with age, appears 
spatially random within the ChP epithelium and does not correlate with actual 
Transthyretin (TTR) expression as tested by immunohistochemistry or in situ 
hybridization (data not shown). Combining these datasets, we filtered and 
aligned 50 bp paired-end reads to the reference mouse genome and 
transcriptome (UCSC mm9), estimated gene expression levels, and performed 
sample-to-sample correlation analysis (Figure 3.1E), as well as PCA (Figure 
3.1F) on the normalized read counts of ~20,000 detected genes. PCA confirmed 
that the majority of variance between samples corresponded to the two variables 
of interest, cell type and ChP regional identity (Figure 3.1F), suggesting that 
significant transcriptome-wide expression patterns distinguish both the 
constituent cell types of the whole ChP, as well as the positional identity of tChP 
versus hChP. In addition, both PCA and sample-to-sample correlation analysis 
(Figure 3.1E,F) showed that these effects were greater than the individual 
variability across two biological replicates. We therefore proceeded to perform 
differential expression analysis using a paired sample, two-factor model 
contrasting both region (tChP vs hChP) and tissue type (whole ChP vs purified 
epithelial cells), identifying a total of 1699 differentially expressed genes at a 
threshold of twofold expression difference and a 5% FDR, including 684 genes  
displaying regional heterogeneity between tChP and hChP (Figure 3.2A; Table 
3.1) and 526 genes enriched in purified epithelial cells that we hypothesized  
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Figure 3.2. Transcriptional heterogeneity reveals regional choroid plexus 
identity.  
(A) Hierarchical clustering of all ~2500 genes showing significant regional 
differential expression between hChP (1426 genes) and tChP (1102 genes) at 
FDR<0.05. Among these, 684 genes showed at least a two-fold regional 
enrichment. Red and blue indicate relatively higher and lower expression, with 
genes independently scaled to a mean of zero and 1 standard deviation for 
display purposes. Vertical bars at the right of the heatmap highlight clusters of 
epithelial cell-specific or -enhanced regional expression differences. (B) Top, 
Section from E18.5 mouse immunostained with anti-PECAM1 (red), anti-AQP1 
(green), and Hoechst (blue). PECAM1 expression was enriched in the vascular 
component of the ChP. Bottom, Section from E16.5 mT/mG/FoxJ1Cre+/- reporter 
mouse, which show recombination (GFP-positive staining cells) in nearly all ChP 
epithelial cells, were immunostained with anti-GFP (green) and Hoechst (blue). 
FOXJ1 expression was enriched in purified ChP epithelial cells. (C) Linear 
regression of log2 fold-change in expression values for tChP- and hChP-enriched 
genes by RNAseq, compared with gene expression microarray (orange) or qRT-
PCR (green) reveals positive correlations in fold-change values between the 
three technologies, providing high confidence in our RNA-seq sample size, data 
quality, and analysis. (D, E) Gene ontology analysis of tChP- and hChP-enriched 
genes compared with the reference mouse transcriptome reveals significant 
overrepresentation of genes encoding putative secreted factors. The top five 
functional clusters for each ChP are plotted (FDR<0.05).  
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Table 3.1. Differentially expressed genes characterize the positional 
identities of tChP and hChP. 
The top 50 genes with the greatest expression differences between tChP and 
hChP, defined by fold-change of expression, are listed along with their functional 
category. Fold-change was calculated from DESeq normalized read counts. In 
total, there are 149 genes upregulated in tChP and 322 genes upregulated in 
hChP (fold-change ≥ 2, FDR < 0.05).  
aDifferential expression of genes validated by qRT-PCR (Table 3.2). 
bTranscript was undetected in one region. 	
25 most enriched genes in telencephalic choroid plexus 
Gene Category Fold-change FDR 
Dmrt1 Transcription factor Infiniteb 0.03102 
Dmrt3 Transcription factor 209.31 0.00000 
Emx2 Transcription factor 119.65 0.00000 
Dmrta2 Transcription factor 101.97 0.00000 
Alx3 Transcription factor 71.29 0.00021 
Six3a Transcription factor 56.86 0.00000 
Six3os1 Non-coding RNA 24.20 0.00000 
Rspo2 Secreted 21.88 0.00000 
Vit Extracellular matrix 21.43 0.00000 
Chodl Membrane component 20.52 0.00000 
Emx2os Non-coding RNA 16.99 0.00000 
Nrn1 Cell surface? 16.30 0.00000 
Fezf1a Transcription factor 15.58 0.00170 
Gm19277 Predicted gene 13.75 0.00020 
Wnt8ba Secreted 12.98 0.00040 
Kcnip1 Ion transport 12.19 0.00000 
Gm11413 Predicted gene 11.82 0.00074 
Vstm2l Secreted 11.23 0.00105 
4930412O13Rik Predicted gene 10.48 0.00032 
Otx1a Transcription factor 10.44 0.00000 
Nmur2 Receptor 9.84 0.00000 
Fgf17 Secreted 9.72 0.03804 
Fezf2a Transcription factor 9.12 0.01878 
Mc3ra Receptor 8.26 0.00000 
Klhl14 Membrane component 8.11 0.00006 
25 most enriched genes in hindbrain choroid plexus 
Gene Category Fold-change FDR 
Hoxa3 Transcription factor Infiniteb 0.00000 
Hoxb2 Transcription factor Infiniteb 0.00001 
Hoxb3 Transcription factor Infiniteb 0.00000 
Gdf7a Secreted 213.59 0.00000 
Irx2 Transcription factor 213.21 0.00000 
Lmx1b Transcription factor 173.13 0.00000 
Hoxa2a Transcription factor 136.73 0.00000 
Msx3 Transcription factor 91.55 0.01816 
Gm20554 Predicted gene 80.09 0.00634 
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Tacr3 Receptor 68.80 0.00000 
Meis1 a Transcription factor 67.70 0.00000 
Penk a Secreted 65.40 0.00000 
C130021I20Rik Non-coding RNA 65.26 0.00000 
Hoxa1 Transcription factor 60.79 0.00071 
Shha Secreted 58.32 0.00000 
Lrrtm4 Plasma membrane 46.18 0.02512 
Gbp11 Extracellular vesicular exosome 43.50 0.00002 
Cnpy1 Regulator of FGF signaling 36.45 0.00028 
Wnt6 Secreted 27.53 0.00173 
Gfra1 Receptor 26.30 0.00000 
Thsd4 Extracellular matrix 22.39 0.00022 
Fibin Secreted 21.87 0.01517 
En2a Transcription factor 19.43 0.00000 
Tmem90b Plasma membrane 19.04 0.02612 
Adamts16 Extracellular matrix 17.53 0.00000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Table 3.1 continued)  
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encode a significant fraction of the ChP secretome. Furthermore, 256 gene 
expression differences between tChP and hChP were only detected in the 
purified epithelial cells, demonstrating the importance of celltype-specific 
transcriptional profiling (Figure 3.2B). Altogether, these data strongly support our 
hypothesis that regional gene expression differences in the ChP contribute to 
differential protein secretion into the CSF. 
 
Transcriptional heterogeneity between choroid plexi 
To validate differentially expressed genes, we first compared the results to 
an independent expression microarray experiment performed on three additional 
biological replicates of whole tChP versus hChP (Figure 3.2C). Due to the 
greater sensitivity and dynamic range of RNAseq, fewer genes were detected 
and identified as differentially expressed by microarray. However, among 477 
candidates detected by both approaches, the direction of change was 
concordant, with a high correlation of fold-change values across platforms 
(R2=0.55). Differential gene expression was further verified by targeted qRT-PCR 
of 35 candidate genes in functional categories of interest, including transcription 
factors, cell surface receptors, and secreted factors (Figures 3.2C, 3.3A, 3.6A; 
Table 3.2), with all genes displaying expression trends consistent with RNAseq 
results (R2=0.86). Finally, we also verified candidates by inspection of in situ 
hybridization data from publically available resources, including GenePaint and 
Allen Brain Atlas to visually confirm gene expression in ChP epithelium (data not 
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Figure 3.3. Transcriptional heterogeneity elucidates distinct positional 
identities for choroid plexi. 
(A) Left, Cufflinks-estimated RNAseq FPKM counts from ChP (n=4) for 
differentially expressed transcription factors represented as mean fold-change 
(tChP/hChP) ± SEM (Emx2, 142.67± 23.23, t test, p = 0.0009; Six3, 48.61 ± 4.75, 
t test, p < 0.0001; Otx1,17.067 ± 2.10, t test, p = 0.0003; En2, -29.69 ± 3.56, t 
test, p < 0.0001; Meis1, -67.99 ± 7.18, t test, p = 0.0002; HoxA2, -177.50 ± 
13.47, t test, p < 0.0001). Right, qRT-PCR validation of differentially expressed 
transcription factors in whole dissected tChP and hChP from E18.5 mouse 
represented as mean fold-change (tChP/hChP) ± SEM (Emx2, 205.40 ± 85.98, t 
test, p < 0.0001; Otx1, 14.36 ± 0.621, t test, p = 0.0061; Six3, 1.993 ± 0.113, t 
test, p = 0.0085; Meis1, -33.85±9.57, t test, p = 0.0016; En2, -167.34 ± 19.42, t 
test, p = 0.0011; HoxA2, -1065.464 ± 302.98, t test, p = 0.0308). (B) 
Immunostaining of E16.5 ChP with anti-EMX2 (red, top) and anti-OTX1 (red, 
bottom) antibodies reveals higher EMX2 and OTX1 expression in tChP than 
hChP. Also shown: anti-AQP1 (green) staining for apical surface of choroid 
plexus epithelium and Hoechst (blue). EMX2 staining of the vasculature marked 
by an arrowhead, weak EMX2 signal detected in hChP, indicated with asterisks.  
(C) Immunostaining of E16.5 ChP with anti-HOXA2 (red, top) and anti-MEIS1 
(red, bottom; whole mount ChP) antibodies reveals higher HOXA2 and MEIS1 
expression in hChP than tChP. Also shown: anti-AQP1 (green) and Hoechst 
(blue). Scalebar, 20 µm. 
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(Figure 3.3 continued)  
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Table 3.2. qRT-PCR measurement of genes detected by RNAseq to be 
differentially expressed between tChP and hChP. 
DAVID was used to functionally annotate differentially expressed genes, and 
candidates from three categories (transcription factors, secreted factors, and cell-
surface receptors) were chosen for validation. Fold expression (Fold exp.) values 
are represented as mean ± SEM with tChP = 1.000. Statistical analysis was 
performed suing two-tailed t test. 
atChP/hChP fold-change graphed in Figure 3.3. 
bqRT-PCR values graphed in Figure 3.6. 
 
Gene Taqman probe tChP fold exp. hChP fold exp. p value 
Upregulated in telencephalic ChP 
Bmp2 Mm01340178_m1 1.000 0.647 ± 0.054 0.056 
Bmp15 Mm00437797_m1 1.000 0.383 ± 0.100 0.015 
Cdh26 Mm01212671_m1 1.000 0.401 ± 0.088 0.012 
Cntn4 Mm00476065_m1 1.000 0.084 ± 0.011 0.037 
Emx2a Mm00550241_m1 1.000 0.014 ± 0.0084 < 0.001 
Fbln5 Mm00488601_m1 1.000 0.719 ± 0.222 0.306 
Fezf1 Mm01164970_g1 1.000 0.043 ± 0.010 0.058 
Fezf2 Mm01320618_g1 1.000 0.024 ± 0.013 0.046 
Lepr Mm00440181_m1 1.000 0.473 ± 0.088 0.012 
Mc3r Mm00434876_s1 1.000 0.237 ± 0.051 0.021 
Otx1a Mm01616047_m1 1.000 0.075 ± 0.016 0.003 
Rdh10 Mm01227200_m1 1.000 0.543 ± 0.035 < 0.001 
Six3a Mm01237639_m1 1.000 0.534 ± 0.117 0.043 
Slit3 Mm01326974_m1 1.000 0.345 ± 0.118 0.032 
Trf Mm00446715_m1 1.000 0.879 ± 0.023 0.025 
Wnt8b Mm00442108_g1 1.000 0.005 ± 0.001 0.003 
Upregulated in hindbrain ChP 
Abca4 Mm00492035_m1 1.000 3.052 ± 0.759 0.044 
En2a Mm00438710_m1 1.000 167.44 ± 19.86 0.001 
Gata6 Mm00802636_m1 1.000 1.862 ± 0.249 0.017 
Gdf7 Mm00807130_m1 1.000 306.962 ± 12.906 < 0.001 
HoxA2a Mm00439361_m1 1.000 1058.461 ± 179.043 0.004 
Igf2 Mm00439565_g1 1.000 1.318 ± 0.057 0.004 
Igsf5 Mm00511211_m1  1.000 3.242 ±0.859 0.027 
Meis1a Mm00487664_m1 1.000 30.208 ± 6.161 < 0.001 
Mstn Mm01254559_m1 1.000 7.481 ± 2.005 0.018 
Osmr Mm01307326_m1 1.000 2.882 ± 0.712 0.046 
Penkb Mm01212875_m1 1.000 78.753 ± 9.654 < 0.001 
Shhb Mm00436528_m1 1.000 198.548 ± 50.537 0.008 
Slc4a10 Mm00473806_m1 1.000 3.001 ± 0.637 0.022 
Sod3b Mm00448831_s1 1.000 5.203 ± 1.459 0.035 
Wisp1 Mm01200484_m1 1.000 4.200 ± 0.695 0.015 
Wnt5a Mm00437347_m1 1.000 5.558 ± 0.187 < 0.001 
Similarly expressed in telencephalic and hindbrain ChP 
Cst3 Mm00438347_m1 1.000 1.021 ± 0.041 0.792 
Igfbp2 Mm00492632_m1 1.000 1.014 ± 0.246 0.866 
Ttrb Mm00443267_m1 1.000 0.902 ± 0.042 0.074 
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shown). We next performed gene ontology annotation clustering of the most 
regionally differentially expressed genes to determine the functions of the most 
highly enriched subset of genes in either the tChP or hChP (Figure 3.2D,E). 
Secreted factors were the top enriched annotations for both tChP- and hChP-
enriched genes (enrichment scores: tChP, 8.12; hChP, 13.31), supporting our 
hypothesis that regional heterogeneity of gene expression within the ChP may 
significantly contribute to differential protein secretion into the CSF. Although 
there are fewer enriched genes in tChP compared with hChP (149 genes vs 322 
genes), a greater proportion of the tChP-enriched genes fall in the secreted 
functional category (30 genes of 149 vs 57 genes of 322). 
 
Conserved positional identities between telencephalic and hindbrain 
choroid plexi 
Our differential gene expression findings reveal that tChP and hChP are 
transcriptionally heterogeneous tissues. We further hypothesized that these 
differences, at least in part, arise from the choroid plexi retaining memories of 
their developmental origins from distinct positions along the rostral-caudal axis of 
the CNS. Consistent with this hypothesis, we found that the tChP is enriched for 
markers of the posterior half of the telencephalon [e.g., prosomeres (p)3/4] 
including Emx2, Otx1, and Six3 (Puelles and Rubenstein, 1993), which we 
verified by qRT-PCR (Figure 3.3A; Table 3.2). We further confirmed the 
regionalized protein expression pattern of EMX2 and OTX1 by immunostaining 
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(Figure 3.3B). EMX2 was found in subsets of tChP epithelial cells, consistent 
with the previous observation that Emx2 mutant mice lack the tChP (Mallamaci et 
al., 2000). OTX1 was observed more uniformly in nearly all tChP epithelial cells 
examined (Figure 3.3B).  
The vertebrate Hox genes play a critical role in patterning the primary and 
secondary axes of the developing embryo (Philippidou and Dasen, 2013) and the 
hChP exhibits a Hox gene cluster signature including En2, HoxA, and HoxB 
genes (Table 3.1). We confirmed the differential expression of these genes, as 
well as Meis1, by qRT-PCR (Figure 3.3A; Table 3.2). By immunostaining, 
HOXA2 and MEIS1 were found to be more highly expressed in hChP than tChP 
(Figure 3.3C). Both transcription factors localized to subsets of hChP epithelial 
cells. Together, these data reflect that at the transcriptome level, distinct lineages 
of cells originate from specific rhombomeres and arrive at the hChP, as 
previously suggested by genetic lineage tracing studies (Awatramani et al., 2003; 
Hunter and Dymecki, 2007).  
We next tested whether the regional identity of tChP and hChP we 
observed in mouse is conserved in macaque and human brain. Normal macaque 
choroid plexi from animals spanning E60 to 13 years old (Figure 3.4A) were 
analyzed for markers of ChP positional identity by qRT-PCR (Figure 3.4B). 
EMX2, OTX1, and SIX3 expression were enriched in tChP compared with hChP 
[mean fold-change (tChP/hChP) ± SEM; EMX2, 69.310 ± 15.467, p = 0.019;  
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Figure 3.4. Positional identities of telencephalic and hindbrain choroid plexi 
are conserved in macaque and human brain. 
(A) H&E staining of 13-year-old macaque tChP and hChP. Scale bar, 50 µm. (B) 
qRT-PCR validation of transcription factor expression in six samples of macaque 
tChP and three samples of hChP, including two paired sets of tChP and hChP 
from the same animal, confirms that positional identity is evolutionarily 
conserved. Gene expression in macaque tChP and hChP is represented as 
mean fold-change (tChP/hChP) ± SEM. EMX2, OTX1, and SIX3 expression were 
enriched in tChP compared with hChP: EMX2, 69.310 ± 15.467, p = 0.019; 
OTX1, 509.212 ± 54.897, p = 0.0004; SIX3, 179.401 ± 83.648; not detected in 1 
of 3 hChPs tested; p = 0.287), whereas MEIS1, EN2, and HOXA2 expression 
were enriched in hChP compared with tChP: MEIS1, -64.673 ± 9.168, p < 
0.0001; EN2, -666.360 ± 586.365, p < 0.0001; HOXA2, -269.846 ± 269.145, p = 
0.171. (C) H&E staining of 36-year-old human tChP and hChP. Scale bar, 50 µm. 
(D) qRT-PCR validation of transcription factor expression in human tChP and 
hChP confirms that positional identity is conserved among primates. Gene 
expression in human tChP and hChP (n = 5, paired samples) is represented as 
mean fold-change (tChP/hChP) ± SEM: EMX2, 5.540 ± 2.953, p = 0.0007; OTX1, 
308.947 ± 294.251, p < 0.0001; SIX3, 312.103 ± 242.809, p < 0.0001; MEIS1,  
-9.070 ± 5.420, p = 0.174; EN2, -150.898 ± 95.988, p = 0.157; HOXA2, -113.994 
± 100.118, p = 0.292. 
  
 100 
 
 
 
 
 
 
(Figure 3.4 continued)  
 101 
OTX1, 509.212 ± 54.897, p = 0.0004; SIX3, 179.401 ± 83.648 (not detected in 1 
of 3 hChPs tested), p=0.287], whereas MEIS1, EN2, and HOXA2 expression 
were enriched in hChP compared with tChP [mean fold-change (tChP/hChP) ± 
SEM; MEIS1, -64.673 ± 9.168, p < 0.0001; EN2,  -666.360 ± 586.365, p < 
0.0001; HOXA2, -269.846 ± 269.145, p = 0.171; Figure 3.4B]. Similarly, paired 
samples of normal human choroid plexi from five individuals 11 days, 5, 13, 36, 
and 44 years of age (Figure 3.4C), were analyzed by qRT-PCR for expression of 
positional identity genes (Figure 3.4D). Conserved among primate ChP, 
expression of EMX2, OTX1, and SIX3 were enriched in the human tChP [mean 
fold-change (tChP/hChP) ± SEM; EMX2, 5.540 ± 2.953, p = 0.0007; OTX1, 
308.947 ± 294.251, p < 0.0001; SIX3, 312.103 ± 242.809, p < 0.0001; Figure 
3.4D]; whereas expression of MEIS1, EN2, and HOXA2 were enriched in the 
human hChP [mean fold-change (tChP/hChP) ± SEM; MEIS1, -9.070 ± 5.420, p 
= 0.174; EN2, -150.898 ± 95.988, p = 0.157; HOXA2, -113.994 ± 100.118, p = 
0.292; Figure 3.4D]. All macaque and human tissue samples were confirmed to 
have similar TTR expression across choroid plexi (data not shown). Of note, the 
directionality of differential gene expression is conserved between the mouse 
and primate choroid plexi, yet the relative enrichment is variable between 
species, which may arise from differences in the starting material (use of the 
entire mouse ChP vs smaller portions of macaque and human ChP). Together, 
these findings suggest that at the transcriptional level, anterior-posterior 
positional identity of choroid plexi is evolutionarily conserved, and furthermore, 
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that at least a subset of gene expression differences that define positional 
identity of tChP versus hChP persist from early development through adulthood. 
 
Defining the ChP epithelial cell secretome 
Transcriptome analysis of FACS-purified epithelial cells allowed us to 
characterize the purified ChP epithelial cell secretome. The robust enrichment of 
vascular genes in whole ChP (e.g., Pecam1, Tie1, and Cd34) and of genes 
associated with multiciliated epithelial cells in the purified ChP epithelial cell 
samples (e.g., FoxJ1, Ift88, and Lrp2) support successful purification of epithelial 
cells from vasculature and mesenchyme (Figure 3.2B). We performed functional 
categorization analysis of 18,133 genes detected in the purified ChP epithelium 
with ≥0.5 normalized read counts and defined the ChP epithelial cell secretome 
as the compilation of 1064 genes annotated to encode for secreted proteins 
(Table 3.3). The ChP transcriptome is significantly enriched for secreted factors, 
which is the top enriched functional category, followed by extracellular matrix 
components. Together, these genes contribute to 5.9% of the ChP transcriptome 
(modified Fisher exact p value, p<0.05). Ttr and Igf2 are the two most abundantly 
expressed genes in the ChP epithelial cell secretome (Table 3.3), and these 
genes are not differentially expressed between tChP and hChP at this age.  
As the choroid plexi are considered the principal source of CSF, we 
determined the concordance between CSF proteins and ChP-derived factors by 
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Table 3.3 Defining the choroid plexus epithelial cell secretome. 
Functional annotation by DAVID of the overall ChP transcriptome revealed 1064 
genes that characterize the ChP epithelial cell-specific secretome. The 25 most 
abundantly expressed genes annotated to be secreted factors are listed, along 
with their mean normalized read counts from DESeq and FDR values. 
 
Gene Mean reads Mean tChP reads Mean hChP reads FDR 
Ttr 3847081.62 4455127.718 3239035.526 0.342 
Igf2 92897.44 76313.778 109481.117 0.360 
Enpp2 67405.69 47432.967 87378.416 0.054 
Sparc 50425.49 56872.126 43978.845 0.671 
Sostdc1 29752.30 27843.994 31660.612 1.000 
Igfbp2 29345.47 34796.683 23894.247 0.105 
Clu 24653.31 30431.046 18875.581 0.350 
1500015O10Rik 19142.38 19654.511 18630.256 1.000 
Fbn1 18107.83 21813.362 14402.295 0.180 
Sfrp1 17118.72 17508.331 16729.101 1.000 
Timp3 16347.37 18360.712 14334.026 0.725 
Hspg2 15489.86 18985.833 11993.877 0.049 
Lbp 13679.64 15298.781 12060.490 1.000 
Apoe 12875.60 14457.881 11293.319 0.649 
Wfikkn2 12229.14 17282.475 7175.813 0.000 
Gpc3 12095.70 14495.916 9695.491 0.149 
Psap 10913.19 12579.000 9247.388 0.308 
Ogn 10458.96 12224.946 8692.978 0.355 
Adamts1 10404.69 10770.837 10038.544 1.000 
Aebp1 10048.43 10539.088 9557.781 1.000 
Ace 10020.11 11343.519 8696.706 0.462 
Nid2 9347.06 10812.944 7881.169 0.400 
Col8a1 9244.87 6800.335 11689.414 0.038 
Bgn 8970.90 7596.718 10345.083 0.536 
Cst3 8481.43 9460.944 7501.910 0.803 
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comparing MS analyses of native CSF and the predicted secretomes of tChP 
and hChP. Pooled CSF samples from lateral and fourth ventricles were collected 
(Zappaterra et al., 2013) from E18.5 mice. We accepted proteins with a false 
discovery rate of 1%. In total, 598 unique proteins were identified (Figure 3.5A; 
data not shown). Five hundred sixty-five proteins had corresponding genes 
detected in the ChP transcriptome, and 140 of these proteins were included in 
our predicted ChP secretome. Furthermore, using this approach, we detected 
proteins encoded by 6 of the top 10 most abundant genes in the ChP secretome 
(in order of transcriptomics defined secretome abundance: TTR, IGF2, ENPP2, 
SPARC, IGFBP2, CLU; Table 3.3; data not shown). Of all proteins identified, 
only 33 proteins did not have corresponding transcripts detected by RNAseq in 
the ChP. Our data suggest that the most abundant proteins identified by MS in 
the embryonic CSF proteome could originate from the ChP. However, in vivo 
native CSF also receives contributions from the vasculature, ependymal cells, 
tissues adjacent to the ventricles, as well as the interstitial fluid (Johanson et al., 
2008; Damkier et al., 2013). Our data represent an improvement in CSF protein 
detection by MS over previous analyses (Parada et al., 2006; Zappaterra et al., 
2007; Lehtinen et al., 2011). Moreover, our MS analyses captured 53% of the 
proteins defined by gene ontology as the ChP secretome (Table 3.3). Of the 
proteins detected by MS, only 19 of the total 598 proteins were identified by 
RNAseq to be differentially expressed between tChP and hChP (Table 3.1), 
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suggesting that detection of additional region-specific proteins in the native CSF 
proteome will require an improved analytical depth.	
 
Molecular heterogeneity contributes to regional choroid plexus protein 
secretion 
Differential gene expression analyses coupled with gene ontology 
annotation suggest that hChP expresses a greater number of genes encoding 
secreted proteins than tChP, which may contribute to the production of 
regionalized CSF proteomes in the fourth versus lateral ventricle. Because 
obtaining sufficient quantities of pure, ventricle-specific native mouse CSF for MS 
analyses is not technically feasible, we isolated secreted CSF/ChP-conditioned 
medium from cultures of whole tChP and hChP (Figure 3.5B) and performed 
quantitative MS on these samples. Differential protein expression analyses 
showed that conditioned medium from the tChP and hChP clustered in a tissue-
specific manner (Figure 3.5). Of the 1388 total proteins detected, 94 were 
identified only in the tChP-conditioned medium, 93 were identified only in hChP-
conditioned medium, and 1201 proteins were found in both (Figure 3.5D).  
We performed a Volcano plot analysis of the quantitative proteomics data, 
i.e., log2-transformed tChP/hChP fold-change versus -log10-transformed p 
values (Figure 3.5E). The vertical blue lines indicate a cutoff fold-change of 2 
and 0.5, respectively, whereas the horizontal red lines indicate a p value cutoff of 
0.05  or  3.6x10-5,  corresponding  to  significance  after  applying  the  extremely  
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Figure 3.5. Mass spectrometry reveals distinct proteomes between 
telencephalic and hindbrain choroid plexus-conditioned media. 
(A) Schematic representing mass spectrometry analysis of E18.5 mouse native 
CSF compared with E18.5 mouse ChP transcriptome. A total of 598 proteins 
were identified in E18.5 mouse CSF, and 33 of these proteins did not have their 
corresponding transcript detected in the E18.5 ChP transcriptome. (B) Schematic 
illustrating approach for preparing ChP-conditioned medium for MS analyses. (C) 
Heatmap of normalized spectral counts reveals differential protein availability in 
replicates of conditioned media obtained from pooled biological samples of 
conditioned media from tChP (n=3) and hChP (n=2). Each conditioned medium 
sample was run in duplicate, as represented by each lane in the heatmap (tChP, 
6 technical runs; hChP, 4 technical runs). Spectral counts were centered and 
scaled across each row (protein) for display purposes. Red and yellow indicate 
relatively higher and lower number of spectral counts, respectively. (D) 
Schematic representing the numbers of proteins identified as shared and region-
specific between conditions analyzed in C. (E) Volcano plot showing distribution 
of proteins obtained by plotting log2(fold-change tChP/hChP) versus -log10(p 
value from two-tailed t test) of the averages of normalized spectral counts from 
sample replicates analyzed in (C). Blue vertical lines: 2- and 0.5-fold cutoffs. Red 
horizontal lines: Log2 of Bonferroni-corrected p value cutoff [log2(0.05/1388) = 
4.33], log2 of uncorrected p value cutoff [log2(0.05) = 1.3]. (F) Functional 
clustering of differentially expressed proteins identified by MS with fold-change ≥ 
1.5, p = 0.05 (tChP-enriched proteins = 57; hChP-enriched proteins = 137). The 
top five enriched functional clusters are shown (FDR < 0.05). (G) Spectral counts 
show more abundant availability of ALDH1A2 and ALDH1L1 in hChP-conditioned 
medium (blue circles) than tChP-conditioned medium (green circles; hChP 
ALDH1A2 = 3.827 ± 0.346, tChP ALDH1A2 = not detected, t test, p = 0.002; 
hChP ALDH1L1 = 3.312 ± 1.020, tChP ALDH1L1 = 0.190 ± 0.190, t test, p = 
0.046). A similar trend is observed for RBP1 (hChP RBP1 = 10.926 ± 1.096, 
tChP RBP1 = 7.038 ± 0.797, t test, p = 0.101). Differential expression of these 
proteins corresponds to similar rends at the transcript level as detected by 
RNAseq (mean normalized read counts from DESeq ± SEM; Aldh1a2, hChP = 
248.188 ±125.197, tChP = 13.381 ± 5.824, FDR = 0.260; Aldh1l1, hChP = 
236.645 ± 37.892, tChP = 93.027 ± 17.053, FDR = 0.029; Rbp1, hChP = 
6811.561 ± 465.403, tChP = 3590.211 ±151.407, FDR = 0.001). Graphed points 
represent individual replicates obtained from pooled samples of ChP-conditioned 
medium. Statistical analyses were performed on pooled samples of ChP-
conditioned medium. Dotted line denotes mean. (H) Spectral counts show more 
abundant availability of Cystatin C (CSTC), Cathepsin B (CTSB), and Cathepsin 
D (CTSD) in tChP-conditioned medium than hChP-conditioned medium (tChP 
CSTC = 4.466 ± 0.452, hChP CSTC = 2.441 ± 0.208, t test, p = 0.018; tChP 
CTSB = 4.698 ± 0.576; hChP CTSB = 2.356 ± 0.424, t test, p = 0.006; tChP 
CTSD = 6.904 ± 0.606, hChP CTSD = 3.286 ± 0.168, t test, p = 0.010). Data 
graphed and analyzed as described in (G).  
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conservative Bonferroni multiple testing correction. The fold-change of all 
proteins unique to either hChP or tChP were set to 2.0x10-5 and 2.0x105, 
respectively (Figure 3.5E). The conservative (Bonferroni-corrected) analysis 
resulted in six proteins that showed significant abundance differences, whereas 
the looser cutoff resulted in 137 proteins being upregulated in hChP and 57 
proteins being upregulated in tChP. 
Enrichment analysis by DAVID of the differentially expressed proteins 
identified in the Volcano plot revealed shared and distinct classes of enriched 
proteins in the tChP- and hChP-conditioned medium (Figure 3.5F). Vesicle and 
protein biosynthesis categories were among the top enriched classes of proteins 
identified (Figures 3.5F). The differential availability of some proteins was 
consistent with predictions based on our RNAseq analyses, including members 
of the Retinoic acid signaling pathway, which overall were more highly 
represented in the hChP-conditioned medium than tChP (Figure 3.5G). Other 
groups of proteins, for example members of the Cystatin-Cathepsin signaling 
pathways, were not predicted to be differentially expressed by our RNAseq 
analyses, yet were detected as differentially expressed by our MS analyses 
(Figure 3.5H). These observations reflect how the availability of extracellular and 
secreted proteins depends on many parameters including but not limited to 
translation, processing, and transport. We also cannot rule-out protein 
contributions from ChP resident cells other than epithelial cells in these cultures. 
Previously suggested ventricular differences in CSF content (Cavanagh et al., 
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1983; Zappaterra et al., 2007) were not detected at the transcript level based on 
our RNAseq analysis. However, 11.5% of the proteins previously identified in rat 
lateral ventricle CSF, but not rat fourth ventricle CSF (Zappaterra et al., 2007) 
were confirmed to be differentially expressed by our MS analyses. Differences in 
CSF protein availability may also vary by CSF protein source, age, and/or 
species.  
The three genes encoding secreted factors predicted by RNAseq to be 
most differentially expressed between hChP and tChP [mean DESeq normalized-
read fold-change (FC) ± SEM; Growth differentiation factor 7 (FC = -540.070 ± 
244.866, p = 0.0001), Proenkephalin (Penk; FC= -76.546 ± 22.146, p = 0.0009), 
and Sonic hedgehog (Shh; FC = -44.721 ±1 5.414, p = 0.0015)], an important 
morphogen for hindbrain, cerebellar, and hChP development (Awatramani et al., 
2003; Huang et al., 2009c; Huang et al., 2010; Nielsen and Dymecki, 2010), were 
not detected by our quantitative MS analyses, potentially due to processing of 
these proteins into smaller peptides and other physicochemical properties of the 
peptides (e.g., their size and hydrophobicity). To determine whether these hChP-
enriched candidates, along with others such as Superoxide dismutase 3 (Sod3), 
which encodes the secreted anti-oxidant Extracellular superoxide dismutase (EC-
SOD), contribute to producing distinct CSF proteomes, we first confirmed their 
expression patterns by qRT-PCR (Figure 3.6A, Table 3.2) and 
immunohistochemistry (Figure 3.6B). As predicted by both RNAseq and qRT-
PCR data, PENK and EC-SOD proteins  were  more  abundant in hChP epithelial 
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Figure 3.6. Differential protein expression and secretion between 
telencephalic and hindbrain choroid plexi establish anterior-posterior 
gradients in an age-dependent manner. 
(A) Left, RNAseq normalized read counts from DESeq analysis (Penk: tChP = 
170.21 ± 296.22, hChP = 11132.09 ± 1815.991, FDR = 3.26x10-19; Sod3: tChP = 
260.48 ± 85.500, hChP = 1039.99 ± 96.738, FDR = 4.55x10-12; Ttr: tChP = 
4455127.72 ± 514497.268, hChP = 3239035.52 ± 322273.113, FDR = 3.42x10-1; 
Shh: tChP = 3.93 ± 2.097, hChP = 229.19 ± 40.774, FDR = 1.55x10-13). Right, 
qRT-PCR validation of differentially expressed genes Penk, Sod3, Shh, and 
similarly expressed gene Ttr at E18.5 represented as mean ± SEM, with tChP 
expression = 1.00. (Penk tChP, 1.00, Penk hChP, 78.75 ± 9.65, n = 4, t test, p = 
0.0002; Sod3 tChP, 1.00, Sod3 hChP, 5.20 ± 1.46, n = 4, t test, p = 0.035; Ttr 
tChP, 1.00, Ttr hChP, 0.90 ± 0.04, n = 4, t test, p = 0.074; Shh tChP, 1.00, Shh 
hChP, 198.55 ± 50.53, n = 4, t test, p = 0.008; Table 3.2). qRT-PCR analyses in 
adult ChP demonstrates overall downregulation of Penk, Sod3, Ttr, and Shh 
gene expression. Additional comparisons between tChP and hChP in adults 
reveals that Penk is more abundantly expressed in adult tChP than hChP, the 
pattern of differential Sod3 expression between adult tChP and hChP is 
maintained, and Ttr is more abundantly expressed by adult hChP than tChP. 
Adult fold expression is represented as mean ± SEM, with E18.5 tChP 
expression = 1.00. (Adult Penk tChP, 4.824 ± 1.194, Adult Penk hChP, 0.818 ± 
0.312, n = 3, t test, p = 0.031; Adult Sod3 tChP, 0.996 ± 0.134, Adult Sod3 hChP, 
2.940 ± 0.362, n = 3, t test, p = 0.007; Adult Ttr tChP, 0.147 ± 0.012, Adult Ttr 
hChP, 0.249 ± 0.005, n = 3, t test, p = 0.001; Adult Shh tChP, 0.010 ± 0.004, 
Adult Shh hChP, 0.018 ± 0.002, n = 5, t test, p = 0.130). (B) Immunostaining of 
E16.5 ChP with anti-PENK, anti-EC-SOD, anti-TTR, anti-AQP1, and Hoechst. 
Top, Expression of PENK (red) was enriched in hChP epithelium. Middle, 
Expression of EC-SOD (red) was enriched in hChP epithelium. Bottom, 
Expression of TTR (red) was similar in tChP and hChP epithelia. (C) Left, E16.5 
mouse tChP and hChP were cultured for 24 hours in equal volumes of base 
medium per ChP. Equal volumes of ChP-conditioned medium were 
immunoblotted with antibodies for PENK, EC-SOD, and TTR. Secretion of PENK 
and EC-SOD was greater by hChP than tChP. Secretion of TTR was similar 
between tChP and hChP. Right, Adult mouse tChP and hChP were cultured and 
analyzed as described above. Secretion of PENK was greater by tChP than 
hChP, secretion of EC-SOD was greater by adult hChP than tChP, and secretion 
of TTR was greater by adult hChP than tChP. (D) Quantification of embryonic 
PENK and EC-SOD immunoblots normalized to TTR, shown in (C). Data are 
represented as mean ± SEM (PENK tChP = 0.167 ± 0.056; hChP = 1.0, n = 4, t 
test, p < 0.0001; EC-SOD tChP = 0.146 ± 0.073; hChP = 1.0, n = 3, t test, p < 
0.001). (E) E14.5 mouse tChP and hChP were cultured for 24 hours in equal 
volumes of base medium per ChP. Equal volumes of ChP-conditioned medium 
were measured for Shh concentration by ELISA, represented as mean 
concentration (pg/ml) ± SEM (tChP = 11.58 ± 0.65, hChP = 56.83 ± 16.79; n = 3, 
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t test, p = 0.027). (F) Immunostaining of hChP with anti-EC-SOD reveals cellular 
gradient of enriched expression. Section taken at level of gestational day 18 
sagittal plate 10 from Prenatal Mouse Brain Atlas (Schambra, 2008). Arrowhead 
indicates region of enhanced EC-SOD expression along the ventral region of the 
hChP. Asterisks mark ChP vasculature. Double-headed arrow orients along 
dorsal (D)-ventral (V) axis. Scale bar, 100 µm. (G) Total CSF protein 
concentration over the course of mouse embryonic and postnatal development 
represented as mean concentration (mg/ml) ± SEM (E10.5, 1.8 ± 0.09, n = 6; 
E12.5, 2.67 ± 0.08, n = 7; E14.5, 2.97 ± 0.06, n = 4; E16.5, 3.15 ± 0.16, n = 6; 
E18.5/P0, 3.01 ± 0.18, n = 7; P2, 2.48 ± 0.14, n = 3; P7, 1.37 ± 0.06, n = 6; adult, 
1.37 ± 0.12, n = 3). CSF protein concentration increases following development 
of choroid plexi at E11–E12 (indicated by arrow; E10.5 vs E12.5, t test, p = 
0.00003; E12.5 vs E14.5, t test, p = 0.031), declines postnatally (P2 vs P7, t test, 
p = 0.00004; and remains stable between P7 and adulthood, t test, p = 0.984). 
(H) Silver stain of 1 µl of E17 and adult rat CSF. Total CSF protein complexity 
decreases in adulthood. (I) Relative SOD activity decreases in rat CSF with age 
(E17 CSF, 11.3 ± 0.7; Adult CSF, 7.1 ± 0.1; n = 3, t test, p < 0.05). 
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cells than tChP epithelial cells (Figure 3.6B). Next, we again isolated secreted 
CSF/ChP-conditioned medium from cultures of whole tChP and hChP, this time 
assaying for specific protein content. Cultured CSF demonstrated that PENK, 
EC-SOD, and Shh were robustly secreted by the hChP compared with tChP 
(Figure 3.6C-E). Similar trends of differential expression and possibly secretion 
are predicted by our RNAseq analyses for various growth factors with known 
roles in the developing nervous system (e.g., members of the FGF and BMP 
families; Tables 3.1, 3.2). We also observed the equal secretion of proteins 
indicated to be similarly expressed across tissues by RNAseq and qRT-PCR 
including TTR (Figure 3.6A-C; Table 3.2). Immunohistological analyses also 
revealed a striking regionalization in protein expression domains within the hChP, 
highly suggestive of hotspots of protein secretion into the CSF in vivo. For 
example, EC-SOD is more abundant ventrally than dorsally in the hChP (Figure 
3.6F), akin to observations made for Shh, whose regionalized expression pattern 
within the hChP, and descendants of these Shh-expressing cells, exhibit 
regionalized character (Awatramani et al., 2003). 
Finally, we observed that the regionalized expression and secretion of 
ChP proteins is regulated in an age-dependent manner. We first confirmed that 
many genes exhibiting positional heterogeneity at E18.5 also exhibited similar 
patterns of positional heterogeneity earlier in development at E14.5 by qRT-PCR 
(data not shown). Because overall CSF protein content (Figure 3.6G,H) 
(Lehtinen et al., 2011), as well as specific proteins including Shh (Huang et al., 
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2009c; Nielsen and Dymecki, 2010), IGF2 (Lehtinen et al., 2011), and 
transporters in the tChP (Liddelow et al., 2012) show age-dependent expression, 
we next assayed gene expression in adult ChP. Overall, ChP gene expression 
decreased in adulthood (Figure 3.6A; data not shown). However unexpectedly, 
many of the gene expression patterns observed embryonically also changed 
postnatally. For example, Penk expression decreased in adult hChP compared 
with tChP, leading to less PENK secretion by hChP than tChP into conditioned 
medium (Figure 3.6C). Ttr, whose expression and protein secretion were similar 
between E18.5 tChP and hChP (Figure 3.6A-C; Table 3.2), was found to be 
differentially expressed and secreted by adult ChP (Figure 3.6A-C). Finally, the 
differential expression pattern of Sod3 was maintained in the adult ChP (Figure 
3.6A,C), and the decrease in overall adult ChP Sod3 expression was 
accompanied by reduced SOD activity in native adult CSF (Figure 3.6I). 
Collectively, these findings demonstrate regional, age-dependent regulation of 
ChP gene expression from development into adulthood.  
Consistent with our findings across rodent choroid plexi, we detected SHH 
and IGF2 in juvenile and adult primate choroid plexi. By qRT-PCR, we observed 
SHH expression in macaque hChP compared with tChP [mean fold-change 
(tChP/hChP) ± SEM, -16.085 ± 13.642, p = 0.3314; not detected in 3 of 6 tChPs 
tested]. Likewise, we detected SHH in two of five human hChP samples, 
whereas it was not detected in any of five tChP samples tested (data not shown). 
We also detected by qRT-PCR IGF2 expression in human tChP and hChP [mean 
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fold-change (tChP/hChP) ± SEM, 1.879 ± 0.900, n = 5, p = 0.394]. Together, our 
findings suggest that the regionalized distribution of ChP-CSF factors regulating 
neurogenesis is conserved from rodent to primate brain. 	
Discussion 
We show that ChP gene expression is spatially heterogeneous; a 
characteristic that may enable ventricle-specific instruction of brain development 
and health. The four key findings of our study are as follows: (1) the identification 
of positional heterogeneity in gene expression between the telencephalic and 
hindbrain mouse choroid plexi which parallels gene expression in axial tissues of 
origin, (2) the discovery that this positional identity of tChP and hChP is 
conserved across macaque and human choroid plexi, (3) the definition of 
secretomes from purified tChP and hChP epithelial cells (compared with the 
whole ChP), and (4) the identification of gene expression domains that contribute 
to functional differences in ChP-specific protein secretion in an age-dependent 
manner. Collectively, our findings suggest that specialized domains of ChP 
secretory cells may contribute to region-specific CSF-signaling niches in the 
rodent and primate brain.  
Many cells are known to secrete signals that instruct development, and it 
is becoming clear that different subtypes of cells, such as astrocytes (Molofsky et 
al., 2014), demonstrate local heterogeneity in what signals are generated and 
secreted. During development, neural stem cells are initially in direct contact with 
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the CSF, and the ChP secretes signals that play an active role in instructing 
neural stem cell proliferation and survival (Huang et al., 2010; Lehtinen et al., 
2011). However, the question of whether regional heterogeneity in ChP-secreted 
signals exists has not been examined in detail. The possibility that CSF 
composition may be regionally specialized is intriguing, as it would provide a 
powerful means for region-specific regulation of stem cells. At early stages of 
development, ventricles arise within the newly closed neural tube (Lowery and 
Sive, 2009; Zappaterra and Lehtinen, 2012), and substantial mixing of CSF 
between ventricles is likely to occur. For example, the cerebral aqueduct first 
emerges as a wide channel that projects caudally from the third ventricle over the 
superior aspect of the pontine flexure and then connects to the fourth ventricle. 
Over the course of embryonic brain development, the aqueduct narrows, thus 
anatomically restricting flow from the lateral and third ventricles to the fourth 
ventricle (Figure 3.1A). According to the traditional model of CSF flow, lateral 
and third ventricle CSF and factors therein will eventually arrive at the fourth 
ventricle if not bound to receptors on cells lining the ventricles (Brinker et al., 
2014). Because factors in fourth ventricle CSF are less likely to flow upstream to 
the lateral ventricle, we reasoned that: (1) certain factors may be present only in 
fourth ventricle CSF, and (2) such factors might arise from a selective production 
and secretion by fourth ventricle choroid plexus (hChP) but not lateral ventricle 
choroid plexus (tChP).  
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Our results lend support to both of these hypotheses. First, although 
previous studies have shown that signals such as CSF-Shh act specifically on 
periventricular cells in the fourth ventricle at late stages of development (Huang 
et al., 2010), it was not known whether factors, such as Shh are produced locally, 
or whether they originate, at least in part, from upstream lateral ventricle ChP. 
We confirmed the abundant availability of Shh and several other factors in hChP-
conditioned medium compared with tChP-conditioned medium (Figures 3.5, 3.6), 
suggesting local production of these factors by hChP. These data were 
confirmed by our finding that Shh expression was greater in hChP than tChP 
(Figure 3.6A; Tables 3.1, 3.2). However, additional investigation is needed to 
determine whether the hChP may be more receptive to Shh signaling as some 
classic downstream signaling factors (e.g., Gli1) are upregulated, whereas others 
(e.g., Ptch1 and Smo) are more similarly expressed between tChP and hChP. 
More generally, there are greater numbers of differentially expressed genes 
encoding for secreted proteins found in the hChP than in the tChP (Figure 3.2). 
Our analyses are unique and highly sensitive to detect such regional differences, 
in part because of our approach to FACS-purify ChP epithelial cells. Validation of 
differential protein secretion by the ChP was performed on isolated ChP cultures 
and their conditioned medium because obtaining sufficient quantities of pure, 
regionalized in vivo embryonic mouse CSF for protein assays is rate limiting. We 
cannot rule out protein contributions from non-ChP epithelial mechanisms that 
selectively regulate age-dependent changes in ChP protein expression and 
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secretion, which should further inform therapeutic approaches of neurologic 
disease (Bateman et al., 2006; Potter et al., 2013; Xie et al., 2013b).  
Differentially expressed genes encoding secreted proteins originating from 
either the hChP or the tChP and positional transcription factor expression 
between choroid plexi may contribute to the production of regionalized CSF. It is 
possible that the retention of HoxA gene function in the hChP may be analogous 
to the developing limb bud, where the Hox clusters exhibit temporal and spatial 
collinearity and coordinate gene expression including Shh (Kmita et al., 2005; 
Tarchini et al., 2006; Philippidou and Dasen, 2013). However, abundance of 
expression and secretion may not correlate with principal sites of biological 
action. Igf2 is the second most abundantly expressed secreted gene by ChP 
epithelial cells (Table 3.3). By RNAseq analyses, Igf2 expression was not more 
abundantly expressed by the hChP than tChP, yet its differential expression was 
suggested by qRT-PCR (Table 3.2). Yet, at the protein level, IGF2 was not 
observed to be differentially available in tChP- versus hChP-conditioned medium, 
as assayed by quantitative MS. IGF2 has confirmed sites of action along the 
ventricular zone of the developing cerebral cortex (Lehtinen et al., 2011), and 
Igf2-deficient mice appear to have a smaller cerebellum than controls (Lehtinen 
et al., 2011). Thus, CSF-IGF2-based signaling may play additional, as yet 
uncharacterized roles in development and maintenance of hindbrain structures 
as well.  
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Previous transcriptome to secretome analyses have revealed a 
decoupling between transcription and release of protein (Meissner et al., 2013). 
Comparisons of our RNAseq data with proteomic analyses of ChP-conditioned 
medium suggest that differences between gene expression, protein expression, 
and protein secretion exist in the ChP as well. Unconventional means of protein 
secretion by the ChP, and other cells in proximity to the ventricles, may also 
contribute to the CSF proteome in unexpected ways (Nickel and Rabouille, 
2009). Nevertheless, our data show that positional heterogeneity in gene 
expression between the tChP and hChP contributes to the production of 
regionalized CSF proteomes, which may provide region-specific CSF cues to 
individual neural stem cell populations located along the brain’s ventricles. 
Regionalization of the hindbrain ChP epithelium has been demonstrated 
by previous fate-mapping studies (Awatramani et al., 2003). Our findings build on 
these studies, showing that positional identities of both the tChP and hChP are 
instructed by patterned cues with origins in the axial nervous system. However, 
in vivo CSF is home to signals derived from sources other than the ChP, 
including the ventricular lining, vasculature, interstitial fluid, and axons 
innervating the ventricular walls (Johanson et al., 2008; Damkier et al., 2013). 
Many factors provided by non-ChP cell types have known roles in patterning the 
forebrain (e.g., BMPs, WNTs, FGFs) (Grove and Monuki, 2013), and the choroid 
plexi express receptors to receive such cues (Table 3.1). Thus, the choroid plexi 
may well be patterned by signals distributed in the fluid that bathes them as well. 
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Finally, the choroid plexi are highly vascularized tissues, and complementary 
patterning cues may derive from the vasculature or possibly from anterior versus 
posterior circulation.  
The conservation of ChP positional identity from mouse to primate brain 
suggests that our findings may inform future therapies for patients with a range of 
CNS disorders. For example, our data may provide clues to putative 
susceptibility loci for tumors of the ChP, which arise predominantly in the tChP in 
children and in the hChP in adults (Safaee et al., 2013a). Our analyses show that 
Twist, a bHLH transcription factor associated with neoplastic ChP epithelial cells 
(Hasselblatt et al., 2009), is typically enriched in the hindbrain ChP. In addition, 
common surgical treatments for patients with hydrocephalus include 
cauterization of the ChP and/or shunting CSF. Following these procedures, 
particularly in cases of overshunting, patients may lack important regional CSF 
signals, raising the possibility that a region-specific, synthetic CSF supplement 
could be engineered as an adjuvant therapy. With the advent of nervous system 
therapies using induced pluripotent stem cells to derive and graft specific cell 
types, including ChP epithelial cells (Watanabe et al., 2012; Lehtinen et al., 
2013), it will be essential to engineer cells and fluids with appropriate regional 
identity and age specificity.  
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Chapter 4 
Results Part II 
Murine DNA ligaseIV mutations result in DNA repair deficiency and 
microcephaly (unpublished observations) 
 
Authorship: Melody P. Lun, Nicole Luche, Erin Fonseca, Douglas Ryan, Sevgi 
Keles, Luigi Notarangelo, and Maria K. Lehtinen. 
 
These studies were performed collaboratively. M.P.L. and M.K.L. designed 
experiments. M.P.L. performed experiments and data analysis. N.L. and D.R. 
were responsible for mouse husbandry. E.F. assisted with tissue processing, 
sectioning, and immunohistochemistry. S.K. provided MRI images from normal 
and Lig4-deficient patients. L.N. provided Lig4 mutant mouse and contributed 
insightful comments on Lig4 syndrome and associated DNA repair deficiencies.  
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Introduction 
In the first case report of Ligase IV (LIG4) deficiency in a patient, a 
missense mutation in the LIG4 gene was found to be the cause of severe 
radiosensitivity and predisposition to leukemia (Plowman et al., 1990; Badie et 
al., 1995; Badie et al., 1997; Riballo et al., 1999). The point mutation responsible 
was a change from guanine to adenine at position 833 of the gene, resulting in 
an arginine to histidine substitution at amino acid position 278 (R278H). Located 
in the highly conserved active site of the LIG4 enzyme (Chistiakov et al., 2009), 
this amino acid substitution severely reduces the enzyme’s ligation activity. A 
knockin mouse model was generated to recapitulate this R278H amino acid 
substitution (Rucci et al., 2010), with confirmed reduction in Lig4 activity. While 
homozygous Lig4R278H/R278H (Lig4R/R) mice demonstrate many of clinical features 
of LIG4 syndrome (i.e. sensitivity to ionizing radiation, defective B and T cell 
development, genomic instability, thymic tumor susceptibility), the brain 
phenotype of this mouse mutant has yet to be carefully characterized, thus 
limiting our knowledge of the scope of this mutant’s modeling of the human LIG4 
syndrome. Here, we investigate the cortical development and susceptibility to 
radiation of this knockin mouse model.  
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Results 
MRI of LIG4-deficient patient indicates microcephaly with no gross 
abnormalities 
A patient with LIG4 syndrome was recently identified and included in a 
review of cases reported in the literature (IJspeert et al., 2013). She presented 
with cytopenia, immunodeficiency, and developmental delay. At 3 months of age, 
she was microcephalic, with a head circumference of 33 cm (average for 
unaffected age-matched female is 37.3-41.1 cm). A brain MRI of the patient 
taken at 3 months shows no gross malformations, atrophy, or tissue loss (Figure 
4.1A). The sulci look relatively normal with no enlargements, and gyral pattern is 
as expected. At 4 months of age, the patient was diagnosed with LIG4 syndrome. 
She was found to be homozygous for LIG4 mutation leading to a histidine to 
arginine amino acid substitution at position 282 (H282R) in the LIG4 active site 
(IJspeert et al., 2013). The patient died at the age of 3 years from sepsis. 
 
 
Single amino acid substitution in Lig4 leads to growth retardation and 
microcephaly 
Reports of microcephaly in LIG4-deficient patients and Lig4 null and 
deficient mice prompted us to examine the brain phenotype of Lig4 R278H mice. 
We investigated the brain and body size at embryonic and postnatal stages. At 
E14.5, there was no significant difference in brain weight, body weight, or brain-
to-body weight ratio (Figure 4.1C-E). Visual comparison of E14.5 embryos and 
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brains from knockin mice revealed no gross abnormalities compared to wild-type 
littermates (Figure 4.1B). By P8, brain weight and body weight are significantly 
reduced in knockin mice compared to wild-type and heterozygous littermates, 
though the brain-to-body weight ratio is unaffected (Figure 4.1C-E). Comparison 
of brains from P8 wild-type and knockin mice shows reduction in cortical size 
(Figure 4.1B). Interestingly, the decreased brain weight of mutants versus 
controls present at P8 is non-progressive, as the brain weights follow the same 
trajectory postnatally until P28 (Figure 4.1C). At P28, knockin brains were 
smaller than wild-type and heterozygous littermates (Figure 4.1B). P28 knockin 
cerebral cortical length and hemispheric surface area were also reduced 
compared to littermate controls (Figure 4.1F). However, both P8 and P28 
heterozygous brains were not microcephalic compared to wild-type (Figure 
4.1C,F), suggesting that a single allele provides sufficient Lig4 expression. 
Studies of LIG4-deficient patients have reported microcephaly that is 
present at birth but is non-progressive, suggesting that mechanisms leading to a 
smaller brain are present during development. We first considered cell death 
during the embryonic period. Immunostaining for cleaved caspase 3 (CC3) at 
E14.5 revealed increased cell death in the Lig4R/R dorsolateral cortex (n=5 from 
two litters; Figure 4.2A,B). While cell death is observed throughout the cortex, it 
is most markedly increased among Tuj1+ regions, where differentiated neurons 
reside (Figure 4.2A,B). While we observe increased cell death at E14.5, 
immunostaining for CC3 postnatally in the P8 cortex did not reveal upregulation 
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in cell death (data not shown), suggesting that neuronal cell death arising from 
Lig4-deficiency may be limited to embryonic until early postnatal stages. We then 
investigated the potential alterations in cell cycle exit that may contribute to a 
smaller brain phenotype. By intraperitoneal injection of pregnant females at 
E13.5, we administered a 24-hour pulse of BrdU (bromodeoxyuridine), a 
synthetic thymidine analog that incorporates into DNA during S phase of the cell 
cycle, when DNA is replicated. We collected the embryos 24 hours following 
injection at E14.5 and immunostained for BrdU, a marker of cells that have 
progressed through S phase, and Ki67, a marker of cells in the cell cycle (Figure 
4.2C). Cells remaining in the cell cycle after the 24-hour BrdU pulse are 
BrdU+Ki67+, while those that exit the cell cycle are BrdU+Ki67−. We quantified 
the ratio of BrdU+Ki67+ out of the total BrdU+ cells (“proliferative fraction”). 
Interestingly, we find an increased proliferative fraction in E14.5 Lig4R/R 
dorsolateral cortex, suggesting that more neuroprogenitors remain in the cell 
cycle (Figure 4.2D). These findings suggest that while the Lig4-deficient cortex 
undergoes greater cell death without the addition of environmental insults, there 
is an accompanying increase in the proliferative cycles of neural progenitors. 
Studies are currently underway to investigate the effect of gamma irradiation, a 
source of exogenous insult, during cortical development in E14.5 Lig4R/R cerebral 
cortex.  
As postmitotic neurons differentiate from neuroprogentiors, the cerebral 
cortex develops in an inside-out manner, such that earlier born neurons populate 
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the deeper, lower layers of the cortex, and later born neurons migrate radially to 
position themselves in the superficial, upper layers of the cortex (Molyneaux et 
al., 2007; Franco and Muller, 2013). We first analyzed for changes in cortical 
thickness at P8, when neuronal migration is complete. We measured 
hematoxylin and eosin-stained paraffin sections in the dorsolateral (parietal) 
cortex, where the thickness is least variable by comparing the thickness of layers 
1-4 (upper cortical region) and layers 5-6 (lower cortical region). We found that 
upper-to-lower cortical thickness ratio is increased significantly in the anterior 
dorsolateral cortex of Lig4 mutants, although this trend was present in the middle 
and posterior dorsolateral cortex as well (n=3 from 2 litters; Figure 4.3A-C). To 
investigate whether cortical lamination is disrupted, we immunostained for 
cortical layer markers at P8. We analyzed the expression of upper layer marker 
Cux1 (layers II-IV; (McEvilly et al., 2002; Nieto et al., 2004) and lower layer 
marker Ctip2 (layers V-VI; (Hevner et al., 2001; Leid et al., 2004). We quantified 
Cux1+ and Ctip2+ cells in the dorsolateral region of the anterior, middle, and 
posterior cortex by partitioning the cortex into six equally-sized regions (“bins”), 
since cortical thickness may be variable across individual sections and samples 
(Figure 4.3D). We find that percentages of Cux1+ and Ctip2+ cells are largely 
similar between mutants and controls in each bin yet there is a reduction in total 
number of nuclei (n=5 from 2 litters; Figure 4.3E). Since the percentages of 
Cux1+ and Ctip2+ cells in each bin are comparable between wild-type and 
knockin brains, yet there is a reduction in the total number of cells in the knockin 
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cortex, it appears that neuronal migration is largely intact in Lig4 knockin mice 
but is accompanied by a proportionate reduction in the number of neurons 
populating the upper and lower layers of the cerebral cortex. 
 
Conclusions 
LIG4 syndrome is a rare, albeit devastating disorder caused by deficiency 
in DNA LigaseIV, an essential component of DNA DSB repair. LIG4 patients 
present with a constellation of clinical features, and the severity of their 
symptoms correlates with the residual activity of DNA ligaseIV enzyme. Here, we 
report the cerebral cortical phenotype of the Lig4 R278H knockin mouse mutant, 
which recapitulates the mutation identified in the first case report of LIG4 
deficiency. We observed a non-progressive microcephaly with intact cortical 
lamination in postnatal mice. Changes in cortical thickness and cellularity were 
most pronounced in the anterior cortical regions, though these trends are present 
in the middle and posterior cortex as well. During development, we observe 
increased neuronal death together with a higher percentage of cells remaining in 
the proliferative state, which likely contribute to the decrease in brain size. While 
we have focused on cell death and cell cycle exit as two factors in Lig4 deficient 
microcephaly, several other factors may also contribute to this phenotype. For 
example, reduction of the progenitor cell pool, extension of cell cycle length 
leading to production of fewer neurons, early differentiation of progenitors, and 
migration defects could also be contributory factors. 
 	
128 
 
 
 
 
 
 
 
Figure 4.1. LigIVR/R mice recapitulate microcephaly and growth retardation 
observed in patients. 
(A) Transverse and coronal MRI images of unaffected control vs. patient 
harboring homozygous LIG4 mutation leading to H282R substitution reveal 
microcephaly with no gross malformations. Note: Images from control and patient 
are not to scale. (B) E14.5, P8, and P28 brains from wild-type (Lig4+/+) and 
knockin (Lig4R/R) mice. Scalebar = 1mm for E14.5 brains, 2mm for P8 and P28 
brains. (C) LigIVR/R mice show decreased brain weight postnatally. Brain weight 
(g): E14.5: WT = 0.029 ± 0.001, Het = 0.028 ± 0.002, KI = 0.026 ± 0.001, 
ANOVA, p = 0.187; P8: WT = 0.282 ± 0.009, Het = 0.278 ± 0.013, KI = 0.227 ± 
0.008, ANOVA, p < 0.0005; P28: WT = 0.404 ± 0.023, Het = 0.370 ± 0.010, KI = 
0.311 ± 0.013, ANOVA, p = 0.002. (D) LigIVR/R mice have reduced body weight at 
P8. Body weight (g): E14.5: WT = 0.213 ± 0.008, Het = 0.213 ± 0.008, KI = 0.196 
± 0.006, ANOVA, p = 0.187; P8: WT = 5.533 ± 0.200, Het = 5.727 ± 0.273, KI = 
4.295 ± 0.166, ANOVA, p < 0.001; P28: WT = 16.489 ± 1.183, Het = 13.806 ± 
0.516, KI = 13.010 ± 1.338, ANOVA, p = 0.105. (E) Decreased brain weight 
observed postnatally does not lead to significant change in brain-to-body weight 
ratio. Brain-to-body ratio (%): E14.5: WT = 13.76 ± 0.67, Het = 12.99 ± 0.25, KI = 
13.29 ± 0.38, ANOVA, p = 0.489; P8: WT = 5.11 ± 0.13, Het = 4.86 ± 0.43, KI = 
5.39 ± 0.29, ANOVA, p = 0.404; P28: WT = 2.48 ± 0.20, Het = 2.72 ± 0.16, KI = 
2.54 ± 0.25, ANOVA, p = 0.690. (F) Cerebral cortical region from P28 LigIVR/R 
knockin (KI) mice is reduced compared to wild-type (WT) and heterozygous (Het) 
littermates with reduced cortical length and cortical surface area. P28 cortical 
length (mm): WT = 8.30 ± 0.14, Het = 8.09 ± 0.60, KI = 7.53 ± 0.19, ANOVA, p = 
0.005. P28 cortical surface area (one hemisphere, mm2):  WT = 32.56 ± 1.64, 
Het = 32.45 ± 0.31, KI = 27.72 ± 1.16, ANOVA, p = 0.010).  
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(Figure 4.1 continued)  
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Figure 4.2. Increased cell death and cell cycle reentry during LigIVR/R 
cortical development. 
(A) Cleaved caspase 3 (CC3, red) staining reveals increased cell death in E14.5 
KI dorsolateral cortex, most pronounced in Tuj1+ (green) neuronal region. (B) 
Quantification of cell death. CC3+/Tuj1- cells per 200µm (blue): WT =  0.8 ± 0.3, 
KI = 2.7 ± 0.3, two-tailed t test, p = 0.15; CC3+/Tuj1+ cells per 200µm (green): 
WT = 4.9 ± 0.6, KI = 13.1 ± 1.4, two-tailed t test, p = 0.017. (C) BrdU (red) and 
Ki67 (green) colabeling in E14.5 dorsolateral cortex following 24-hour BrdU 
pulse. (D) Quantification of BrdU+/Ki67+ cells in the dorsolateral cortex reveals 
increased cell cycle reentry of Lig4 KI neural progenitors. Proliferative fraction 
(BrdU+/Ki67+ in total BrdU+ cells per 200µm-wide region), WT= 0.42±0.02, 
KI=0.54±0.03, two-tailed t test, p = 0.012.  
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(Figure 4.2 continued) 
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Figure 4.3. LigIVR/R mice show reduction in cortical thickness with 
decreased cellularity but intact laminar architecture. 
(A-B) The dorsolateral regions were analyzed from P8 wild-type (WT) and 
knockin (KI) mice from selected anterior, middle, and posterior positions of the 
brain, as indicated by dotted line. (C) P8 KI mice show regionalized change in 
cortical thickness, specific to the anterior dorsolateral cortex. Cortical thickness 
ratio (Upper:Lower): Anterior, WT = 0.25 ± 0.01, KI = 0.36 ± 0.04, Mann Whitney, 
p = 0.049; Middle, WT = 0.28 ± 0.04, KI = 0.37 ± 0.09, two-tailed t test, p = 0.275; 
Posterior, WT = 0.35 ± 0.04, KI = 0.49 ± 0.9, two-tailed t test, p = 0.127. (D-E) 
Staining with Cux1 and Ctip2 markers reveal intact lamination of the cortex but 
overall decrease in total number of cells across the entire thickness of the cortex. 
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(Figure 4.3 continued) 
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Chapter 5 
Discussion 
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Summary 
 
The focus of this dissertation research is to elucidate the interplay 
between cell intrinsic and extrinsic mechanisms that regulate brain development. 
First, I considered the role of extrinsic cues delivered by cerebrospinal fluid to the 
developing brain. I identified distinct transcriptomes of the telencephalic and 
hindbrain choroid plexi, illustrating that these tissues are different in their gene 
expression profile (Lun et al., 2015b). By identifying transcription factors that are 
differentially expressed between the choroid plexi, I have also demonstrated that 
the choroid plexi are patterned along the anterior-posterior axis of the neural 
tube, and after differentiation into a non-neural tissue, the choroid plexi 
nevertheless retain these positional identities. Furthermore, I have demonstrated 
that the choroid plexus secretome contributes to production of a regional 
cerebrospinal fluid across the ventricular system. I have extended these findings 
to investigate the cell morphological changes in choroid plexus pathologies, 
including choroid plexus papillomas and carcinomas (Li et al., 2016). Lastly, I 
investigated the requirement for genomic fidelity during brain development. I 
focused on DNA repair by DNA ligaseIV in the cortex and characterized the 
phenotype of a Lig4-deficient mouse model. In this chapter, I will consider these 
findings in the context of the cortical development field and suggest potential 
future directions for these studies.  
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Part I. Regionalized choroid plexus transcriptomes and CSF factors as cell 
extrinsic cues guiding mammalian brain development 
 
It was long held belief that CSF functions in a passive, supportive role for 
the CNS as a fluid cushion and waste removal system. My dissertation research 
identified regionalized signaling factors and morphogens expressed and secreted 
by the choroid plexi, the tissue responsible for secreting the majority of CSF. 
Together with evidence from previous publications (Martin et al., 2006; 
Zappaterra et al., 2007; Lehtinen et al., 2011), results from my research support 
the hypothesis that CSF plays an active role during brain development, and may 
also function to deliver regionalized signals across the ventricular system.  
CSF is a complex fluid, teaming with growth factors, morphogens, and 
other signaling molecules. The sources of these signals, the ChP tissues, have 
largely been overlooked in the field of neurobiology despite ChP epithelial cells 
having a direct lineage from neuroepithelial cells. By investigating the 
transcriptional profiles of the ChP tissues, I have demonstrated that as each ChP 
develops from distinct regions of the neural tube, it retains transcription factor 
expression patterns that reflect their region of origin. These transcription factors 
endow positional identities to the ChP of each ventricle and likely contribute to 
regulating the secretome from each region, such that there is regionalization of 
signals throughout the ventricular system. In addition, I identified a dorsal-ventral 
gradient of EC-SOD expression in the hindbrain ChP. Such gradients may also 
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exist for other secreted factors to establish microenvironments within each 
ventricle. Thus, the CSF acts as a powerful means to distribute region-specific 
cues to the developing brain. 
 Evidence from previous studies indicates that regional and cell fate 
identity is specified through the integration of intrinsic and extrinsic signals 
(Chenn and Walsh, 2002; Lien et al., 2006; Lehtinen et al., 2011). Together with 
extrinsic signals emanating from the meninges and vasculature, ventricle-specific 
CSF may be a source of extrinsic cues to promote regional identity. Studies are 
currently underway to test the functional role of regionalized CSF and whether 
disrupting the availability of signals across the ventricular system may lead to a 
developmental consequence. We reasoned that by the traditional model of CSF 
flow, CSF from the lateral ventricle flows down to the third and fourth ventricles, 
which suggests that factors present in the fourth ventricle CSF are not expected 
to be in the lateral ventricle. Therefore, we aim to respecify the telencephalic 
(lateral ventricle) ChP in order to alter its secretome to resemble that of the 
hindbrain (fourth ventricle) ChP. We have successfully driven the expression of 
several candidate transcription factors using mouse genetic and viral 
approaches. By misexpression in the telencephalic ChP of transcription factors 
encoding positional identity in the hindbrain ChP, we hypothesize that we may 
then detect in the lateral ventricle secreted factors that are endogenously 
enriched in the fourth ventricle, including PENK, EC-SOD, and Shh (Lun et al., 
2015b). Currently, we have identified a few candidate secreted factors which we 
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are testing by gain-of-function/loss-of-function experiments to understand their 
impact on cortical development and other local brain regions. Additionally, we 
suspect that changing the secreted signals within each brain ventricle may affect 
regionalization in the local environment. For example, we detected a dorsal-to-
ventral gradient of EC-SOD expression in the hindbrain ChP (Figure 3.6F) (Lun 
et al., 2015b). By our mouse genetic and viral approaches to change the 
positional identity of the telencephalic ChP, we may also be changing the 
microenvironments present within the ventricle, including the dorsal-ventral 
identity within the forebrain and the roof plate-floor plate regionalization in the 
hindbrain. 
 While receptors for CSF-borne signals are found along the ventricular 
surface, cell surface receptors are highly expressed in the ChP transcriptome 
(Lun et al., 2015b), and by immunostaining, receptors are found to be highly 
enriched along the apical surface of ChP epithelial cells as well (Lehtinen et al., 
2011). This suggests that the ChP may be susceptible to negative feedback 
regulation, whereby ChP epithelial cells sense the availability of signals they 
themselves secrete and regulate their expression or release. Indeed, an 
autoregulatory loop has been reported in the hindbrain ChP, where mature 
epithelial cells secrete Shh, which are sensed in the adjacent progenitor field to 
regulate their proliferation (Huang et al., 2009c). This adds an additional 
complexity to the regulation of CSF composition during development and into 
adulthood, as the expression of receptors may change over lifespan to regulate 
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the decline of CSF protein concentration in adulthood (Lun et al., 2015b). Indeed, 
the function of the ChP epithelium in secreting CSF factors may be subject to 
intrinsic and extrinsic mechanisms as well. 
Our transcriptional profiling also revealed the ChP tissues to be a rich 
source of microRNAs (Lun et al., 2015b), opening a potential avenue to study the 
ChP’s role in post-transcriptional regulation. MicroRNAs are small (~23 
nucleotide) RNAs that bind to messenger RNAs to repress their expression 
(Bartel, 2009). Post-transcriptional regulation via microRNA targeting is thought 
to be a responsive and reversible mechanism to regulate gene expression, 
allowing for refinement of gene expression on a shorter time scale (Bartel and 
Chen, 2004). Nanoparticles in the CSF are reported to carry microRNAs along 
with proteins to regulate cortical progenitors (Feliciano et al., 2014), though it is 
unclear whether the ChP is the source of these nanoparticles. There is also 
evidence that proliferation of radial glial and basal progenitors are regulated by 
microRNAs (Nowakowski et al., 2013a; Nowakowski et al., 2013b). The 
possibility that ChP may be a source of microRNAs that are then packaged to 
traverse the ventricular space via CSF would be another novel and powerful 
means to regulate cortical development. MicroRNAs have been shown to bind 
the 3’ untranslated region of genes, including Igf2 (Ge et al., 2011), the second 
most abundantly expressed secreted factor by the ChP (Lun et al., 2015b). 
 Several recent papers have investigated the kinetics of CSF flux, and 
most excitingly, has demonstrated that CSF convection in the adult brain 
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increases during sleep and anesthesia states (Iliff et al., 2012; Iliff et al., 2013; 
Xie et al., 2013b). From the perspective of the neurodegeneration field, 
increasing CSF flux may provide a means to clear metabolites, such as β-
amyloid, but these studies also raise the question of whether CSF flux changes 
in the embryonic brain. Furthermore, as CSF flux increases, is there an obligate 
increase in CSF production such that the water and ionic composition increases 
or is there an accompanying increase in the signaling molecules as well? Lastly, 
these studies of CSF flux raise the tantalizing possibility that choroid plexi are 
regulated by circadian rhythms. Recent studies have also demonstrated the 
coupling of circadian transcription and translation (Lipton et al., 2015). While our 
transcriptome and proteome studies were performed at approximately the same 
time of day, circadian fluctuations in transcription and secretion by the choroid 
plexi might enable rhythmic restoration or maintenance of the neural stem cells in 
the embryonic and adult brain.  
 While our studies of the ChP have largely focused on the mouse, we have 
extended our findings to the primate brain. We confirmed that the positional 
identities of the tChP and hChP are conserved in the macaque and human brain, 
which presents an interesting link to human neuropathology. ChP tumors, while 
rare, are most common tumor type found in children, accounting for 10-20% of 
tumors in this population (Safaee et al., 2013a). Age and location of tumor are 
highly correlated (Wolff et al., 2002). When found in children, ChP tumors are 
typically located in the lateral ventricle, while in adults, ChP tumors are more 
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frequently located in the fourth ventricle. This raises the possibility that an age-
dependent regulatory mechanism may be present, leading to this spatial pattern 
of tumor susceptibility. Furthermore, our findings in the mouse may provide an 
ideal segue to study the origins of ChP tumors. ChP epithelial cells are the 
presumed cell-of-origin for ChP tumors, though it is unclear whether these 
tumors arise in situ or may metastasize from elsewhere. More recent studies 
suggest that ChP tumors may also arise from progenitors in the roof plate that 
undergo aberrant Notch signaling (Li et al., 2016). A recent gene expression 
profiling of ChP tumors has demonstrated that ChP tumors can be classified into 
subgroups that can be diagnostically and prognostically stratified based on their 
molecular signatures (Merino et al., 2015). Application of the mouse ChP 
epithelial transcriptome to the gene expression profiles of human ChP tumors 
should provide improved diagnostic and therapeutic avenues.  
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Part II. LigaseIV syndrome as a model to study DNA stability as a cell 
intrinsic mechanism regulating mammalian cortical development 
 
 While the majority of this dissertation has focused on the role of cell 
extrinsic cues in regulating brain development and health, I have also delved into 
the contribution of DNA stability as a cell intrinsic mechanism that regulates 
neural progenitor behavior. To better understand the underlying neuropathology 
of LIG4 syndrome, in which mutations in Lig4 encoding the DNA ligaseIV enzyme 
leads to DNA repair deficiency, I have used the Lig4 R278H mouse model to 
study the neurodevelopmental defects that may arise from accumulation of 
unrepaired DNA DSBs. First, I observed that the homozygous Lig4R/R mouse 
also exhibits microcephaly, with ~20% reduction in brain weight of P28 mutants 
compared to wild-type littermates. However, brain histology of Lig4R/R mice is 
grossly normal, though there is decreased cellularity specific to the anterior 
dorsolateral cortex. These findings are in line with MRI from a LIG4-deficient 
patient, who exhibited reduction in head circumference but no gross 
malformations or changes in gyral patterns. I further demonstrate that increased 
cell death in the E14.5 Lig4R/R cerebral cortex, which may contribute to 
microcephaly observed postnatally. While cell death was observed in all layers of 
the embryonic cortex, it was most pronounced in the Tuj1+ cortical plate, though 
it is unclear whether cell death is initiated following neuronal differentiation or 
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whether susceptibility to DNA DSBs is greater among progenitors and 
accumulate as they are differentiating into neurons. 
 These results are a starting point to gain insight into the neurological 
deficits that may arise in LIG4-deficient patients. However, to provide greater 
clinical applicability of our study, I propose several future studies. LIG4-deficient 
patients are highly sensitivity to ionizing radiation, and studies in other Lig4 
mutant mouse models have demonstrated unique susceptibility of specific neural 
progenitor subtypes to radiation (Gatz et al., 2011). Since there is reported 
variability in clinical features among LIG4-deficient patients, radiation studies in 
our Lig4 R278H model will confirm whether neuropathology is comparable across 
several Lig4 mutant mouse models or whether certain Lig4 mutations may confer 
heightened radiation sensitivity. These findings would be directly applicable to 
treating future patients with LIG4 syndrome, as it may be preferable to avoid 
radiation to treat malignancy in certain LIG4 mutations. 
Furthermore, it will be important to study the impact of DNA repair 
deficiency in other regions of the CNS. While our studies have focused on the 
cerebral cortex, we suspect that other regions in the brain must also contribute to 
the significant reduction in brain weight and size in the postnatal Lig4-deficient 
mouse. Previous reports have reported cell death throughout the CNS in Lig4 
null mice (Frank et al., 2000), as well as reduced cellularity of the hippocampus 
following deletion of Lig4 using the Emx1-Cre driver, which is expressed in all 
progenitor and postmitotic neurons in the medial and dorsolateral cortex (Lee et 
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al., 2012). Comparison of several broad regions of the brain, including the 
hippocampus and subcortical areas, may direct investigation of neurobehavioral 
phenotypes that may be present in Lig4 deficiency and provide more insight into 
how the Lig4 R278H mutant models human LIG4 syndrome. 
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Appendix I 
Sonic Hedgehog promotes proliferation of Notch-dependent monociliated 
choroid plexus tumor cells 
 
 	
This work is published in: Li L, Grausam KB, Wang J, Lun MP, Ohli J, Lidov 
HGW, Calicchio ML, Zeng E, Salisbury JL, Wechsler-Reya RJ, Lehtinen MK, 
Shϋller U, Zhao H (2016). Sonic Hedgehog promotes proliferation of Notch-
dependent monociliated choroid plexus tumour cells. Nature Cell Biology 
18(4):418-430. 
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Abstract 
Aberrant Notch signaling has been linked to many cancers including 
choroid plexus (ChP) tumors, a group of rare and predominantly pediatric brain 
neoplasms. We developed animal models of ChP tumors by inducing sustained 
expression of Notch1 that recapitulate properties of human ChP tumors with 
aberrant NOTCH signaling. Whole transcriptome and functional analyses showed 
that tumor cell proliferation is associated with Sonic Hedgehog (Shh) in the tumor 
microenvironment. Unlike ChP epithelial cells, which have multiple primary cilia, 
tumor cells possess a solitary primary cilium as a result of Notch-mediated 
suppression of multiciliate differentiation. A Shh-driven signaling cascade in the 
primary cilium occurs in tumor cells but not in epithelial cells. Lineage studies 
show that ChP tumors arise from monociliated progenitors in the roof plate 
characterized by elevated Notch signaling. Abnormal SHH signaling and distinct 
ciliogenesis are detected in human ChP tumors, suggesting the SHH pathway 
and cilia differentiation as potential therapeutic avenues.  
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Introduction 
 Choroid plexus (ChP) neoplasms represent rare primary brain tumors 
found predominantly in children. While ChP papillomas (CPPs) are benign, ChP 
carcinomas (CPCs) are malignant (Gopal et al., 2008; Ogiwara et al., 2012). 
These tumors are believed to originate from ChP epithelium, which differentiate 
from the roof plate to form the ChP, a specialized tissue that produces 
cerebrospinal fluid (CSF) in each ventricle of the brain (Lun et al., 2015a). 
Surgical resection remains the primary treatment for CPPs and is associated with 
excellent prognosis. However, clinical outcomes for patients with incompletely 
resected tumors, recurrent tumors, metastatic spread, or CPCs can be 
devastating (Safaee et al., 2013b; Sun et al., 2014). Notch signaling, tumor 
protein p53 (TP53) mutations, and genetic and epigenetic changes have been 
described (Dang et al., 2006; Nupponen et al., 2008; Hasselblatt et al., 2009; 
Tabori et al., 2010; Fouladi et al., 2011; Beschorner et al., 2013; Safaee et al., 
2013a; Ruland et al., 2014; Merino et al., 2015; Tong et al., 2015).  
Sonic hedgehog (Shh) signaling, a crucial pathway in development and 
cancers, is mediated by Patched (Ptch1) and Smoothened (Smo) receptors in 
the primary cilium where they orchestrate a signaling cascade that activates the 
expression of downstream targets, including Gli1, Mycn, and cyclin D1 (Ccnd1) 
(Jiang and Hui, 2008; Barakat et al., 2010). By inducing sustained Notch1 
expression, we developed mouse models of ChP tumors that closely resemble 
human ChP tumors with abnormal NOTCH signaling. We show that Notch-
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induced ChP tumor relies on Shh from the tumor microenvironment through their 
primary cilium. Aberrant SHH signaling and unique cilia patterns found in human 
ChP tumors may serve as potential therapeutic targets. 
 
Methods 
Mice 
Gt(ROSA)26Sortm1(Notch1)Dam/J (Rosa26-NICD1) mice, B6.129X1-
Gt(ROSA)26Sortm1(EYFP)Cos/J (Rosa26-EYFP) mice, B6.129S-Atoh1tm4.1Hzo/J 
(Math1M1GFP) mice, and B6.Cg-Tg(Atoh1-cre)1Bfri/J (Math1-Cre) transgenic mice, 
and C57BL/6 mice (all from Jackson Laboratory), and Tg(Lmx1a-cre)1Kjmi 
(Lmx1a-Cre) transgenic mice were maintained by breeding with C57BL/6 mice. 
Experimental procedures on animals housed at Sanford Research were 
approved by Sancrod Research Instituational Animal Care and Use Committee 
and performed in compliance with national regulatory standards. No statistical 
method was used to predetermine sample size in animal experiments. The 
animal experiments were not randomized. The investigators were not blinded to 
group allocation during experiments and outcome assessment. Experimental 
animals were administered 100mg/kg vismodegib (LC laboratories, V-4050) or 
vehicle following two regimens: daily treatment from day E15.5 to E18.5 
(Mcre;NICD1 mice: 10 animals for each treatment); or from day E17.5 to day P7 
(Lcre;NICD1 mice: 29 animals for vismodegib, 26 animals for vehicle), by gastric 
gavage of pregnant or nursing females. 
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Human Samples  
All human ChP tumor and normal ChP tissue samples were procured with 
informed consent from patients following the requirements by Institutional Review 
Boards at Sanford Research, Sanford Burnham Prebys Medical Discovery 
Institute, and Ludwig-Maximilans-University. All ChP specimens from Boston 
Children’s Hospital were obtained under approved institutional review board 
protocol (Supplementary Table 7). Normal human ChP epithelial cells (ScienCell) 
were used as the control in gene expression analysis. All tissues were handled in 
accordance with guidelines and regulations for the 26 research use of human 
brain tissue set forth by the NIH (http://bioethics.od.nih.gov/humantissue.html). 
Diagnoses of human ChP specimens from Boston Children's Hospital were 
reviewed by two neuropathologists (H.G.W.L., S.S.) using standard WHO criteria.  
 
Isolation and culture of primary ChP cells 
Multiple sets of ChP specimens from Mcre;NICD1 and/or wild-type mice were 
collected. To obtain sufficient number of cells, each set of specimens included 
tissues pooled from multiple animals of the same genotype. Gender information 
is not available for animals at P0 and P7. Both male and female animals were 
used at other time points (see Supplementary Table 9 for information on animals 
used for each experiment). Dissected ChP specimens were dissociated with 
forceps under a stereoscope followed by enzymatic digestion at 37°C for 20min 
in 0.7mg/ml of hyaluronic acid (H3506, Sigma-Aldrich), 0.2mg/ml of kynurenic 
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acid (Sigma-Aldrich K3375), and 1mg/ml of trypsin in Hank's balanced salt 
solution (HBSS, 14170-112; Life Technologies) supplemented with 2mM glucose. 
The trypsin inhibitor ovomucoid (LS003085, Worthington Biochemical 
Corporation) was added to stop enzymatic digestion and dissociated ChP cells 
were centrifuged at 200g for 5min at 4°C. Cell pellets were resuspended in 
Dulbecco's modified Eagle's medium/Nutrient Mixture F-12 Ham's-Liquid Media 
(DMEM/F12, SH30271; Thermo Fisher Scientific), and cultured in DMEM/F12 
supplemented with 30 ng/ml of EGF (Sigma-Aldrich E4127), 30 ng/ml of FGF2 
(Sigma-Aldrich F0291), B27 supplement, 2mM glutamine, and 100U/ml 
penicillin/streptomycin (all from Life Technologies). After treatment under serum-
free conditions for 96 h, cells were dissociated mechanically by pipetting and 
quantified. For culture with serum, medium was supplemented with 10% fetal 
bovine serum. Cytosine β-D-arabinofuranoside (Ara-C, 20 µM; Sigma-Aldrich 
C1768) was added the following day to eliminate contaminating fibroblasts. 
Cultured cells were treated with ShhN (200 ng/ml) (Zhao et al., 2008), or SAG 
(200 nM; 11914, Cayman Chemical Company), with or without cyclopamine (10 
µM; LC laboratories C-8700). Primary ChP tumor or epithelial cells were not 
listed in the database of commonly misidentified cell lines maintained by ICLAC 
and NCBI Biosample. Analyses of gene expression, proliferation and signal 
transduction were performed in cultured primary ChP cells (Figures A1.4a-d, 
A1.6b-d,f-h; A1.S7g). Results from these studies confirmed their identity. Given 
the short time (<8 days) during which ChP cells were maintained as primary 
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cultures supplemented with antibiotics, we did not test for mycoplasma 
contamination. 
 
Histology, immunohistochemistry, immunofluorescence, and 
immunocytochemistry 
Whole brains were fixed overnight in 4% paraformaldehyde (PFA) and processed 
for paraffin embedding and sectioning. Tissue sections were deparaffinized with 
CitriSolv (Decon Labs), and then rehydrated with graded ethanol series. For 
frozen tissues, samples were further equilibrated in 20% sucrose at 4°C for 24-48 
h, embedded in Tissue-Tek Optimal Cutting Temperature (O.C.T.) compound 
(Sakura Finetek), and sectioned (15-20 µm thickness) on a cryostat. Cultured 
cells were fixed in 4% PFA at room temperature for 10min and stored in 
phosphate-buffered saline (PBS). For primary cilia staining, cells were fixed with 
cold methanol for 10min and stored in PBS at 4°C.  
No randomization was used to determine how samples were allocated to 
experimental groups and processed. Immunostaining was carried out as 
described previously (Zhao et al., 2008). Heat-induced epitope retrieval was 
performed for paraffin-embedded tissue sections in Rodent Decloaker (Biocare 
Medical). For immunohistochemistry, endogenous peroxidase activities were 
inactivated in 3% H2O2 for 10 min at room temperature. Tissue sections were 
blocked with 10% normal sera in PBS-0.1% Triton X-100 for 1 h at room 
temperature and incubated with primary antibodies for 1 h. After washes with 
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PBS, biotinylated secondary antibodies were applied for 1 h, followed by 
treatment with avidin/biotinylated enzyme complex and substrate/chromogen 
incubation (Vector laboratories). Slides were counterstained with hematoxylin. 
For immunofluorescence, tissue sections or cells were sequentially probed with 
primary antibodies and fluorescently labeled secondary antibodies (Jackson 
Immunoresearch). Primary antibodies used and dilution ratios are: mouse 
monoclonal anti-acetylated α-tubulin (1:500, ab24610, clone 6-11B-1, Abcam), 
mouse monoclonal anti-acetylated α-tubulin (1:500, Sigma-Aldrich T7451, clone 
6-11B-1), mouse monoclonal anti-Arl13b (1:500, clone N295B/66, NeuroMab), 
rabbit anti-Arl13b (1:500, 17711-1-AP, Proteintech), mouse monoclonal anti-
aquaporin 1 (1:1,000, clone 1/22, Abcam ab9566), rabbit anti-aquaporin 1 
(1:1,000, AB2219, EMD Millipore), rabbit monoclonal anti-cleaved caspase-3 
(Asp175; clone 5A1E; 1:800, 9664, Cell Signaling Technology), mouse 
monoclonal anti-Ccnd1 (1:100, sc-450, clone 72-13G, Santa Cruz 
Biotechnology), mouse monoclonal anti-Cdkn1b (p27 Kip1; 1:100, 610242, clone 
57/Kip1/p27, BD Biosciences), rabbit anti-cytokeratins (1:100, Z0622, Dako, 
Carpinteria), mouse monoclonal anti-Foxj1 (1:50, 14-9965, Clone 2A5, 
eBioscience), chicken anti-GFP (1:1,000, GFP-1010, Aves Lab), mouse 
monoclonal anti-γ-tubulin (Sigma-Aldrich T6557, clone GTU-88, 1:10,000), 
guinea pig anti-Hes1 (1:150, from R. Kageyama), rabbit monoclonal anti-Ki-67 
(abcam ab16667, clone SP6, 1:100), goat anti-Lmx1a (Santa Cruz sc-54273, 
1:100), rabbit anti-MafB (1:200, IHC-00351, Bethyl Laboratories), rabbit anti-Otx2 
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(EMD Millipore AB9566, 1:500), rabbit anti-Smo ((Kim et al., 2010a); 1:100), 
sheep anti-transthyretin (Abcam ab9015, 1:500). 
The investigator was blinded to group allocation in the following two 
experiments. First, EYFP+ or GFP+ cells in 300 Otx2+ cells were assessed by 
analyzing three distinct tissue regions of each sample. The percentage of EYFP+ 
or GFP+ cells was obtained by averaging the numbers of EYFP+ or GFP+ cells 
per 100 Otx2+ cells of all samples for each genotype at each time point. Second, 
in analysis of cell proliferation, the numbers of Ki-67+ cells in 300 Lmx1a+ or 
GFP+ cells were assessed from three distinct tissue regions for each animal. The 
percentage of Ki-67+ cells in the total Lmx1a+ or GFP+ cell population was 
calculated by averaging the numbers of Ki-67+ cells per 100 Lmx1a+ or 100 
GFP+ cells of all samples for each genotype at each time point or each 
treatment. For proliferation analysis of cultured cells, Ki-67 expression was 
assessed by analyzing three distinct fields: the percentage of Ki-67+ cells was 
calculated by averaging the numbers of Ki-67+ cells per 100 cells of all samples 
for each treatment. 
For primary cilia staining of ChP specimens from mice, the cilia pattern 
was assessed by analyzing three distinct tissue regions of each animal. To 
measure the length of primary cilia, 12 primary cilia from tumor cells and 10 
primary cilia from epithelial cells were examined. Smo ciliary translocation was 
assessed by analyzing three distinct fields: the percentage of cells with ciliary 
accumulation of Smo was calculated by averaging the number of cells with Smo 
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translocation per 100 cells of all samples for each treatment. Information on 
animals used for each experiment can be found in Supplementary Table 6.9. 
For staining of primary cilia in human ChP tumors and normal human 
ChPs, the investigator was blinded to group allocation. Tissues used include: 
normal ChP: 6 disease-free individuals; CPP: 17 tumor specimens from 16 
individuals; CPC: 13 tumors from 10 individuals (Supplementary Table 9). Cilia 
staining was assessed by analyzing 5 distinct tissue regions. 
 
EdU (5-ethynyl-2'-deoxyuridine) incorporation experiment  
One hour after intraperitoneal injection of 100mg/kg EdU (7180, Setareh 
Biotech), whole brains were collected from animals. Tissue sections were rinsed 
with Tris-buffered saline (TBS) and then incubated for 20min with solution 
consisting of 100mM pH 8.5 Tris, 1 mM CuSO4, 10 mM Cy5-azide (B3030, 
Lumiprobe) and 100 mM ascorbic acid. Information on animals used is provided 
in Supplementary Table 9. 
 
Image Acquisition 
Whole-mount images were obtained using a Nikon SMZ1000 Stereomicroscope. 
Light and fluorescent microscopic images were obtained by Nikon Eclipse 90i 
microscope system or Nikon confocal microscope system A1+.   
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Transmission Electron Microscopy 
ChP specimens were collected at different time points. To ensure collection of a 
sufficient amount of normal ChP specimens, each normal ChP specimen 
includes tissues pooled from two wild-type animals for P7, P14 and P22. 
Information on animals used is available in Supplementary Table 6.9.  The 
investigator was blinded to group allocation. Tissues were fixed in 4% PFA, 1% 
glutaraldehyde in 0.1M cacodylate buffer (pH 7.4) at 4°C overnight. After washing 
specimens with cacodylate buffer supplemented with 10% sucrose, tissues were 
post-fixed wit 1% osmiumtetroxide (OsO4), followed by incubation with 1% uranyl 
acetate in 30% ethanol. Tissue samples were dehydrated, then transferred to 
propylene oxide, and embedded in Eponate-12 epoxy resin (Ted Pella). Tissue 
samples were sectioned (85 nm thickness) with a Leica UC-6 ultramicrotome. 
Sections were counterstained with uranyl acetate and lead citrate, and observed 
under the JEOL 1400 transmission electron microscope (JEOL). Images were 
taken with a Gatan UltraScan 1000 CCD (charge-coupled device) digital camera 
(Gatan). 
 
Immunoblotting 
Immunoblotting was carried out as described previously (Zhao et al., 2008). 
Multiple sets of ChP specimens were collected at each time point. To obtain a 
sufficient quantity of protein, each set of specimens may contain tissues pooled 
from several animals of the same genotype. Gender information is not available 
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for animals at P0 and P7 (See Supplementary Table 9 for information on animals 
used). Tissues were homogenized in protein lysis buffer 
(Tris/HCl pH 7.4, 1 mM EDTA, 150 mM NaCl, 1% NP40, 0.25% sodium 
deoxycholate, 1X protease inhibitor cocktails  (Research Product International, 
Mount Prospect, IL)). Protein concentrations were measured by a standard BCA 
assay (Life Technologies). Equal amounts of protein samples were resuspended 
in a reduced sample buffer, separated by SDS-PAGE, and transferred to a 
polyvinylidene difluoride membrane. After incubation with 5% nonfat milk in TBST 
(TBS, 0.5% Tween 20) for 1 h, the membrane was incubated with primary 
antibodies for 1 h. The membrane was washed and incubated with horseradish 
peroxidase (HRP)-conjugated secondary antibodies (GE Healthcare) for 1 h. 
After washes, chemiluminescence detection was performed using Western 
Lightning Plus-ECL (PerkinElmer). β-actin was used as a protein loading control. 
Primary antibodies used include:  mouse monoclonal anti-β-actin (Sigma-Aldrich 
A5441, clone AC-15, 1:2,000), rabbit anti-Aquaporin 1 (EMD Millipore AB2219, 
1:1,000), rabbit anti-Ccnd1 (Santa Cruz sc-450, clone 72-13G, 1:200), rabbit anti-
Hes1 (R. Kageyama, 1:1,000), rabbit anti-Otx2 (EMD Millipore AB9566, 1:500). 
 
RNA preparation, quantitative RT-PCR, in situ hybridization, microarray, 
and RNA-seq 
For murine tissues, three independent sets of tumor specimens from 
Mcre;NICD1 mice and three sets of ChP specimens from wild-type mice were 
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collected at each time point. To ensure that a sufficient amount of RNA can be 
extracted, each set of specimens included tissues pooled from several animals of 
the same genotype. Gender information was not available for animals at P0 and 
P7 (see Supplementary Table 9 for information on animals used for each set of 
specimens). For human tissues, seven CPPs from seven individuals, two CPCs 
from two individuals, and normal human ChP epithelial cells (ScienCell) were 
used (Supplementary Table 9). Total RNA was extracted using Trizol and 
PureLink RNAMini Kit (Life Technologies) according to the manufacturer's 
instructions. For quantitative RT-PCR (Q-RT-PCR), total RNA samples were 
converted to cDNA using the GoScript Reverse Transcription System (Promega). 
All reactions were set up in triplicate with ABsolute Blue QPCR Mix (Thermo 
Fisher Scientific) and run on an ABI 7000 Sequence Detection System (Life 
Technologies). Gene-specific primers and probes for mouse Aqp1, Ttr, Gli1, 
Mycn, Shh, Ptch1, Smo, Hes1, Hes5, Foxj1, Mcidas and control Actinb were 
used (Supplementary Table 6.8). The following Taqman assays for human genes 
were used (Life Technologies): GLI1 (Hs01110766_m1), PTCH1 
(Hs00181117_m1), MYCN (Hs00232074_m1), HES5 (Hs01387463_g1), HES1 
(Hs00172878_m1), HEY1 (Hs01114113_m1), ACTB (Hs99999903_m1). Data 
were analyzed using ABI Fast System SDS software. Transcript levels were 
determined as the number of transcripts for each gene relative to those of Actb 
(mouse) or ACTB (human). The results for each set of specimens were obtained 
by averaging transcript levels of technical triplicates and used for subsequent 
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analyses. Data from Q-RT-PCR experiments can be found in Supplementary 
Table 9. Exclusion was applied only on rare occasions when one of the three 
wells of the triplicate was a significant outlier; however, for each sample in 
question, Q-RT-PCRs were repeated in independent experiments, which 
validated the exclusion. 
In situ hybridization was performed by RNA In Situ Hybridization Core 
facility at Baylor College of Medicine as described previously (Yaylaoglu et al., 
2005). For analysis of Shh, Mycn and Gli1 expression, ChP specimens from 
multiple animals were collected at P0 and P14. For analysis of Mycn expression 
in Mcre;NICD1 animals treated with vismodegib or vehicle, three tumors from 
three vismodegib-treated mice, and five tumors from five vehicle-treated mice 
were examined at P0. For Hes1 and Hes5 expression analysis, two Mcre;NICD1 
mice and one wild-type mouse were collected at day E14.5. Gender information 
was not available for embryos, P0 animals, and the P8 animal for sense probe 
controls (see Supplementary Table 9 for information on animals used for each 
experiment). For human tissue samples, SHH (probe no. 600951), PPIB (positive 
control, probe no. 313901), dapB (negative control, probe no. 310043) RNA were 
visualized using RNAscope 2.0 HD detection kit-BROWN (Advanced Cell 
Diagnostics) according to the manufacturer's protocol. Human tissues used 
include: normal ChP: 5 disease-free individuals; CPP: 11 tumor specimens from 
10 individuals; CPC: 10 tumors from 10 individuals (Supplementary Tables 7 and 
9). SHH expression was assessed in five distinct tissue regions: percentage of 
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SHH-expressing cells was calculated by averaging the numbers of SHH+ cells 
per 100 cells in five distinct tissue regions of each specimen. 
Microarray and RNA-seq studies were performed at the DNA Analysis 
Core at Sanford Burnham Prebys Medical Discovery Institute. For microarray 
experiments, labeled cRNA was prepared from 500 ng RNA using the Illumina 
RNA Amplification Kit from Ambion (Life Technologies). The labeled cRNA 
(1,500 ng) was hybridized overnight at 58°C to the SentrixMouseWG-6 
Expression BeadChip (>46,000 gene transcripts; Illumina) according to the 
manufacturer's instructions. BeadChips were subsequently washed and 
developed with fluorolink streptavidin-Cy3 (GE Healthcare). BeadChips were 
then scanned with an Illumina BeadArray Reader. tumorPathway analysis using 
the GeneGoMetaCore Analytical Suite (http://genego.com; GeneGo) was used to 
score and rank pathways enriched in data sets by the proportion of pathway-
associated genes with significant expression values. 
For RNA-seq experiments, total RNA samples were ribo-depleted using 
the Ribominus Eukaryote System (Life Technologies), and used to generate 
sequencing libraries of barcoded fragment using the Ion Total RNA-Seq Kit V2 
(Life Technologies). Libraries were sequenced on the Ion Proton sequencer, 
three libraries per Ion Proton PI Chip, using 200 bp sequencing reagents. Reads 
were aligned to the mouse genome (mm10) using a combination of Tophat2, and 
Bowtie2 (http://tophat.cbcb.umd.edu). Differentially expressed transcripts were 
detected using the Cuffinks Cuffdiff package (http://cu_inks.cbcb.umd.edu) and 
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transcripts with a q value <0.05 (Cuffdiff) were analyzed by ingenuity pathway 
analysis (Ingenuity Systems). Principal component analysis was performed using 
R package rgl (http://cran.r-project.org/web/packages/rgl/index.html), a three-
dimensional visualization system based on OpenGL. Hierarchical clustering was 
performed using Genesis (http://genome.tugraz.at/genesisclient/genesisclient_ 
description.shtml). 
 
Statistical analysis and reproducibility 
Statistical analyses were performed with GraphPadPrism 6.0 (GraphPad 
Software). All pooled data were expressed as the mean ± s.e.m. Differences 
between two groups were compared using an unpaired two-tailed t-test. 
Differences between multiple groups were analysed with one-way or two-way 
ANOVA followed by Tukey's multiple comparisons test. Results were considered 
significant at P<0.05. (*); P<0.01 (**); P<0.001 (***); P<0.0001 (****). 
For western blot analysis, the expression of Aqp1 and Otx2 at P14, Hes1 
expression at P0 and P7, were repeated in one independent experiment. 
Analyses of the expression of Hes1 at P90, and Ccnd1 expression were 
repeated in two independent experiments with similar results. RNA-seq and 
microarray studies were performed in single experiments. For in situ 
hybridization, analyses of Mycn expression in vismodegib-treated animals, and 
Mycn and Gli1 expression at P0 and P14, were repeated in one independent 
experiment with similar results. Analysis of Shh, Hes1 and Hes5 expression was 
performed in single experiments (Supplementary Table 9). SHH expression 
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analysis in human tissues was conducted in one experiment with samples 
divided into two groups. For Q-RT-PCR analysis, the expression of Hes1, Hes5, 
Ttr, Ptch1, Smo and Mcidas was examined in single experiments, while Aqp1, 
Gli1, Mycn, Shh and Foxj1 expression analysis was repeated in one independent 
experiment with similar results. Q-RT-PCR analysis of human samples was 
performed in a single experiment. Analyses of cell proliferation (Ki-67 or EdU 
staining), percentage of EYFP+ or GFP+ cells in ChP epithelium, tumor cell 
numbers, and Smo translocation were performed in single experiments. The 
measurement of cilia length was repeated in one independent experiment with 
similar results. Representative images were selected from two independent 
experiments. 
 
Accession numbers 
Published human ChP tumor data sets (GSE14098, GSE60886) were 
downloaded from GEO database for analysis. Data sets from our studies were 
deposited at NCBI. Sequencing: BioProject ID, PRJNA282889; Microarray: 
GSE77123.  
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Results 
Notch pathway activation leads to ChP tumors 
A molecularly-defined boundary exists between the rhombic lip consisting 
of neural progenitors expressing the transcription factor Atonal Homolog 1 
(Atoh1, also known as Math1), and the roof plate, characterized by the 
expression of Wnt1, Gdf7, and the transcription factor Lmx1a (Machold and 
Fishell, 2005; Wang et al., 2005; Chizhikov et al., 2006; Chizhikov et al., 2010). 
Some Lmx1a+ cells are present in the rhombic lip and contribute to the 
cerebellum (Chizhikov et al., 2006; Chizhikov et al., 2010). To determine whether 
rhombic lip progenitors contribute to the roof plate/ChP lineage, we utilized 
Math1-Cre to drive Cre expression in Atoh1+ progenitors (Matei et al., 2005) 
(Figure A1.1a). When crossed with Rosa26-EYFP Cre reporter strain (Srinivas 
et al., 2001), the resulting Math1-Cre;Rosa26-EYFP mice have cells expressing 
enhanced yellow fluorescent protein (EYFP) in the ChP in addition to cerebellum 
(Figure A1.1b). Though these EYFP+ cells comprise ˂0.5% of hindbrain ChP 
epithelium, they express ChP markers Lmx1a, orthodenticle homeobox 2 (Otx2), 
cytokeratins, and Aquaporin 1 (Aqp1) (Figure A1.1c,d; A1.S1a), indicating some 
Atoh1+ progenitors contribute to hindbrain roof plate/ChP lineage. 
To determine the effects of Notch signaling on ChP, Math1-Cre;Rosa26-
EYFP mice were crossed with a Rosa26-NICD1 strain that conditionally 
expresses the intracellular domain of Notch 1 (NICD1) and green fluorescent 
protein (Murtaugh et al., 2003) (GFP, Figure A1.1a). In Math1-Cre;Rosa26- 
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NICD1;Rosa26-EYFP animals, hindbrain ChP is significantly enlarged with many 
EYFP+ cells (Figure A1.1b). Sustained NICD1 expression in Atoh1+ lineage 
leads to ˃50-fold increase (~50%) in its contribution to hindbrain ChP epithelium 
at birth that peaks at postnatal day 14 (P14) (~80%) (Figure A1.1d, A1.S1a). 
While wild-type ChP epithelium exhibits an orderly cobblestone-like appearance 
with a rough, “hobnail” configuration on apical surfaces, ChPs from Math1-
Cre;Rosa26-NICD1 (Mcre;NICD1) mice are characterized by papillary projections 
lined by flattened epithelium with cell crowding, elongation, and stratification, 
reminiscent of human CPP (Figure A1.1e,f; A1.S1b). When the Rosa26-NICD1 
strain was crossed with Lmx1a-Cre transgenic mice that express Cre in the roof 
plate/ChP lineage (Chizhikov et al., 2006), abnormal ChP growth with identical 
characteristics developed in the lateral ventricles and hindbrain of Lmx1a-
Cre;Rosa26-NICD1 (Lcre;NICD1) animals (Figure A1.S2). Although these 
abnormal ChP growths do not invade surrounding regions, CSF accumulation 
and ventricular dilation are present in these animals (Figure A1.1e; A1.S1b, 
A1.S2), and 40-50% of Lcre;NICD1 animals die from hydrocephalus. ChP tumors 
of Mcre;NICD1 mice exhibit increased expression of Hes1 and Hes5, indicating 
Notch pathway activation (Figure A1.1g; A1.S1c,d). While no Ki-67 expression 
is detected in wild-type ChP epithelium at P7, abundant Ki-67+ cells are present 
in ChPs from age-matched Mcre;NICD1 or Lcre;NICD1 mice, resembling cell 
proliferation in human ChP tumors (Figure A1.1h), indicating that Notch pathway 
activation causes aberrant growth of ChP into tumors. 
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Enhanced proliferation in Notch-induced ChP tumor 
While ChP epithelial cells in wild-type and Math1-Cre;Rosa26-EYFP mice 
(EYFP+ or EYFP-) remain post-mitotic after birth, ~40% of NICD1+/GFP+ cells in 
Mcre;NICD1 mice are Ki-67+. This percentage gradually decreases to ~1% after 
3 weeks of age (Figure A1.2a,b; A1.S3a). EdU (5-ethynyl-2'-deoxyuridine) 
incorporation assays also revealed enhanced tumor cell proliferation in 
Mcre;NICD1 mice (A1.S4a). As tumor cells exit the cell cycle, Ccnd1 expression 
is downregulated, while Cdkn1b (p27 Kip1) expression is upregulated (Figure 
A1.2c; A1.S4b,c). Cleaved caspase-3 expression is not detected (Figure 
A1.S4d). Together, these results indicate that Notch-induced ChP tumor 
undergoes enhanced proliferation transiently after birth. 
Tumor cells express the ChP marker Lmx1a, but not mesenchymal marker 
MafB (Nielsen and Dymecki, 2010), and the expression of Aqp1, Transthyretin 
(Ttr), cytokeratins, and Otx2 is consistently reduced compared to ChP epithelial 
cells (Johansson et al., 2013) (Figure A1.2d-f; A1.S3b; A1.S4e,f), indicating that 
sustained Notch signaling interferes with differentiation of tumor cells even after 
they become post-mitotic. 
 
Abnormal Shh signaling in ChP tumor cells 
To identify signals that drive tumor cell proliferation, we compared 
transcriptional profiles of tumors and wild-type ChPs at P0 (tumor cells are 
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proliferative) and P21 (tumor cells are postmitotic) using RNA-seq. Tumors and 
ChPs clustered separately in principal component analysis, indicating distinct 
molecular profiles (Figure A1.3a). Tumor cells exhibit gene expression profiles 
defined by differential expression of 2,738 (P0) and 4,964 (P21) transcripts 
(Supplementary Table 1; Figure A1.3b). Study of these differentially expressed 
transcripts identified 1,705 common targets, including Hes1 and Hes5, Aqp1, 
cytokeratins, and Otx2, all of which show significant differential expression by Q-
RT-PCR and immunostaining analyses, validating RNA-seq results (Figures 
A1.1g, A1.2d-f, and A1.3d,e, A1.S1c,d, A1.3b, A1.4e; Supplementary Table 1). 
Although tumor cells express higher mRNA levels for roof plate markers Lmx1a, 
Gdf7, Zic3, Zic4, and Msx2, the expression of many genes found in ChP 
epithelium is significantly lower (Liu et al., 2004; Elsen et al., 2008; McMahon 
and Merzdorf, 2010; Marques et al., 2011; Bowyer et al., 2013; Janssen et al., 
2014) (Figure A1.3c,e; Supplementary Table 1). 
Comparison of tumor expression profiles at P0 and P21 uncovered 4,910 
differentially expressed transcripts (Figure A1.3b; Supplementary Table 2). We 
reasoned that differential genes unique to P0 tumor cells may include those 
involved in proliferation. To identify these genes, we excluded the 1,705 common 
differential targets between tumors and ChPs at each time point to obtain 1,033 
differential transcripts in tumors at P0 (Figure A1.3b). We overlapped these 
1,033 unique targets with the 4,910 differential genes between tumors of P0 and 
P21, further narrowing it down to 663 genes (Figure A1.3b; Supplementary 
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Table 3). Interrogating this shortened list of genes using ingenuity pathway 
analysis led us to a promising candidate, Shh signaling, which is also identified in 
analysis of larger dataset (Supplementary Tables 1, 3). Tumor cells exhibit 
increased expression of Gli1, Gli2, Mycn and Ccnd1 compared to wild-type ChP 
epithelium at P0 and P7. After P7, when tumor cells start to exit the cell cycle, the 
expression of these genes decreases to levels of those in control ChPs, 
suggesting that decreased proliferation correlates with attenuated Shh signaling 
(Figure A1.3d-g,I, A1.S4b). In addition, while the expression of p27 and Cdkn2b 
is upregulated in non-proliferating tumor cells, Cdkn1c (p57 Kip2) is expressed at 
higher levels in mature ChP (Figure A1.2c, A1.S4c, Supplementary Table 1). 
Among hedgehog ligands, only Shh is abundantly expressed in hindbrain ChP 
epithelial cells at birth and declines to undetectable levels after P14, resulting in 
lower expression levels in tumors than in wild-type ChPs at P0 (Figures 
A1.3d,e,h,i).  
 
Shh drives ChP tumor cell proliferation 
To determine the role of Shh signaling in Notch-induced ChP tumor, we 
treated tumor cells with recombinant N-terminal fragment of Shh (ShhN). Tumor 
cells formed spheres under serum-free conditions and continued to express 
Lmx1a, indicating intact lineage characteristics under these conditions (Figure 
A1.4a,c). After 96 hours, more Ki-67+ cells were detected in tumor spheres 
treated with ShhN than in untreated tumor spheres (Figure A1.4b). While 
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epithelial cells formed aggregates that remained unresponsive, the size of tumor 
spheres and number of tumor cells were increased by ShhN, including post-
mitotic tumors at P21 or later, whereas Smo inhibitor cyclopamine abolished 
such effects, indicating ShhN stimulates tumor cell proliferation (Figure A1.4c,d). 
To determine whether tumor growth requires Shh, we treated Lcre;NICD1 and 
Mcre;NICD1 animals with Smo inhibitor vismodegib (100 mg/kg) or vehicle daily 
from embryonic day 17.5 (E17.5) through P7, or from day E15.5 for 4 days, 
respectively (De Smaele et al., 2010; Xie et al., 2013a). Vismodegib treatment 
shrank hindbrain ChP tumors, significantly reduced the number of tumor cells, 
and improved the survival of Lcre;NICD1 mice (Figure A1.4e,f). Vismodegib also 
decreased tumor cell proliferation and suppressed Mycn expression in 
Mcre;NICD1 animals without affecting ChP development in wild-type littermates 
(Figure A1.4g-I, A1.S5). Together, these results indicate that Shh drives the 
growth of Notch-induced ChP tumors. 
 
SHH and NOTCH signaling in human ChP tumors 
 We examined NOTCH and SHH signaling in human ChP tumors. First, we 
used published data sets and analyzed tumor transcriptomes, epigenomes and 
genomes. Principal component analysis of human CPPs and normal ChPs 
revealed distinct molecular profiles for CPPs (Hasselblatt et al., 2009) (Figure 
A1.4j). MetaCore enrichment analysis of differential genes in human CPPs 
placed NOTCH and SHH signaling among significantly enriched pathways 
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(Figure A1.4k; Supplementary Table 4). Second, we repeated gene expression 
profiling of ChP tumors in Mcre:NICD1 animals and wild-type ChPs at P0 and 
P21 using similar microarray approach. The differentially expressed genes in 
murine CPPs overlapped with those identified in human CPPs (Figure A1.4l). 
MetaCore analysis of these common differential transcripts between murine and 
human CPPs revealed significant enrichment for genes in both pathways, 
indicating murine CPPs display striking resemblance to human CPPs (Figure 
A1.4m; Supplementary Table 5). Third, we examined data sets from recently 
published studies of human ChP tumors and found higher expression levels of 
roof plate markers in CPPs compared to CPCs (Merino et al., 2015; Tong et al., 
2015) (Figure A1.S6a). MetaCore gene expression analysis showed significant 
enrichment for SHH and NOTCH pathways in human CPCs, an observation also 
supported by analysis of methylation and copy number variation data (Figure 
A1.S6b-d; Supplementary Table 6). Q-RT-PCR analysis of human ChP tumors 
revealed increased expression for genes of both pathways in ChP tumors 
compared to normal human ChP epithelial cells (Figure A1.4n). In situ 
hybridization demonstrated SHH mRNA in both CPPs and CPCs (Percentage of 
SHH-positive cells in CPP: 24.82 ± 3.32, n=11 specimens examined from 10 
individuals; CPC: 36.33 ± 5.40, n=10; disease-free control: 100%; n=5; of note, 
signal strength varied among samples, possibly owing to brain regions sampled, 
specimen age and storage (Figure A1.S6e). Together, these results indicate that 
 	
169 
human ChP tumors exhibit aberrant NOTCH and SHH signaling, suggesting that 
both pathways may play a similarly important role in human ChP tumorigenesis. 
 
Notch-induced ChP tumor cells are monociliated 
 In vertebrates, Shh-driven signaling occurs via the primary cilium (Jiang 
and Hui, 2008; Barakat et al., 2010). To understand the mechanisms by which 
tumor cells with sustained Notch signaling respond to Shh, we examined primary 
cilia in ChP tumor and epithelial cells. Transmission electron microscopy and 
staining for cilia markers ADP-ribosylation factor-like 13b (Arl13b) (Caspary et al., 
2007), γ-tubulin and acetylated α-tubulin revealed multiple short primary cilia in 
wild-type and EYFP+ epithelial cells in Math1Cre;Rosa26-EYFP mice, whereas a 
single, longer primary cilium is present in tumor cells (epithelial cells: 1.70 ± 0.11 
µm, n = 10; tumor cells: 3.78 ± 0.13 µm, n = 12; two-tailed unpaired t test, p < 
0.0001; data from a single experiment are shown, raw data are available in 
Supplementary Table 9; Figure A1.5a-c, A1.S7a,b). Gene expression profiling 
showed that many genes involved in ciliogenesis are downregulated in tumor 
cells (Thomas et al., 2010; Hoh et al., 2012; Choksi et al., 2014) (Figure A1.5d). 
The expression of forkhead box J1 (Foxj1) and multiciliate differentiation and 
DNA synthesis associated cell cycle protein (Mcidas), two crucial regulators of 
the differentiation of cells with numerous motile cilia (Gomperts et al., 2004; Yu et 
al., 2008; Stubbs et al., 2012), is consistently reduced in tumor cells (Figure 
A1.5e, A1.S7c), indicating that Notch signaling suppresses Mcidas and Foxj1 
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expression, and blocks multiciliate differentiation of tumor cells. Similar to tumor 
cells, progenitors in hindbrain roof plate display increased expression of Hes1 
and Hes5 at day E14.5, and possess single primary cilium (Figure A1.5f,g; 
Figure A1.S7d,e), suggesting that active Notch signaling preserves the single 
primary cilium of the progenitors during development. We characterized cilia 
pattern in human ChP tumors (17 CPPs and 13 CPCs). Compared to normal 
human ChP epithelial cells with multiple cilia, CPPs comprise either monciliated 
tumor cells alone or mixed populations of monociliated and multiciliated cells. All 
CPC cilia observed were solitary primary cilia (Figure A1.5h,I; Figure A1.S7f). 
 
Monociliated ChP tumor cells are uniquely capable of transducing Shh 
signals 
To determine whether the distinct cilia pattern of tumor cells affects Shh 
signaling, we characterized Shh-driven Smo ciliary translocation. Both ChP 
epithelial and tumor cells express Lmx1a when grown with serum; however, only 
tumor cells can proliferate (Figure A1.6a,b, A1.S7g). After serum removal, cells 
were treated with ShhN or SAG, a Shh pathway agonist (Chen et al., 2002) 
(Figure A1.6a). While such treatment failed to promote ciliary accumulation of 
Smo in epithelial cells, it led to translocation of Smo into the solitary primary 
cilium of tumor cells (Shh: n = 3, 71.78 ± 6.93%, p<0.0001; SAG: n = 3, 74.99 ± 
3.03%, p<0.0001; two-way ANOVA; Figure A1.6c,d), even though both cell 
types express similar levels of Ptch1 and Smo (Figure A1.6e), indicating that 
Shh signaling in the primary cilium is preserved in tumor cells, but lost in 
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epithelial cells despite their multiple primary cilia. Indeed, ShhN or SAG restored 
the percentage of Ki-67+ tumor cells after serum removal, an effect that can be 
reversed by cyclopamine, indicating that tumor cells are uniquely capable of 
responding to Shh through proliferation (Figure A1.6f-h). 
 
Notch-induced ChP tumor arises from roof plate progenitors 
The similarity in gene expression between tumor and roof plate cells, 
together with elevated Notch signaling and solitary primary cilium in the latter, 
suggests that Notch-induced ChP tumor is related to the roof plate. To delineate 
the developmental origin of ChP tumor, we first analyzed the distribution of 
Atoh1+ progenitors in hindbrain roof plate using Math1M1GFP mice with enhanced 
green fluorescent protein (EGFP) fused to the C-terminal of Atoh1 (Rose et al., 
2009). In addition to rhombic lip, Atoh1:EGFP+ cells are present in the 
Lmx1+/Otx2+ upper roof plate but largely absent from lower roof plate (Figure 
A1.7a; A1.S8a). Second, we analyzed tumor formation in Mcre;NICD1 animals 
during development. At day E12.5, though many NICD1+/GFP+ cells are located 
in rhombic lip bordering Lmx1a+ roof plate, some NICD1+/GFP+ cells are 
present within ChP forming into papillary structures (Figure A1.7b). These 
prospective Lmx1a+ tumor cells undergo proliferation (Ki-67+), and remain 
undifferentiated (Aqp1-; Figure A1.7b; A1.S8b). At day E14.5, most 
NICD1+/GFP+ tumor cells are found in Lmx1a+ upper roof plate and rostral half 
of the ChP (Figure A1.7c). Third, proliferative progenitors (Lmx1a+/Ki-67+/Aqp1-
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) in hindbrain roof plate differentiate into post-mitotic epithelial cells that form the 
ChP epithelium (Lmx1a+/Ki-67-/Aqp1+) during embryogenesis (Awatramani et 
al., 2003; Hunter and Dymecki, 2007). The shape and size of the roof plate are 
similar between wild-type and Mcre;NICD1 mice; however, tumor cells remain 
proliferative and undifferentiated (Ki-67+/Aqp1-) even after their incorporation into 
ChP epithelium (Figure A1.8a; A1.S8c). Together, these results indicate that 
ChP tumors in these animals arise from roof plate progenitors and migrate into 
the ChP where they continue to undergo Shh-driven proliferation throughout 
development (Figure A1.8b,c). 
 
Discussion 
In this study, we examined Notch signaling in ChP tumors, a group of rare 
brain neoplasms most commonly found in children. Consistent with a role for 
NOTCH pathway in these tumors (Dang et al., 2006; Fouladi et al., 2011; 
Beschorner et al., 2013; Safaee et al., 2013a), analysis of human ChP tumor 
datasets revealed significant enrichment for NOTCH signaling. Using animal 
models, we showed that sustained Notch 1 signaling leads to ChP tumors that, 
similar to human ChP tumors, express ChP markers and undergo increased 
proliferation. Cross-species molecular analysis demonstrates that these ChP 
tumors closely resemble their human counterpart, validating our animal models 
as accurate representation of human disease. 
ChP tumors are thought to originate from ChP epithelium (Merino et al., 
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2015; Tong et al., 2015). Analysis of Math1-Cre;Rosa26-EYFP mice indicates 
that EYFP+ epithelial cells derived from Atoh1+ progenitors in roof plate exhibit 
properties similar to the rest of ChP epithelium. Indeed, the identical ChP tumors 
in Lcre;NICD1 and Mcre:NICD1 mice indicate that both Atoh1+ and Atoh1- 
lineages in ChP are sensitive to Notch signaling activation. However, despite the 
expression of ChP markers, expression of many genes found in mature 
epithelium fails to be upregulated in tumor cells, suggesting a related but distinct 
developmental origin, or a block in differentiation, or both. The presence of 
Atoh1+ progenitors and nascent tumor cells from Mcre:NICD1 mice in roof plate 
suggest ChP tumors arise from progenitors within this region (Awatramani et al., 
2003; Hunter and Dymecki, 2007). In agreement, tumor cells and these 
progenitors display similar characteristics: increased expression of roof plate 
markers, 
elevated Notch signaling, and single primary cilium. The development of ChP 
tumor induced by sustained Notch signaling may reflect its inherent role in roof 
plate/ChP morphogenesis (Bill et al., 2008; Garcia-Lecea et al., 2008; Imayoshi 
et al., 2008; Broom et al., 2012): Notch pathway suppresses multiciliate and 
epithelial differentiation of progenitors, thereby preserving the primary cilium-
based Shh signaling (Figure A1.8b). Compared to CPCs, human CPPs express 
higher levels of roof plate markers (Figure A1.S5a), consistent with their 
developmental origin. 
We provide evidence that ChP epithelial cells secrete Shh that drives the 
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proliferation of a distinct population of Shh-responsive progenitors in upper roof 
plate. Consistent with previous reports, we showed Shh expression in hindbrain 
ChP epithelium at birth that gradually disappears within two weeks (Huang et al., 
2010; Lun et al., 2015b). Interestingly, low-level cell proliferation and Mycn 
expression is detected in tumor cells from Mcre;NICD1 animals at P14, 
presumably driven by residual or transvesicular Shh from other brain regions, as 
shown for ChP-derived signals regulating distant cell populations in the brain 
(Huang et al., 2010; Lehtinen et al., 2013; Spatazza et al., 2013). Tissue-specific 
deletion may delineate the role of Shh from these sources in tumor growth 
(Huang et al., 2009c; Nielsen and Dymecki, 2010). 
Analysis of published datasets demonstrated enrichment for SHH 
signaling, suggesting a role for deregulated SHH expression in human ChP 
tumors, including CPCs (Hasselblatt et al., 2009; Merino et al., 2015; Tong et al., 
2015). Consistently, tumors from Mcre;NICD1 or Lcre;NICD1 mice exhibit active 
proliferation similar to that observed in CPCs at P0 when Shh is robustly 
expressed. Our results suggest that Shh pathway inhibition may represent a 
viable strategy for targeted therapy for ChP tumors. SHH pathway inhibitors, 
clinically approved for treating other more common cancer types, may be 
“repurposed” for treating patients with ChP tumors exhibiting abnormal SHH 
signaling. Indeed, vismodegib treatment interevenes with tumor progression in 
our models, although further validation with xenograft models would be 
necessary. The tumor becomes quiescent as Shh expression decreases, 
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suggesting that additional changes are present to support aggressive growth of 
ChP tumors as seen in human CPCs with aberrant NOTCH signaling. Tumor 
cells proliferate in the presence of serum (Figure A1.7b), indicating that serum 
may contain factors capable of driving tumor growth. Amplifications of TAF12, 
NFYC, and RAD54L play an important role in CPCs (Tong et al., 2015). Their 
expression is not significantly changed in our ChP tumors; however, deregulation 
of these genes may alter the behavior of Notch-induced ChP tumors. TP53 
alterations play a cruical role in human CPCs (Tabori et al., 2010; Merino et al., 
2015). ChP tumors in our models retain the wild-type Tp53 and exhibit signs of 
Tp53 signaling and DNA damage response (Supplementary Tables 1, 2, 3, 5; 
Figure A1.4m), suggesting that Tp53 loss may facilitate malignant 
transformation of Notch-induced ChP tumors.  
Aberrant NOTCH signaling has been linked to different cancers in humans 
and therapeutically targeted (Koch and Radtke, 2010; Groth and Fortini, 2012; 
South et al., 2012). The single primary cilium on tumor cells with constitutive 
Notch signaling proves to be essential for Shh signaling, while multiple primary 
cilia may interfere with cilium-dependent signaling activities (Mahjoub and 
Stearns, 2012; Mahjoub, 2013; Kong et al., 2015; Stasiulewicz et al., 2015). A 
Notch-regulated signaling cascade involving Mcidas, Myb and Foxj1 plays an 
important role in the differentiation of cells with multiple motile cilia (Gomperts et 
al., 2004; Yu et al., 2008; Morimoto et al., 2010; Marcet et al., 2011; Stubbs et 
al., 2012; Tan et al., 2013). Our results reveal the interaction between Notch 
 	
176 
signaling and primary cilia crucial for ChP tumorigenesis (Figure A1.8c): 
sustained Notch signaling preserves single primary cilium by suppressing Mcidas 
and Foxj1 expression to block multiciliate differentiation, transforming progenitors 
into tumor cells that undergo Shh-driven proliferation. Targeting Notch-mediated 
multiciliate differentiation may represent a rational strategy for ChP tumor 
treatment. Human ChP epithelial cells exhibit a “hobnail” contour on the apical 
side, whereas the surface of ChP tumor cells is more flattened (Dang et al., 
2006; Imai et al., 2011). Our results suggest that cilia pattern of tumor cells may 
mediate this distinct morphology. Indeed, most human ChP tumors (including all 
CPCs) display solitary primary cilium. Understanding the interaction between 
Notch signaling, ciliogenesis, and epithelial differentiation in ChP tumors is 
essential to validate the therapeutic potential of Notch inhibitors. 
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Figure A1.1. Constitutive Notch 1 signaling leads to ChP tumor. 
(a) Schematic illustration of the strategy for Notch 1 signaling activation in vivo. 
(b) Brain hemispheres and ChPs from postnatal day 7 (P7) mice are shown. 
Notice that the enlarged ChP from Math1-Cre;Rosa26-NICD1;Rosa26-EYFP 
(Mcre;NICD1;EYFP) animal contains many EYFP+ cells (arrows), while EYFP+ 
cells (arrowheads) are sparsely found in the ChP from Math1-Cre;Rosa26-EYFP 
(Mcre;EYFP) animals. Scale bar: 1 mm. (c) Analysis of gene expression in ChP 
of Math1-Cre;Rosa26-EYFP mice. EYFP expression (green) labels cells derived 
from Atoh1+ progenitors. The expression of Lmx1a (red), Otx2 (red), cytokeratins 
(red), and Aqp1 (red) labels ChP epithelial cells. Scale bar: 25µm. (d) 
Quantitation of the percentage of EYFP+ cells or NICD1+/GFP+ cells in Otx2+ 
hindbrain ChP epithelium of Mcre;EYFP mice or Math1-Cre;Rosa26-NICD1 
(Mcre;NICD1) mice, respectively, at different time points (n = 3 tumors from three 
Mcre;NICD1  per time point; ChPs from Mcre;EYFP mice: n = 4 (P0, P14), n = 6 
(P7, P21), n = 5 (P90), data from a single experiment are shown, raw data are 
available in Supplementary Table A.9; mean ± SEM, two-way ANOVA, **, 
P<0.01; ***, P<0.001; ns, non-significant). (e) H&E staining of ChPs from 
Mcre;NICD1 and wild-type (WT) mice at P0 and P14. Notice that ChP epithelium 
exhibits the “hobnail” configuration (arrowhead), while the enlarged ChP in 
Mcre;NICD1 mice appear “flattened” on ventricular surfaces (arrow). Vesicular 
sac with accumulated CSF is shown (asterisk). Scale bars: white, 500µm; black, 
25µm. (f) H&E staining of human ChP papilloma (CPP) and normal ChP. Scale 
bar: 25µm. (g) Quantitative RT-PCR (QRT-PCR) analysis of Hes1 and Hes5 
expression in ChP tumors (black circles) and wild-type ChPs (white circles) at 
P0, P7, P14, and P21 (n = 3 specimens per genotype per time point, data from a 
single experiment are shown, raw data are available in Supplementary Table A.9; 
mean ± SEM, two-way ANOVA, *, P<0.05; **, P<0.01; ***, P<0.001). (h) The 
expression of Ki-67 is shown in tumors from Mcre;NICD1 mice, Lmx1a-
Cre;Rosa26-NICD1 (Lcre;NICD1) mice, and normal ChPs from wild-type mice. 
Dotted lines mark the boundary of lateral ventricles. The expression of Ki-67 in 
human CPP and normal ChP is shown. Scale bar: 50µm.   
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Figure A1.2. Notch-induced ChP tumors undergo enhanced proliferation 
and exhibit defects in differentiation.  
(a) The expression of Ki-67 is shown in ChP tumors from Mcre;NICD1 mice at 
P0, P7, and P14; ChPs from P0 wild-type (WT) and Mcre;EYFP mice, 
respectively, serve as control. Ki-67 expression (red) labels proliferating cells, 
GFP expression (green) marks NICD1+ tumor cells, expression of Lmx1a (green) 
labels ChP epithelium in wild-type mice, and EYFP expression (green, 
arrowheads) detected with a GFP antibody demarcates ChP epithelial cells 
derived from Atoh1+ progenitors in Mcre;EYFP mice. DAPI staining (blue) marks 
nuclei. Scale bar: 25µm. (b) Quantitation of the percentage of Ki-67+ cells in 
NICD1+/GFP+ tumor cells from Mcre;NICD1 mice and Lmx1a+ wild-type ChP 
epithelial cells at different time points (n = 3 ChPs from 3 animals per genotype 
per time point, data from a single experiment are shown, raw data are available 
in Supplementary Table A.9; mean ± SEM, two-way ANOVA, ****, P<0.0001). (c) 
The expression of Ki-67 and Cdkn1b (p27 Kip1) is shown in tumors from 
Mcre;NICD1 mice and wild-type (WT) ChPs at P7. Notice that staining for Ki-67 
and p27 is mutually exclusive, and p27 or Ki-67 expression is absent in wild-type 
ChP epithelium despite positive staining in the cerebellum (Cb). Scale bar: 25µm. 
(d) The expression of Lmx1a (red), Otx2 (red), Ttr (red), Aqp1 (red), and 
cytokeratins (red) is shown in ChP tumors. GFP expression (green) labels 
NICD1+ tumor cells. Dotted lines mark the boundary between GFP+ tumor cells 
and epithelium. DAPI staining (blue) marks nuclei. Scale bar: 25µm. (e) Q-RT-
PCR analysis of Ttr and Aqp1 expression in tumors from Mcre;NICD1 mice 
(black circles) and wild-type (WT) ChPs (white circles) at different time points (n 
= 3 specimens per genotype per time point, data from a single experiment are 
shown, raw data are available in Supplementary Table A.9; mean ± SEM, two-
way; mean ± SEM, two-way ANOVA, ***, P<0.001). (f) Western blot analysis of 
Aqp1 and Otx2 expression in ChP tumors and wild-type (WT) ChPs at P14. β-
actin serves as loading control. Molecular size marker and representative image 
of unprocessed blots can be found in Supplementary Figure A1.9.  
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Figure A1.3 Notch-induced ChP tumors display aberrant Shh signaling. 
(a) Principal component analysis of ChP tumors (black dots) and wild-type ChPs 
(WT, red dots) at P21 (n = 3 specimens per genotype). (b) Venn diagram of 
differential genes (FDR < 0.05) between tumors and ChPs at P21 (A, n = 3 
specimens per genotype), at P0 (B, n = 3 specimens per genotype), and of tumor 
cells between P0 and P21 (C, n = 3 specimens per time point). (c) Hierarchical 
clustering of tumors and ChPs (n = 3 specimens per genotype per time point) 
based on genes expressed in roof plate (RP) and ChP (one-way ANOVA, FDR < 
0.05, fold change is shown). (d) Volcano-plot analysis of gene expression of 
tumors and ChPs at P0 (n = 3 specimens per genotype), and of tumors at P0 and 
P21 (n = 3 specimens per time point). Differential transcripts with statistical 
significance (FDR < 0.05, -log10 of P value, y-axis) are shown in red (˂ 2 fold 
change) or green (˃ 2 fold change) dots. Non-significant genes (FDR > 0.05) are 
shown in black or yellow dots (2-fold cutoff). Arrows label select genes with 
significant differential expression. (e) Median FKPM values of differential genes 
between tumors and ChPs (n = 3 specimens per genotype per time point, mean 
± SEM, two-way ANOVA, *, P˂0.05; **, P<0.01; ***, P<0.001). Q-RT-PCR 
analysis of the expression of Gli1 and Mycn (f), and Shh (h) in tumors (black 
circles) and ChPs (white circles) at different time points (n = 3 specimens per 
genotype per time point, data from a single experiment are shown, raw data are 
available in Supplementary Table A.9; mean ± SEM, two-way ANOVA, *, P˂0.05; 
***, P<0.001). (g) Western blot analysis of Ccnd1 expression in tumors and 
ChPs. β-actin serves as loading control (n = 3 specimens per genotype per time 
point, data from one of three independent repeated experiments are shown, raw 
data are available in Supplementary Table A.9; mean ± SEM, two-way ANOVA, 
*, P<0.05; **, P<0.01; ns, non-significant). Molecular size marker and 
representative image of unprocessed blots can be found in Supplementary 
Figure A1.9. (i) In situ hybridization analysis of Shh, Gli1, and Mycn expression in 
tumors and wild-type ChPs. Shh expression is detected in epithelium 
(arrowheads), but absent in tumor cells (arrows) at P0, a pattern complementary 
to those of Gli1 and Mycn. Scale bar: 25µm.   
 	
182 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Figure A1.3 continued)  
 	
183 
 
 
 
 
 
 
Figure A1.4. Shh drives the proliferation of Notch-induced ChP tumors.  
Lmx1a (a) (red) and Ki-67 (b) (red) expression is shown in cultured tumor cells 
from Mcre;NICD1 mice. GFP (green) marks tumor cells, DAPI staining (blue) 
labels nuclei. Scale bar: 10µm. (c) Images of tumor cells and wild-type (WT) 
epithelial cells. Scale bar: 50µm. (d) Quantitation of tumor cells after 96-hour 
treatments (n = 3 specimens per treatment per time point, raw data are available 
in Supplementary Table 6.9; mean ± SEM, two-way ANOVA, ****, P<0.0001; ns, 
non-significant). (e) Kaplan-Meier curve depicting the survival of Lcre;NICD1 
mice treated with vismodegib (n = 22 animals) or vehicle (n = 19 animals). (f) 
Hindbrain ChPs from day P7 Lcre;NICD1 mice treated with vismodegib (lower) or 
vehicle (upper). Scale bar: 1 mm. Quantitation of tumor cells in treated animals is 
shown (n = 7 animals per treatment, raw data are available in Supplementary 
Table 6.9; mean ± SEM, two-tailed unpaired t test, **, P<0.01). (g) H&E staining 
of tumors from treated Mcre;NICD1 mice. Ki-67 expression (red) labels 
proliferating cells, while GFP (green) marks tumor cells. DAPI staining (blue) 
labels nuclei. Scale bar: 25µm. (h) Analysis of tumor cell proliferation in animals 
shown in (g) (n = 10 animals per treatment; mean ± SEM, two-tailed unpaired t 
test, **, P<0.01). (i) In situ hybridization analysis of Mycn expression in tumor 
(arrows) or epithelial cells (arrowheads) in animals shown in (g). Scale bar: 
25µm. (j) Principal component analysis of human CPPs (red dots, n = 7 tumors 
from 7 individuals) and normal ChPs (blue dots, n = 8 ChPs from 8 individuals). 
(k) MetaCore analysis of differential genes in human CPPs. (l) Venn diagram 
shows the overlap of differential genes (FDR < 0.05) between human CPPs and 
normal ChPs (A), with those between murine tumors and wild-type ChPs at P21 
(B, n = 3 specimens per genotype) and P0 (C, n = 3 specimens per genotype). 
(m) MetaCore analysis of overlapping genes between mouse and human CPPs 
shown in (l). (n) Q-RT-PCR analysis of gene expression in human ChP tumors 
(CPP: n = 7 tumors from 7 individuals; CPC: n = 2 tumors from 2 individuals, raw 
data are available in Supplementary Table 6.9). Values represent relative fold 
changes in expression levels compared to normal human ChP epithelial cells.  
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Figure A1.5 Notch-induced ChP tumors possess solitary primary cilium.  
(a) Transmission electron micrographs of primary cilia in tumor cells (arrow) from 
Mcre;NICD1 animals and wild-type (WT) ChP epithelium (arrowheads). Scale 
bar: 0.5µm. (b) The expression of cilia markers Arl13b (red) and γ-tubulin (red) in 
tumor cells is shown. Dotted lines mark the boundary between GFP+ (green) 
tumor cells and Aqp1+ (yellow) epithelium. DAPI staining (blue) labels nuclei. 
Primary cilia in epithelial (arrowheads, upper) or tumor cells (arrows, lower) are 
magnified in inset pictures. Scale bar: 10µm. (c) The expression of Arl13b (red), 
γ-tubulin (red), and acetylated α-tubulin (act-α-tubulin, red) is shown in cultured 
ChP cells. GFP (green) labels tumor cells, while Aqp1 (yellow) labels epithelial 
cells. DAPI staining (blue) labels nuclei. Scale bar: 5µm. (d) Hierarchical 
clustering of tumors and normal ChPs at P0 based on 147 genes involved in cilia 
differentiation (n = 3 specimens per genotype; one-way ANOVA, FDR < 0.05, 
fold change is shown). t test, **, P<0.01). (e) Q-RT-PCR analysis of the 
expression of Mcidas and Foxj1 in tumors (black circles) and ChPs (white circles) 
at different time points (n = 3 specimens per genotype per time point, data from a 
single experiment are shown, raw data are available in Supplementary Table A.9; 
mean ± SEM, two-way ANOVA, *, P˂0.05; **, P˂0.01; ***, P<0.001). (f) In situ 
hybridization analysis of the expression of Hes1 and Hes5 is shown in hindbrain 
roof plate (red dotted lines) and tumor cells (arrows) in Mcre;NICD1 or wild-type 
animals at day E14.5. Scale bar: 100µm. (g) Primary cilia are shown for cells in 
hindbrain roof plate, ChP epithelium, and tumors shown in (f). Arl13b (red) and γ-
tubulin (red) expression marks primary cilia and basal body, respectively. DAPI 
staining (blue) labels nuclei. RP: roof plate. Scale bar: 10µm. (h) Representative 
images show ARL13B expression (red) in human ChP tumor cells (arrows) or 
normal ChP epithelium (arrowhead). Primary cilia are magnified in inset pictures. 
DAPI staining (blue) labels nuclei. Scale bar: 10µm. (i) Summary of cilia pattern 
in human CPPs (n = 17 tumors from 16 individuals), CPCs (n = 13 tumors from 
13 individuals), and normal ChPs (n = 6 ChPs from 6 disease-free individuals).   
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Figure A1.6. Monociliated ChP tumor cells are uniquely capable of 
transducing Shh signals.  
(a) Dissociated ChP tumor cells from Mcre;NICD1 animals were initially cultured 
in the presence of 10% fetal bovine serum (FBS). Cultured hChP tumor cells 
were then switched to serum-free conditions for 2 days followed by treatment 
with ShhN or SAG for 1.5 or 3 days for signaling and proliferation analysis, 
respectively. (b) The expression of Lmx1a (red) and Ki-67 (red) is shown in ChP 
tumor cells cultured with FBS. GFP (green) labels NICD1+ ChP tumor cells, while 
Aqp1 labels ChP epithelial cells. DAPI staining (blue) labels nuclei. Scale bar: 
25µm. After treatment with ShhN, SAG, or vehicle, Smo (red) localization is 
shown in ChP tumor (c) or epithelial cells (d). Arl13b expression (green) labels 
primary cilia, while DAPI staining (blue) labels nuclei. Scale bar: 10µm. (e) Q-RT-
PCR analysis of Ptch1 and Smo expression in ChP tumors from Mcre;NICD1 
animals (black circles) and wild-type ChPs (WT, while circles) at genotype, data 
from a single experiment are shown, raw data and information on animals used 
can be found in Supplementary Table 9 and methods; mean ± SEM, two-tailed 
unpaired t test, ns, non-significant). (f) The expression of Ki-67 (green) in ChP 
tumor cells from Mcre;NICD1 animals treated with ShhN for 48 hours treatment is 
shown. Arl13b expression (red) labels primary cilia, DAPI staining (blue) labels 
nuclei. Notice that Ki-67 expression is present in mono-ciliated ChP tumor cell, 
while multi-ciliated ChP epithelial cell lacks Ki-67 expression. Scale bar: 10µm. 
(g) The expression of Ki-67 (red) in ChP tumor cells from Mcre;NICD1 animals 
treated as indicated is shown. GFP (green) labels NICD1+ tumor cells. DAPI 
staining (blue) labels nuclei. Scale bar: 25µm. (h) Quantitation of the percentage 
of Ki-67+ cells in NICD1+/GFP+ tumor cells after 72-hour treatment as indicated  
(n = 4 specimens per treatment, data from a single experiment are shown, raw 
data are available in Supplementary Table A.9; mean ± SEM, two-way ANOVA, 
***, P˂0.001; ****, P<0.0001).  
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Figure A1.7. Notch-induced ChP tumors arise from progenitors in the roof 
plate. (a) Atoh1:EGFP expression in Math1M1GFP mice at day E14.5 is detected 
with a GFP antibody and shown in green signals. Lmx1a expression (red) marks 
the roof plate (marked by dotted lines), while DAPI staining (blue) labels nuclei. 
Notice that Atoh1:EGFP+ progenitors (arrows) are present only in Lmx1a+ upper 
roof plate. Scale bar: 50µm. (b) Schematic illustration of hindbrain roof plate (RP) 
and ChP at day E12.5. Solid line marks the transverse plane across the roof 
plate shown in the H&E staining and diagram. Boxed region in the diagram 
representing the interface of the rhombic lip and roof plate is shown in 
Mcre:NICD1 mice at day E12.5. GFP (green) marks Atoh1+ rhombic lip 
progenitors and prospective tumor cells (arrows) in the roof plate and ChP. The 
expression of Lmx1a (red) marks the roof plate/ChP lineage. While Ki-67 
expression (red) labels proliferating cells, Aqp1 expression (red) marks 
differentiated epithelial cells. DAPI staining (blue) labels nuclei. Scale bars: black, 
1 mm; white, 30µm. (c) Gene expression in the roof plate and ChP in 
Mcre:NICD1 mice at day E14.5. Boxed regions of progenitors within upper (a1, 
a2) and lower (b1, b2) roof plate as well as tumor cells (c) in ChP are shown in 
higher magnification. GFP expression (green) marks NICD1+ tumor cells in the 
roof plate and ChP. Lmx1a expression (red) labels the roof plate and ChP 
lineage, while DAPI staining (blue) marks nuclei. Scale bar: 300µm.  
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Figure A1.8 Notch-induced ChP tumor cells retain properties of roof plate 
progenitors.  
(a) Analysis of gene expression and cell proliferation in tumor cells and 
progenitors within hindbrain roof plate in Mcre;NICD1 and wild-type (WT) 
animals, respectively, at day E12.5. The expression of Lmx1a (red) marks the 
roof plate and ChP lineage. Ki-67 expression (green) labels proliferating cells, 
and Aqp1 expression (green) marks differentiated epithelial cells. White dotted 
lines demarcate domain of progenitors in hindbrain roof plate. Boxed regions of 
Lmx1a+/Ki-67+/Aqp1- progenitors (a, c, e, f), tumor cells (b, d) (arrows), and 
Lmx1a+/Ki-67-/Aqp1+ differentiated epithelial cells (b, d) (red bracket lines) are 
shown in higher magnification. Scale bar: 100µm. (b) Schematic diagram of 
interaction between Notch and Shh pathways during the roof plate/ChP 
morphogenesis and tumor formation. Epithelial progenitors in the roof plate (RP, 
yellow) next to the rhombic lip (RL) exhibits active Notch signaling, possess a 
solitary primary cilium, and proliferate in response to Shh (green dots) secreted 
from multiciliated epithelial cells (grey). The self-renewal will cease as Notch 
pathway activity in progenitor cells is attenuated to allow for multiciliate 
differentiation, thereby abolishing the response of the progenitors to Shh that 
drives their expansion during development. (c) Epithelial progenitors with 
constitutive Notch pathway activity (red) remain mono-ciliated and undergo 
aberrant proliferation to become tumor cells that retain the ability to respond to 
Shh signals in the local environment and undergo Shh-driven proliferation.  
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Figure A1.S1. Morphological and gene expression analysis of ChPs in 
Mcre;NICD1 mice. (a) EYFP expression (green, arrowheads) detected with a 
GFP antibody demarcates ChP epithelial cells derived from Atoh1+ progenitors in 
Mcre;EYFP mice, while GFP expression (green) labels NICD1+ tumor cells in 
Mcre;NICD1 mice at P0, P7, P14, P21, and P90. The expression of Otx2 (red) 
marks ChP epithelial cells. DAPI staining (blue) labels nuclei. Scale bar: 25 µm. 
(b) H&E staining of ChPs from Mcre;NICD1 mice and wild-type (WT) littermates 
at P0, P7, P14, and P21. Boxed regions of the abnormal growth of ChP in the 
enlarged fourth ventricle of Mcre;NICD1 animals are shown in higher 
magnification. Notice that wild-type ChP epithelium exhibits the “hobnail” 
configuration (arrowheads), while abnormal ChP growth in Mcre;NICD1 mice 
displays a “flattened” appearance on ventricular surfaces (arrow). Scale bars: 
white, 250 µm; black: 40 µm. (c) The expression of Hes1 (red) in ChPs from 
Mcre;NICD1 mice. GFP expression (green) labels NICD1+ ChP cells. Dotted 
lines mark the boundary between ChP epithelial cells and NICD1+ cells. DAPI 
staining (blue) labels nuclei. Scale bar: 25 µm. (d) Western blot analysis of Hes1 
expression in ChP tumors from Mcre;NICD1 mice and wild-type (WT) ChPs at 
P0, P7 and P90. β-actin serves as loading control. Molecular size marker and 
representative image of unprocessed blots can be found in Supplementary 
Figure 9.  
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Figure A1.S2. Morphological analysis of ChPs in Lcre;NICD1 mice. (a) Bright 
field images of brain hemispheres in Lcre;NICD1 mice and wild-type (WT) 
littermates at P14. Notice that Lcre;NICD1 mice develop abnormal growth of ChP 
(dotted red lines) and display enlarged lateral ventricle (arrows). Vesicular sacs 
with accumulated cerebrospinal fluid are shown (asterisks). Scale bar: 1 mm. (b) 
H&E staining of ChPs in hindbrain and lateral ventricles of Lcre;NICD1 animals 
and wild-type littermates at P7, P14, and P30. Notice that compared to ChPs in 
wild-type (WT) littermates (arrowheads), Lcre;NICD1 mice develop abnormal 
ChP growth (arrows) and exhibit enlarged fourth and lateral ventricles. Vesicular 
sacs with accumulated cerebrospinal fluid are shown (asterisks). Scale bars: 
white, 100 µm; black: 300 µm.  
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Figure A1.S3. Analysis of proliferation and gene expression in ChP tumors 
from Lcre;NICD1 mice. (a) The expression of Ki-67 in tumor cells in the 
hindbrain and lateral ventricles of Lcre;NICD1 animals at P0, P7, P14, and P90, 
respectively. Dotted lines mark the boundary of tumors in lateral ventricles. 
Notice that the expression of Ki-67 in tumor cells is gradually reduced over time. 
Scale bar: 25 µm. (b) The expression of Lmx1a, Otx2, Aqp1, and cytokeratins in 
ChP tumors in the hindbrain and lateral ventricles of Lcre;NICD1 mice at P7. 
ChPs at these sites from P7 wild-type (WT) littermates serve as control. Dotted 
lines mark the boundary of the fourth and lateral ventricles. Notice that tumor 
cells display reduced expression of Aqp1 and cytokeratins. Scale bar: 25 µm.  
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Figure A1.S4. Analysis of ChP tumors from Mcre;NICD1 mice and ChPs of 
wild-type (WT) mice. (a) Results of 5-ethynyl-2'-deoxyuridine (EdU) 
incorporation assays are shown for tumors at P0, P7, and P14, respectively. EdU 
staining (magenta) labels cells in S-phase of the cell cycle. GFP expression 
(green) labels NICD1+ tumor cells. Dotted lines mark the boundary between 
GFP+ tumor cells and ChP epithelium. DAPI staining (blue) labels nuclei. Scale 
bar: 25 µm. (b) The expression of cyclin D1 (Ccnd1) in tumors from Mcre;NICD1 
mice at P0 and P14, respectively. Aqp1 expression (green) labels ChP 
epithelium, while Ccnd1 expression (red) labels proliferating cells. Dotted lines 
mark the boundary between proliferative tumor cells and Aqp1+ epithelial cells. 
DAPI staining (blue) labels nuclei. Scale bar: 25 µm. (c) The presence of EdU-
incorporating cells (magenta) and Cdkn1b+ (p27 Kip1, green) cells in tumors and 
WT at P7. Though tumors contain abundant cells positive for EdU or p27 
expression, staining for EdU or p27 is mutually exclusive. Notice that p27+ or 
EdU-incorporating cells are absent in wild-type ChPs despite positive staining in 
neighboring cerebellum (Cb). Scale bar: 25 µm. (d) The expression of Cleaved 
Caspase-3 in ChP tumors and WT ChPs at P7. Cleaved Caspase-3 expression 
(red) is undetectable in tumor and ChPs. DAPI staining (blue) marks nuclei. 
Scale bar: 25 µm. (e) Gene expression in WT ChP epithelium at P7. The 
expression of Lmx1a (red), Otx2 (red), and Aqp1 (red) labels ChP epithelial cells. 
DAPI staining (blue) marks nuclei. Scale bar: 25 µm. (f) The expression of 
mesenchyme marker MafB in ChPs from Mcre;NICD1 animals at P7. GFP 
(green) labels NICD1+ tumor cells. Dotted lines mark the boundary between 
GFP+ tumor cells and ChP epithelium. MafB expression (red) is detected in 
normal ChP tissue, but absent from GFP+ tumor cells. DAPI staining (blue) 
marks nuclei. Scale bar: 25 µm.  
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Figure A1.S5. Morphological and gene expression analysis of ChPs from 
treated wild-type animals. H&E staining of ChPs from wild-type mice treated 
with either vismodegib or vehicle from day E15.5 for 4 days. The expression of 
Ki-67 (red) labels proliferating cells. Lmx1a expression (green) marks ChP 
epithelial cells. DAPI staining (blue) labels nuclei. Notice that Ki-67+ proliferative 
cells are present in neighboring cerebellum (Cb); however, there is no Ki-67+ 
cells in ChP epithelium. Scale bar: 25 µm.  
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Figure A1.S6. Transcriptome, epigenome, and genome analysis of human 
ChP tumors. (a) Hierarchical clustering of human CPPs and CPCs based on the 
expression of roof plate genes (CPP: n=24 tumors from 24 individuals; CPC: 
n=15 tumors from 15 individuals; one-way ANOVA, FDR < 0.05, fold change is 
shown). (b) MetaCore gene enrichment analysis of differentially methylated 
genes between human CPPs and CPCs (CPP: n=5 tumors from 5 individuals; 
CPC: n=15 tumors from 15 individuals). (c) Schematic illustration of results from 
MetaCore network analysis of differentially methylated genes between human 
CPPs and CPCs shown in (b). The red colored nodes indicate relatively higher 
expression and green nodes indicate relatively lower expression in CPPs 
compared to CPCs. (d) MetaCore gene enrichment analysis of copy number 
variations in human ChP tumors (CPP: n=37 tumors from 37 individuals; CPC: 
n=38 tumors from 38 individuals). (e) Representative images show in-situ 
hybridization analysis of SHH expression in normal human ChP (n=5 ChPs from 
5 disease-free individuals) and human ChP tumors (CPP: n=11 tumor specimens 
from 10 individuals; CPC: n=10 tumors from 10 individuals). Notice that SHH 
expression is present in normal hindbrain ChP epithelium (arrowheads) and 
tumor tissue (arrows). Signal intensity varied among samples, likely as a result of 
brain regions examined, conditions under which specimens were collected and 
stored, and the length of time of specimens in storage. Representative images 
are shown. Scale bar: 50 µm.  
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Figure A1.S7. Analysis of primary cilia and gene expression. (a) 
Transmission electron micrograph of primary cilia on ChP tumor cells (arrow) or 
ChP epithelium (arrowheads). Scale bar: 0.5 µm. (b) The expression of Arl13b 
(red) and ã-tubulin (red) in EYFP+ ChP epithelial cells of Mcre;EYFP mice. EYFP 
(green) detected with a GFP antibody demarcates epithelial cells derived from 
Atoh1+ progenitors in Mcre;EYFP mice, while Aqp1 (yellow) marks differentiated 
epithelial cells. DAPI staining (blue) labels nuclei. Inset pictures show high 
magnification images of EYFP+ (arrows, upper) or EYFP- epithelial cells 
(arrowheads, lower). Scale bar: 10 µm. (c) The expression of Foxj1 (red) in ChP 
tumor cells from Mcre;NICD1 mice at P14. Dotted lines mark boundary between 
tumor cells and Aqp1+ (green) ChP epithelium. DAPI staining (blue) labels 
nuclei. Notice that Foxj1 expression is reduced in tumor cells compared to 
epithelial cells. Scale bar: 25 µm. (d) Schematic illustration of hindbrain roof plate 
and ChP in mouse embryo at day E14.5. Solid line marks the transverse plane 
across the cerebellum, roof plate, and ChP. H&E staining and the diagram show 
structures in this plane. LRL: lower rhombic lip; URL: upper rhombic lip; LRP: 
lower roof plate; URP: upper roof plate; CB: cerebellum. Scale bar: 1mm. (e) 
Cilia pattern in cells within the roof plate and ChP epithelium of wild-type animals 
is shown at day E14.5. Arl13b (red) and ã-tubulin expression (red) marks primary 
cilia and basal bodies, respectively. DAPI staining (blue) labels nuclei. Scale bar: 
10 µm. (f) Representative images show the expression of acetylated α-tubulin 
(act-α-tubulin, red) and AQP1 (red) in normal human ChP and human ChP 
tumors. solitary cilium (arrows) or multiple cilia (arrowheads) are magnified in 
inset pictures. Hoechst staining (blue) labels nuclei. Scale bar: 10 µm. (g) The 
expression Lmx1a (red) and Ki-67 (red) in ChP cells from Mcre;NICD1 mice 
cultured in the presence of serum. GFP (green) labels NICD1+ tumor cells, while 
Aqp1 marks epithelial cells. DAPI staining (blue) labels nuclei. Scale bar: 25 µm.  
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Figure A1.S8. Notch-induced ChP tumors arise from progenitors in the roof 
plate. (a) Atoh1:EGFP expression in Math1M1GFP mice at day E14.5 is 
detected with a GFP antibody and shown in green signals. Otx2 expression (red) 
labels the roof plate (marked by dotted lines), while DAPI staining (blue) marks 
nuclei. Notice that Atoh1:EGFP+ progenitors (arrows) are present in Otx2+ upper 
roof plate, but absent in lower roof plate. Scale bar: 50 µm. (b) Gene expression 
in ChPs from Mcre:NICD1 mice at day E14.5. GFP (green) marks tumor cells. Ki-
67 expression (red) labels proliferating cells, and Aqp1 expression (red) marks 
differentiated epithelial cells. DAPI staining (blue) labels nuclei. Scale bar: 30 µm. 
(c) Analysis of gene expression and proliferation of tumor cells and progenitors 
within hindbrain roof plate in Mcre;NICD1 and wild-type (WT) mice, respectively, 
at day E14.5. The expression of Lmx1a (red) marks the roof plate and ChP 
lineage. While Ki-67 expression (green) labels proliferating cells, Aqp1 
expression (green) marks differentiated epithelial cells. White dotted lines mark 
domain of progenitors (Lmx1a+/Ki-67+/ Aqp1-) in hindbrain roof plate. Boxed 
regions in upper roof plate are shown in higher magnification. Red bracket lines 
mark differentiated epithelial cells (Lmx1a+/Ki-67-/Aqp1+). Stars demarcate 
tumor cells (Lmx1a+/Ki- 67+/Aqp1-). Scale bar: 25 µm.  
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Figure A1.S9. Representative unprocessed scanned images of blots. 
Western blot analysis of Hes1. (a), Aqp1 and Otx2 (b), and Ccnd1 (c) 
expression in ChP tumors from Mcre;NICD1 mice and ChPs from wild-type (WT) 
mice at different time points. β-actin serves as loading control. N/A: protein 
samples for unrelated study run on the same gel (c). 
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(Figure A1.S9 continued)  
 	
211 
Appendix II 
Progressive differentiation and instructive capacities of amniotic fluid and 
cerebrospinal fluid proteomes following neural tube closure 		
This work is published in: Chau KF, Springel MW, Broadbelt KG, Park HY, Topal 
S, Lun MP, Mullan H, Maynard T, Steen H, LaMantia AS, and Lehtinen MK 
(2015). Progressive differentiation and instructive capacities of amniotic fluid and 
cerebrospinal fluid proteomes following neural tube closure. Developmental Cell 
35(6):789-802  
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Summary 
 
After neural tube closure, amniotic fluid (AF) captured inside the neural tube 
forms the nascent cerebrospinal fluid (CSF). Neuroepithelial stem cells contact 
CSF-filled ventricles, proliferate and differentiate to form the mammalian brain, 
while neurogenic placodes, which generate cranial sensory neurons, remain in 
contact with the AF. Using in vivo ultrasound imaging, we quantified the 
expansion of the embryonic ventricular-CSF space from its inception. We 
developed tools to obtain pure AF and nascent CSF, before and after neural tube 
closure, and define how the AF and CSF proteomes diverge during mouse 
development. Using embryonic neural explants, we demonstrate that age-
matched fluids promote Sox2-positive neurogenic identity in developing forebrain 
and olfactory epithelia. Nascent CSF also stimulates Sox2-positive self-renewal 
of forebrain progenitor cells, some of which is attributable to LIFR signaling. Our 
resource should facilitate the investigation of fluid-tissue interactions during this 
highly vulnerable stage of early brain development.   
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Introduction 
 
 Morphogenesis of the cerebrospinal fluid (CSF)-filled ventricular system 
requires a series of highly stereotyped, conserved events (Bjornsson et al., 2015; 
Lowery and Sive, 2009; Massarwa and Niswander, 2013; Wilde et al., 2014). 
Tremendous changes in ambient fluid composition and brain morphology occur 
at embryonic day (E) 8.5-E10.5 in the mouse embryo, yet the relationship 
between these changes is poorly understood. At E8.5, the neuroectoderm 
destined to become the mammalian brain is exposed to amniotic fluid (AF). As 
the anterior neural tube closes, the AF captured inside the neural tube becomes 
the nascent CSF, and the entire mammalian brain subsequently develops around 
CSF-filled ventricular spaces (Ek et al., 2005; Zappaterra and Lehtinen, 2012). 
Subsequently, the neurogenic placodes that give rise to cranial sensory neurons 
(Moody and LaMantia, 2015) remain exposed to AF, while the developing brain is 
exposed to CSF. As brain development progresses, the forebrain neuroectoderm 
consists of neuroepithelial cells that rapidly divide to expand the neural 
progenitor cell pool (Bjornsson et al., 2015). Over subsequent days, the 
neuroepithelium becomes patterned, with well-defined gene expression domains 
along the anterior-posterior and dorsal-ventral axes, ultimately giving rise to the 
wealth of cells in distinct regions of the mammalian brain (Grove and Monuki, 
2013; Rallu et al., 2002a). The progressive lineage restriction of neural 
progenitors and transition to radial glial progenitors of the cerebral cortex occurs 
during this period. While pressurization of the ventricles is essential for normal 
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brain development to proceed (Desmond and Jacobson, 1977; Lehtinen and 
Walsh, 2011), little is known about the signals delivered by the AF versus 
nascent CSF and whether they instruct the development of adjacent epithelia 
during these early stages of brain development.  
 Cell intrinsic genetic programs regulate progenitor cell lineage restriction 
(Shen et al., 2006). However, extrinsic signals play important roles in specifying 
progenitor identity as well (Hunter and Hatten, 1995; LaMantia et al., 1993; 
McConnell and Kaznowski, 1991). The interplay between genetic programs 
(Manzini and Walsh, 2011; Shen et al., 2006), CSF (Lehtinen et al., 2011; Lun et 
al., 2015b), meningeal (Chatzi et al., 2013; Siegenthaler et al., 2009), and 
vascular (Kokovay et al., 2010; Shen et al., 2004; Tavazoie et al., 2008) signals 
help coordinate and synchronize brain development at later ages. At these later 
stages, secreted signals in the embryonic CSF (Lehtinen et al., 2011), many of 
which originate from the choroid plexus (Huang et al., 2009b; Lun et al., 2015a; 
Yamamoto et al., 1996), instruct the proliferation and survival of polarized radial 
glial progenitor cells as well as adult neural stem cells, in part via signal 
transduction at the cilium (Higginbotham et al., 2013; Tong et al., 2014; Yeh et 
al., 2013). Proteomic approaches have begun to characterize the composition of 
the CSF during later stages of development in different species (e.g. Chang et 
al., 2015; Dziegielewska et al., 1981; Lehtinen et al., 2011; Lun et al., 2015a; 
Parada et al., 2005; Zappaterra et al., 2007), as well as in adult (e.g. Dislich et 
al., 2015). However, around the time of neural tube closure (E8.5-E10.5), the 
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choroid plexus does not exist (Lun et al., 2015b), and the meninges as well as 
the brain’s vasculature are only beginning to form (Bjornsson et al., 2015). The 
only source of soluble extrinsic cues for neural stem cells at this time is the AF 
and nascent CSF, which contact the apical surface of all neural stem cells. 
Nevertheless, it is not known whether distinct AF and nascent CSF instruct early 
neuroepithelial cells and very few clues exist regarding the identity of such 
instructive signals. Indeed, even the basic proteomic composition of early 
embryonic AF and nascent CSF remains undefined.  
 To provide a resource to formulate and answer critical questions of how 
early neural stem cells in the central as well as peripheral nervous system are 
regulated by the adjacent fluid proteomes, we developed techniques to collect AF 
and nascent CSF from developing embryonic mouse before and after neural tube 
closure. We demonstrate the dynamic capacity of these fluids to signal via 
cardinal morphogenetic signaling pathways including Sonic hedgehog (Shh), 
Bone morphogenetic proteins (Bmps), and retinoic acid (RA). Using quantitative 
mass spectrometry (MS) of these fluids, we define their progressive proteomic 
differentiation from their common AF origin at E8.5, through E10.5 and E14.5 
when distinct AF and CSF compartments exist. We developed a neural explant 
culture system to establish that age-matched fluid-tissue interactions promote 
Sox2-positive neurogenic identity in developing forebrain neuroepithelium as well 
as peripheral olfactory epithelium. Nascent CSF promotes Sox2-positive self-
renewal of forebrain neural stem cells, and we demonstrate a role for signaling 
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via the LIFR in this process. Thus, our comprehensive resource defines 
divergence between the AF and CSF proteomes and validates the functional 
significance of these differences using in vitro and ex vivo approaches, facilitating 
the investigation of fluid-tissue interactions during the initial formation of the 
nervous system.  
 
 
Results 
 
Rapid morphological changes in brain-ventricular system during early 
development 
 In the vertebrate embryo, the transition from an open anterior neural plate 
contacted by AF to a closed forebrain adjacent to CSF-filled ventricles is a key 
morphogenetic event in brain development. At E8.5 in mouse, the 
neuroectoderm, which is home to Sox2-positive neuroepithelial cells, directly 
contacts the AF (Figure A2.1A). As the anterior neural tube closes, the AF 
captured inside the neural tube becomes the nascent CSF (Ek et al., 2005; 
Zappaterra and Lehtinen, 2012). By E9.5, Sox2-positive neuroepithelial 
progenitor cells in the developing forebrain directly contact the CSF (Figure 
A2.1A), and the forebrain continues to expand around this CSF-filled ventricle 
(Figure A2.1A). To evaluate the influence of these morphogenetic changes for 
defining the CSF as a distinct entity, we performed in utero ultrasound imaging of 
live embryos (Figure A2.1B) and quantified regional differences in the 
establishment and expansion of the ventricular system during this early phase of 
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brain development (Figure A2.1C, D). Following neural tube closure at E9, the 
lateral ventricles continuously expanded until E12.5 (E9.5: 0.092 ± 0.015 µl; 
E12.5: 1.392 ± 0.193 µl; t-test, p < 0.005, n=3; Figure A2.1C, D), while third and 
fourth ventricle expansion was most prominent between E9.5-E10.5 (Figure 
A2.1C, D). Ventricular volume in live embryos was quite distinct from that 
measured in fixed tissue in a separate set of samples. Paraformaldehyde fixation 
caused shrinkage of the ventricles by approximately 60% (data not shown). 
Taken together, following its definition with the closure of the anterior neural tube, 
the mouse ventricular system undergoes dynamic morphological changes in a 
ventricle-specific manner. 
 
Age-matched AF and CSF support neurogenic cell fate 
 Given the striking change in fluid environment that neural tube closure 
imposes on the developing neuroectoderm, we tested if E8.5 AF and E10.5 CSF 
have the capacity to differentially instruct neuroepithelial cell fate before and after 
neural tube closure. We first developed methods to collect pure samples of AF 
and CSF at these early ages. To collect E8.5 AF, the decidua and parietal yolk 
sac were removed to expose the visceral yolk sac, and AF was withdrawn from 
the amniotic cavity (Figure A2.2A). The E8.5 embryo did not appear to incur 
damage due to AF collection (Figure A2.S1A, S1B). AF was similarly collected 
from the amniotic cavity at E10.5 (Figure A2.2B). To collect E10.5 CSF, the 
extra-embryonic membranes were removed and CSF was withdrawn from the 
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telencephalic vesicles, aqueduct, and fourth ventricle (Figure A2.2C). Following 
fluid collection, samples were verified for purity (based upon absence of red 
blood cells or other particulate matter) and processed (Zappaterra et al., 2013). 
Standard litters (10-12 embryos) yielded the following volumes: E8.5 AF = 10-
15µl; E10.5 AF = 180-225µl; E10.5 CSF = 30-40µl. CSF yield was comparable to 
the ventricular size calculated by ultrasound (e.g. E10.5 ventricular volume = 3.9 
± 0.7µl/embryo; Figure A2.1D).  
We then developed a protocol for forebrain neuroectodermal explants at 
E8.5 and E10.5 and tested for the instructive capacity of AF and nascent CSF. 
Once the neuroepithelium was separated from mesenchyme and surface 
ectoderm (both are sources of local signals that might confound assessment of 
AF or CSF signaling capacity: LaMantia et al., 2000; Tucker et al., 2008), 
explants were exposed to AF or CSF from different ages (Figure A2.2D). 
Heterochronic forebrain neuroectodermal explants using Sox2:EGFP knock-in 
mice (Ellis et al., 2004) suggested that progenitor cell identity is differentially 
regulated by secreted signals received from E8.5 AF vs. E10.5 CSF. Survival as 
well as the neurogenic phenotype of immature neuroectodermal cells at E8.5, as 
assessed by Sox2:EGFP in explants, appeared optimally supported by age-
matched E8.5 AF (Figure A2.2E, F). Conversely, E10.5 CSF optimally supported 
E10.5 neuroectodermal cells (Figure A2.2G, H). These data demonstrate that 
compartment/fluid/tissue age-matching—either via changes in osmolality or 
 	
220 
through distinct signaling capacities—contributes to the maintenance of 
neurogenic progenitor cell fate. 
 
Dynamism of AF and CSF, and age-dependent instructive capacities of AF 
 There is very little insight into the quantitative changes in soluble factors 
that occur during the time that the CSF becomes a distinct fluid compartment 
from the AF. Measurement of the total protein concentration in AF and nascent 
CSF suggested that the proteomes of these fluids are tightly regulated. The total 
AF and CSF protein concentrations started to decrease from E8.5-E10.5 (Figure 
A2.3A), and the total AF protein concentration continued to decrease to E14.5 
(Figure A2.3A).  In contrast, the total CSF protein concentration sharply 
increased from E10.5-E14.5 (Figure A2.3A), consistent with previous studies (Ek 
et al., 2005; Lun et al., 2015a). Unexpectedly the E14.5 CSF proteome appeared 
less complex in comparison with E8.5 AF and E10.5 CSF when analyzed by 
silver staining (Figure A2.3B). The increase in E14.5 CSF protein concentration 
was apparently due to robust increases in certain proteins, such as albumin, 
which appeared saturated by silver staining (Figure A2.3B) and which we 
verified by quantitative MS to increase approximately two-fold between E10.5 
CSF to E14.5 CSF (albumin mean spectral counts ± SEM: E10.5 CSF = 97.1 ± 
16.6; E14.5 CSF = 201.6 ± 23.6; Mann-Whitney, p<0.05, n=3; see also Table 
S1).  
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 As the ventricular system expands during the course of early 
development, the CSF draws fluid from the AF, a process suggested to be driven 
in part by an osmolarity gradient (Alonso et al., 1998; Gato and Desmond, 2009). 
Despite the changes observed in total protein concentration between the fluids 
(Figure A2.3A), we did not detect differences in global osmolality between AF 
and CSF during this time frame (Figure A2.3C). These data agree with the 
model in which high colloid osmotic pressure, which typically constitutes a small 
fraction of the total osmotic pressure and is generated locally by individual or 
groups of proteins, drives ventricular expansion (Ek et al., 2005).  
We next tested if the AF, like the CSF, harbors instructive signaling 
activities for adjacent tissues. We asked whether a cranial neurogenic placodal 
epithelium, where neural stem cells for peripheral neurons are established and 
maintained (Moody and LaMantia, 2015), depends selectively on the signaling 
capacity of the AF, which contacts these structures. We developed an E10.5 
olfactory placode explant culture system (Figure A2.3D), which gives rise to the 
olfactory sensory neurons and which under normal conditions directly contacts 
the E10.5 AF. The neurogenic phenotype of developing E10.5 olfactory epithelial 
cells was optimally supported by E10.5 AF vs. E8.5 AF, as assessed by 
Sox2:EGFP (Figure A2.3E, F), and the lateral to medial patterning of Sox2 
(Rawson et al., 2010; Tucker et al., 2010) was also optimally maintained in the 
presence of E10.5 AF. These data demonstrate that the AF can regulate cranial 
placode neuroepithelial cells in an age- and tissue-specific manner.   
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Quantitative proteomic analyses reveal dynamic transition from AF to CSF 
To characterize the differentiating CSF proteome as it emerges from E8.5 
AF, we performed quantitative MS using label-free spectral counts on E8.5 AF, 
E10.5 CSF, and E14.5 CSF. Consistent with the silver staining results (Figure 
A2.3B), E8.5 AF had the most complex proteome (764 proteins identified), 
followed by E10.5 CSF (504 proteins), while E14.5 CSF had the least complex 
proteome (410 proteins) (Figure A2.4A,B; Table S1). All three fluid 
compartments shared 225 proteins (e.g. Apoa4, Fstl1) (Figure A2.4A,B; Table 
S1). Beyond these shared constituents, we found 383 proteins exclusive to E8.5 
AF (e.g. Eef1g, Rpl6), whereas 126 and 32 were exclusive to E10.5 CSF (e.g. 
Actg1, Efnb2) and E14.5 CSF (e.g. Blbp/Fabp7, Cdh13), respectively (Figure 
A2.4A,B; Table S1).  
Unsupervised clustering using GProX (Rigbolt et al., 2011) partitioned the 
proteomes into six individual clusters with distinct temporal expression patterns 
as the fluids diverged from E8.5 AF (Figure A2.4C; Table S1). Cluster 1 
consisted of 452 proteins that were more abundant at E8.5 AF than at later 
stages. Enrichment analysis using DAVID webtool (Huang et al., 2008; Huang et 
al., 2009a) showed that ribosomal proteins and other proteins involved in 
translation constituted the most enriched class of proteins in cluster 1 (Figure 
A2.4D; Table S1). The early neuroepithelium releases membrane particles 
(Marzesco et al., 2005). Consistent with these findings, immunostaining analyses 
of some ribosomal protein subunits suggested to be enriched in E8.5 AF based 
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on our MS analyses (e.g. Rps12 and Rpl11) were expressed in the E8.5 
neuroepithelium at higher levels than in the E10.5 neuroepithelium (Figure 
A2.S1C, D), strongly suggesting that ribosomal protein content in E8.5 AF arises 
from normal membrane shedding that occurs during this age. Cluster 2 (181 
members) represented proteins that were more abundant in E10.5 CSF than in 
E8.5 AF and E14.5 CSF. The most enriched class within cluster 2 was 
glycoproteins (Figure A2.4D; Table S1), many of which were membrane proteins 
(e.g. cadherins, prominin1) and extracellular matrix (ECM) proteins (e.g. 
collagens, laminins, reelin), likely reflecting the active proliferation and membrane 
shedding of the neuroepithelium at E10.5. Supporting these data, KEGG 
pathway analysis of cluster 2 showed that ECM-receptor interaction (p-value = 
5.89 x 10-9) and focal adhesion (p-value = 6.84 x 10-6) were the two most 
enriched pathways within this cluster (Table S1). The third most enriched 
pathway was axon guidance (p-value = 4.03 x 10-5, Table S1), with members 
such as semaphorins, ephrin receptors, ephrin-B2, and Dcc (netrin-1 receptor) 
(Figure A2.4E; Table S1), reflecting the active cellular movement in the embryo 
at this age. Whether these activities have active roles in instructing migration, as 
has been suggested for CSF-Slit in adult (Sawamoto et al., 2006), remains to be 
determined. A number of proteins involved in canonical signaling pathways, 
including Bmp1, Mstn, Dkk3, and Tgfbr3, were also found in cluster 2 (Table S1), 
demonstrating that these activities are already present in E10.5 CSF, before the 
development of the choroid plexus. The availability of these proteins was 
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downregulated by E14.5, suggestive of roles in early brain development. Cluster 
3 (87 members) represented proteins enriched in E14.5 CSF, and the most 
enriched class within this cluster was proteins with immunoglobulin domains. 
Taken together, these data demonstrate that the AF-to-CSF transition during 
neural tube closure is accompanied by dynamic changes in protein availability 
and putative functions.  
 
Canonical signaling activities in AF and CSF   
A number of canonical signals (e.g. Shh, Bmps, and RA) act on neural 
stem cells in the developing brain during the time when the CSF becomes a 
distinct fluid compartment (Wilde et al., 2014), and we found that these activities 
are tightly regulated in the nascent CSF during this time frame. First, from our 
MS analysis, the non-canonical Shh receptors, Boc and Gas1, were detected in 
E10.5 CSF (Table S1). Consistent with these data, CSF-Shh, quantified by 
ELISA, peaked in E10.5 CSF (Figure A2.5A). The fourth ventricle choroid plexus 
secretes Shh into the CSF at later ages (Huang et al., 2010; Lun et al., 2015a); 
however, the choroid plexi have not yet developed at E10.5. Shh enrichment in 
the nascent CSF supports a model in which secretion of signals from cells 
adjacent to the ventricles, and/or diffusion of signals from surrounding tissues 
(e.g. floor plate), contribute to the CSF proteome, akin to secretion of Sema3B 
into the CSF in the spinal cord (Arbeille et al., 2015).  
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Previous studies have demonstrated activation of Bmp signaling in apical 
progenitor cells along the length of the dorsal telencephalic ventricular surface 
(Doan et al., 2012; Lehtinen et al., 2011), and we found Bmp signaling activity to 
change dynamically in the nascent CSF. Bmp4 availability measured by ELISA 
showed a trend to increase from E8.5 AF to E14.5 CSF, but was not significant 
(mean Bmp4 [nmol/ml] ± SEM: E8.5 AF = 745.1 ± 111.7; E10.5 CSF = 941.6 ± 
201.4; E14.5 CSF = 1018.3 ± 231.4; n=3, not significant). We observed 
progressively increased phospho-SMAD1/5/8-positive staining cells along the 
ventricular surface during neurulation (mean forebrain phospho-SMAD1/5/8 
frequency/mm ± SEM: E8.5 = 28.0 ± 1.6 [n=8]; E9.5 = 75.3 ± 3.2 [n=5]; E10.5 = 
83.0 ± 2.9 [n=6]; E8.5 vs. E9.5, t-test, p < 0.0001; E9.5 vs. E10.5, t-test, p < 0.05 
and Figure A2.5B), suggesting that these cells have the ability to transduce Bmp 
signals from the AF and CSF. In contrast, overall Bmp activity progressively 
decreased from E8.5 AF to E14.5 CSF, as revealed by a luciferase-based assay 
in a Bmp-sensitive cell line (Figure A2.5C). Finally, retinoic acid (RA) activity was 
similarly low between E8.5 AF and E10.5 CSF, and increased by E14.5 (Figure 
A2.5D), after choroid plexus formation, consistent with a requirement during 
initial neural tube formation to “protect” the anterior neural plate from the 
posteriorizing influence of RA (Durston et al., 1989), followed by increased RA 
signaling in more mature forebrain neural stem cells (Figure A2.5E) (Haskell and 
LaMantia, 2005; LaMantia et al., 1993; Lehtinen et al., 2011; Siegenthaler et al., 
2009). Together, these data show that signaling activities with established roles 
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in brain development are dynamically available in the AF and nascent CSF and 
parallel changes in signaling in the neural progenitors.  
 
Nascent CSF supports progenitor self-renewal 
 We next asked if these distinct, dynamic AF and CSF proteomes could be 
mined as a resource for signaling activities that might influence neural stem and 
progenitor progression. Proteomic analyses revealed the dynamic availability of 
many receptors from E8.5 AF-E14.5 CSF (e.g. TGFβ, EGFR, LIFR, 
representative of 41 proteins annotated as receptors by DAVID; Figure A2.S2A-
C, Table S1). For example, availability of the Leukemia inhibitory factor (LIF) 
receptor (LIFR) declined during the course of AF to CSF fluid maturation (LIFR 
mean spectral counts ± SEM: E8.5 AF = 14.8 ± 1.2; E10.5 CSF = 7.8 ± 2.8; 
E14.5 CSF = not detected, n=3; Figure A2.S2C, Table S1). While LIFR was not 
detected by MS in E14.5 CSF, immunoblotting revealed bands consistent with 
some LIFR availability in E14.5 CSF (Figure A2.S2D). Soluble LIFR binds LIF 
and can inhibit its biological activity (Layton et al., 1992; Tomida, 2000). These 
observations suggest that neural tube closure could decrease access of an 
inhibitory factor into the CSF.  
 The LIF signaling pathway represents one compelling example of 
signaling activity in AF and nascent CSF. LIF regulates Sox2 expression in stem 
cells (Foshay and Gallicano, 2008; Niwa et al., 2009; Onishi and Zandstra, 2015; 
Pitman et al., 2004; Shimazaki et al., 2001). LIF also stimulates neural progenitor 
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proliferation (Hatta et al., 2002) and influences cell fate at later developmental 
stages (Onishi and Zandstra, 2015). Thus, we tested if CSF-LIF mediated 
signaling regulates neural stem cells following neural tube closure. We observed 
membrane-associated LIFR and phospho-STAT3 in P-Vimentin-positive apical 
progenitor cells at E10.5 (Figure A2.6A,B). In agreement with a previous report 
showing LIF availability in the CSF at E11 (Hatta et al., 2006), we detected LIF-
reactive bands in E10.5 CSF treated with the deglycosylating enzyme PNGase F 
(Figure A2.6C). Direct injection of recombinant LIF into E10.5 telencephalic 
ventricles ex vivo stimulated P-STAT3 activity in neuroepithelial progenitor cells 
(Figure A2.6D). We then used a pair-cell assay to test for the functional effects 
of LIF on E10.5 neural progenitor self-renewal (Figure A2.6E). Using Sox2 to 
identify neural progenitors and Tuj1 to identify neurons, we found that LIF 
stimulated self-renewal (progenitor-progenitor division; P-P) of Sox2-positive 
neural progenitors at the expense of differentiation (progenitor-neuron division; 
P-N) or transient cells that co-express Sox2 and Tuj1 (Transient-Transient 
division; Tr-Tr; Hutton and Pevny, 2011; Figure A2.6F). Pair-cell assays using 
20% E10.5 CSF revealed a similar ability to promote progenitor self-renewal 
(Figure A2.6G). The frequency of Sox2-positive P-P divisions declined in cells 
cultured with CSF containing LIFR blocking or LIF neutralization (NAb) antibodies 
(Figure A2.6H), showing that CSF-based signaling via the LIFR can promote 
neuroepithelial cell self-renewal, though other CSF-borne signals likely work in 
concert in vivo to regulate this process.  
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 Lifr-deficient mice are microcephalic by E12.5, a time when LIF is 
beginning to be produced by the choroid plexus (Gregg and Weiss, 2005). 
Because the choroid plexus is not yet developed at E10.5, our findings suggest 
that CSF-LIF must originate from another source to contribute to progenitor 
proliferation at this earlier developmental stage. While we cannot rule out a 
contribution by the neuroepithelium (Figure A2.S2E), LIF is abundantly 
expressed by the amniotic sac and yolk sac (Figure A2.S2E). Consistent with 
CSF drawing fluid from the AF at this stage (Alonso et al., 1998), 10 kDa 
fluorescein-conjugated dextrans injected into the intra-amniotic space of E10.5 
mouse embryos were detected in the CSF 30 minutes following injection 
(average relative fluorescent units: 10 kDa dextran = 445 and 153.3; Vehicle = 
21.3; 33.7; and 50.1). These data suggest that factors available in the AF —
possibly including LIF— can reach the CSF by classic diffusion through the 
neuroepithelium at this age. The zebrafish neuroepithelium is permeable to 
fluorescent dyes up to 70kDa (Chang and Sive, 2012).  
 Our proteomic and functional analyses were performed using pooled 
samples of AF and CSF. However, silver staining analyses of lateral and fourth 
ventricle CSF revealed that the CSF proteome was regionalized, with distinct 
protein bands detected in each sample already at E10.5 (Figure A2.6I), prior to 
choroid plexus-driven regionalization that occurs at later ages (Lun et al., 2015a). 
These data suggest differential diffusion or secretion of proteins into each CSF-
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filled ventricular sub-compartment, and potentially, differential effects on local 
progenitor progression. 
 
Quantitative proteomic analysis of maturing AF 
We have limited knowledge regarding the mouse AF proteome and how it 
develops over time. Based upon the observation that E10.5 AF supports the 
developing olfactory placode (Figure A2.3E), we performed quantitative MS to 
reveal changes in the AF proteome as it develops from E8.5 to E10.5 and E14.5.  
The composition of E10.5 AF and E14.5 AF were less complex than E8.5 AF 
(Figure A2.7A; Table S2). Only 80 proteins found in the older AF samples were 
not detected at E8.5 (Figure A2.7B; Table S2). Conversely, 476 proteins were 
exclusive to E8.5 AF (Figure A2.7B; Table S2). Unsupervised clustering of 
expressed proteins followed by enrichment analysis revealed that many proteins 
enriched in E8.5 AF were ribosomal proteins and translation factors (Figure 
A2.7C, D; Table S2; cluster 1, 515 members). E14.5 AF was enriched in proteins 
that were secreted (e.g. collagens) or important for cell adhesion (e.g. Ncam1, 
Vcam1) (Figure A2.7C, D; Table S2; cluster 2, 88 members). Cluster 3 (88 
members) hosted proteins that were more abundant at later ages than at E8.5 
(Figure A2.7C; Table S2). Many of these proteins were secreted (e.g. Dkk3, 
Igf2) or ECM proteins (e.g. collagens, fibronectin; Figure A2.7D; Table S2). Only 
37 proteins were enriched in E10.5 AF (Figure A2.7C; Table S2; cluster 5), and 
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some of these (e.g. Gas1, Mstn, Tgfbr3) were members of canonical signaling 
pathways.  
Despite the expansion of the brain’s ventricles between E8.5-E10.5 
(Figure A2.1), direct comparison of the AF and CSF proteomes revealed that 
only 14 proteins found in E10.5 AF were not detected in E10.5 CSF (Figure 
A2.7E). These data are consistent with the model that the CSF draws fluid and 
proteins from the AF (see above; Alonso et al., 1998; Chang & Sive, 2012). 
Conversely, many proteins were enriched in the E10.5 CSF vs. E10.5 AF, 
including Shh (mean Shh concentration [pg/ml] represented as mean ± SEM at 
E10.5: AF = 50.6 ± 11.9; CSF = 197.6 ± 12.7; n = 3; p < 0.01, t-test; see also 
Figure A2.5A). Importantly, 264 proteins in E10.5 CSF were not detected in 
E10.5 AF, indicating other sources including the adjacent neuroepithelium (e.g. 
Marzesco et al., 2005) as major contributors to the nascent CSF proteome  
(Figure A2.7E). By E14.5, the CSF and AF were even more distinct from each 
other, with 131 proteins exclusively detected in E14.5 CSF and 110 proteins 
exclusively detected in E14.5 CSF (Figure A2.7F), reflecting progressive, age-
dependent divergence of the AF and CSF. Principal component analysis showed 
that E8.5 AF and E14.5 CSF were the most distinct fluid compartments, whereas 
E10.5 CSF, E10.5 AF and E14.5 AF were more similar to each other (Figure 
A2.7G). Thus, the developing AF and CSF undergo a progressive differentiation 
with instructive capacities matched to adjacent neurogenic tissues.  
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Discussion 
 
 We present a resource in which we have: 1) developed tools to collect AF 
and CSF before and after neural tube closure, 2) quantified ventricular expansion 
in live mouse embryos before and after neural tube closure, 3) systematically 
documented the dynamic signaling capacity, and protein content of the AF and 
CSF proteomes as they differentiate over the course of embryonic development, 
4) developed robust, heterochronic ex vivo explant systems to assess functional, 
instructive activities for AF and nascent CSF in promoting neural progenitor cell 
fate in the developing neural plate, neural tube, and brain as well as the 
neurogenic cranial placodes, and 5) demonstrated that CSF-based signaling via 
the LIFR stimulates neuroepithelial cell self-renewal. Paired with the dynamic 
morphological features of the early developing head and brain, our findings 
should accelerate future studies investigating the regulation of fluid/tissue 
interactions and their consequences for signaling during these early, 
understudied stages of brain development. Since many tissues of the developing 
embryo, particularly the precursors of the central and peripheral nervous system, 
are in contact with AF/CSF, our proteomic dataset serves as an important 
resource for investigators across multiple developmental fields that are interested 
in studying fluid-tissue interactions and related mechanisms during mid-gestation 
when embryos are particularly vulnerable to the consequences of disrupted 
signaling.  
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Analyzing fluid proteomes and their activities in early embryos 
We addressed several challenges in developing this resource for 
understanding AF and CSF function in mammalian embryos. A number of studies 
have used proteomics tools to analyze the AF or CSF at older ages or in other 
species (e.g., Chang et al., 2015; Dislich et al., 2015; Dziegelewska et al., 1981; 
Lehtinen et al., 2011; Lun et al., 2015a; Parada et al., 2005; Zappaterra et al., 
2007).  However, to our knowledge, analysis of the murine AF proteome over the 
course of early development has not been undertaken, likely due to challenges of 
reliably collecting small amounts of AF and CSF from early mammalian embryos. 
We minimized variability in AF collection and preparation, with careful dissection, 
pooling samples across litters, and assessment of contamination by embryonic or 
maternal tissues. We similarly standardized CSF collection from embryos after 
neural tube closure and emergence of distinct brain vesicles. While the CSF 
between ventricles is regionalized by E10.5 (Figure A2.6I), analysis of total CSF 
samples from individual embryos using silver stained gels indicated basic 
uniformity within and across litters (data not shown). MS analyses showed 
quantitative differences between pooled AF and CSF samples, which may 
indicate biological variability independent of technical issues, or subtle 
differences in embryo stages when fluids are collected. Some variability 
suggested by MS may not reach a threshold for impacting signaling capacity. 
Quantitative MS may also be limited in its ability to detect low abundance 
proteins, proteins that have been processed into small peptides, and proteins 
 	
233 
with other physicochemical properties (e.g. hydrophobicity). However, our 
analyses of cardinal signaling activity (e.g. Bmps, RA, Shh) support the model 
that overall AF and CSF signaling activity is stable among pooled samples. We 
also detected some variation in AF and CSF activity on neural progenitors in our 
explant assays; however, these differences may reflect details of the reporter 
allele (Arnold et al., 2011; Ellis et al., 2004) rather than distinctions of AF or CSF 
activity on the neuroepithelium. Pair-cell analyses of LIF, a likely AF/CSF signal, 
indicate stage-specific consistency. Future studies analyzing the influence of 
AF/CSF on neural stem cell identities in functional assays will further elucidate 
the biological significance of variability in AF and CSF proteomes.  
 
The Signaling Capacity of the AF and CSF 
The AF and nascent CSF have dynamic morphogenetic signaling capacity via 
Bmps, RA, and Shh. The effective activity of these signals varies in register with 
patterning in the embryo, including the brain and the neurogenic cranial 
placodes. The decrease in total Bmp activity during the transition from E8.5 AF to 
E10.5 CSF may indicate changes in inhibition. For example, Fstl1, a Bmp4 
antagonist (Geng et al., 2011), was more abundant in E10.5 CSF than in E8.5 
AF, while Bmp4 was identified in each fluid compartment. The timed delivery of 
fluid-based signals is also demonstrated by the delayed availability of RA in the 
E14.5 CSF, presumably protecting the developing brain from posteriorizing cues, 
while permitting local signaling via cranial mesenchymal sources once the neural 
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tube closes (Moody and LaMantia, 2015). Finally, our findings of elevated Shh in 
E10.5 CSF suggest that the developing dorsal forebrain, as well as the ventral 
forebrain that is thought to receive Shh signals from local tissue sources (Chiang 
et al., 1996; Rallu et al., 2002b), is exposed to Shh quite early in 
embryrogenesis. In all cases, the action of CSF-borne signals on target cells 
relies on appropriate receptor expression and ability to transduce signals 
delivered by the CSF.  
Since no individual tissue is solely responsible for the production of AF 
and nascent CSF at the early ages examined (e.g. E8.5 and E10.5; the choroid 
plexus contributes to CSF production in our E14.5 samples), there is no 
transcriptome from which to derive the early AF and CSF proteomes. Therefore, 
our MS approach provides a singular directory of hundreds of differentially 
available proteins in the maturing AF and CSF over time. The diversity of 
proteins identified in early AF and CSF includes growth factors and their 
receptors (e.g. Boc and Gas1 for Shh), axon guidance molecules (e.g. 
semaphorins, DCC, ephrins), and extracellular matrix components (e.g. reelin, 
laminin subunits). The presence of prominin-1-containing membrane particles 
(Dubreuil et al., 2007; Marzesco et al., 2005) in the E10.5 and E14.5 CSF, but 
not E8.5 AF (Table A2.S1) suggest that the developing neuroepithelium 
contributes to the CSF proteome. Whether these particles have an active role in 
CSF-based signaling (Cossetti et al., 2014; Feliciano et al., 2014), or are cellular 
waste products cleared from the developing neural tissue, remains to be 
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determined. Nevertheless, signaling components of many of the pathways 
represented in the AF and CSF proteomes have roles in neural tube closure 
(Wilde et al., 2014), inviting hypotheses for fluid-based regulation of this 
developmental stage.  
 
AF and CSF proteomes and hypotheses for early mammalian brain 
development 
The resources of AF/CSF proteomes, activities, and embryo-based assays to 
evaluate signaling capacities also provide an essential foundation for generating 
and testing hypotheses of mammalian neural development and how it is 
compromised by genetic and environmental disruption. We found that AF and 
CSF vary in several dimensions within 48 hours during early to mid-stage mouse 
embryogenesis. Changes in osmolality and fluid volumes may have substantial 
consequences for morphogenetic movements that maintain the neural plate, and 
then support neural tube closure. Importantly, distinctions in AF/CSF protein 
constituents—especially metabolic and receptor proteins in the fluids at different 
stages—suggest key changes in cells of embryonic surface tissues that directly 
contact AF or CSF during the transition from neural plate to forebrain vesicle 
epithelium. Such changes may be driven by the AF versus CSF proteomes, and 
may be metabolic indicators of molecular and cellular distinctions in embryonic 
tissues that influence stem cell progression and early neurogenesis. Despite 
tremendous focus on neural stem cell progression at later stages of brain 
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development in the spinal cord, hindbrain, and forebrain (e.g. Dias et al., 2014), 
there has been far less attention paid to the key transition between early 
neuroectodermal stem cell and neural stem cell identity as the neural tube 
closes. Mining of our proteomic resource, combined with use of our assays to 
evaluate stem cell progression will provide important insights into mechanisms 
that mediate this key period of mammalian brain development. 
 The early AF and CSF proteomes reflect, in varying degrees, the balance 
between maternally derived protein constituents and other small molecules, and 
those derived from the embryo. These proteomes are likely altered dramatically 
in response to maternal illness, changes in nutrition, substance abuse, and 
exposure to environmental toxins (Wilde et al., 2014). Thus, the definition of 
dynamic AF and CSF activities we have provided constitutes an essential 
resource for understanding risk and consequence of maternal/fetal interactions 
during first trimester development. 
 
 
Experimental procedures 
 
Animals. Timed pregnant CD1 dams were obtained from Charles River 
Laboratories. Sox2:EGFP (Ellis et al., 2004) was shared by L. Pevny. All animal 
experimentation was carried out under protocols approved by the IACUCs of 
Boston Children’s Hospital and The George Washington University School of 
Medicine.   
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Ventricular system measurements. Uterine horns were placed on Sylgard 
plates, immersed in PBS, and ultrasound image sequences were captured (Vevo 
2100, Visual Sonics; MS550 transducer; step size: 0.076mm). 3D reconstruction 
of ventricular system was performed for visualization (Vevo 2100) and 
quantification (Fiji-TrakEM).  
 
AF and CSF collection and measurements. AF was collected by inserting a 
glass capillary into the intra-amniotic space. CSF was collected by inserting glass 
capillary into telencephalic ventricles, aqueduct, fourth ventricle or cisterna 
magna, and processed as described (Zappaterra et al., 2013). Protein 
concentration (BCA kit) and osmolality (10µl fluid input, Vapro 5600) were 
measured.  
 
Forebrain neuroectodermal explants. E8.5 anterior neuroectoderm containing 
the presumptive forebrain, was dissected from the anterior neural ridge to the 
optic vesicle. E10.5 dorsal telencephalic neuroepithelium was isolated by: 1] 
dissecting the cortical neuroepithelium caudal to the olfactory bulb at the anterior 
boundary of the lateral ganglionic eminence (LGE), 2] dissecting caudal to the 
posterior boundary of the LGE and extending to the medial wall of the developing 
cortical rudiment, 3] separating the LGE from the developing cortex, and 4] 
removing the midline at the apex of the neocortex where the lateral cortical 
surface meets the interhemispheric wall. Following 30 minutes of enzymatic 
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digestion with pancreatin on ice, neuroepithelium was separated from 
mesenchyme and surface ectoderm using tungsten needles. Explants were 
placed on polycarbonate membranes (8.0µm pore size; Whatman) in imaging 
dishes (Mat-Tek), and cultured in 20% AF or CSF in Neurobasal medium 
supplemented with antibiotics and L-glutamine. Explants were cultured for 24 
hours.  
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Figure A2.1. Expansion of the mouse ventricular system following neural 
tube closure. (A) Sox2-positive neuroepithelial cells (green) contact the AF 
before neural tube closure at E8.5 (left panel), and the nascent CSF following 
neural tube closure at E9.5 (middle panel) and E10.5 (right panel). Nuclei 
counterstained with Hoechst. Scale bars: 50µm (left panel); 200µm (middle, right 
panels). (B) Representative ultrasound images of developing mouse (E8.5-
E12.5). Dashed white line (left panel) outlines embryo. Scale bar: 2mm. (C) 3D 
reconstruction of ventricular system from ultrasound images sequences captured 
in (B) from E9.5-E12.5 with the following color representation: turquoise: lateral 
ventricles; yellow: third ventricle and aqueduct; dark blue: fourth ventricle. (D) 
Quantification of ventricle size based on 3D reconstructions of ultrasound image 
sequences (B, C, data not shown; ventricular volume (µl) represented as mean ± 
SEM: Lateral ventricles: E9.5 = 0.09 ± 0.02; E10.5 = 0.77 ± 0.12; E11.5 = 0.83 ± 
0.07; E12.5 = 1.39 ± 0.19; E13.5 = 1.08 ± 0.05; Third ventricle and aqueduct: 
E9.5 = 0.31 ± 0.03; E10.5 = 1.48 ± 0.37; E11.5 = 1.33 ± 0.15; E12.5 = 1.40 ± 
0.11; E13.5 = 1.16 ± 0.03; Fourth ventricle: E9.5 = 0.54 ± 0.04; E10.5 = 1.63 ± 
0.22; E11.5 = 1.36 ± 0.06; E12.5 = 1.27 ± 0.27; E13.5 = 0.50 ± 0.14; Total 
ventricular volume: E9.5 = 0.94 ± 0.04; E10.5 = 3.92 ± 0.70; E11.5 = 3.51 ± 0.16; 
E12.5 = 4.06 ± 0.06; E13.5 = 2.74 ± 0.09; n = 3; ANOVA statistical analyses of 
total ventricular volume represented as (*) p < 0.05 and (***) p < 0.0001; n=3).  
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Figure A2.2. Heterochronic explants show tissue-fluid age matching 
promotes Sox2-positive progenitors. Schematics of (A) E8.5 AF collection; (B) 
E10.5 AF collection; (C) E10.5 CSF collection; (D) Heterochronic forebrain 
neuroectodermal explant dissections: isolated neuroepithelium (dashed line) 
placed on membrane with ventricular surface down contacting AF or CSF. (E) 
E8.5 explants grown on E8.5 AF or E10.5 CSF. Sox2:EGFP suggests age-
matched fluid best supports neural stem cell identity (E8.5 explant with E8.5 AF 
[n=8] or with E10.5 CSF [n=8]). (F) qPCR of explants cultured as in (E) suggest 
that E8.5 AF more favorably supports E8.5 explants compared to E10.5 explants. 
(E8.5 AF = 1.63 ± 0.49; E10.5 CSF = 1.00; n=3 of 4 pooled explants each, p = 
n.s., Mann-Whitney). Two experiments (n=2) of 4 pooled explants each were 
excluded from statistical analyses. While E8.5 AF supported these E8.5 explants, 
the experiments had undetectable Sox2 expression in the E10.5 CSF condition, 
suggesting a role for age-matched AF and CSF in cell survival and 
demonstrating experimental variability at this age (see also Discussion). (G) 
E10.5 explants grown on E8.5 AF [n=9] or with E10.5 CSF [n=11]. Note 
increased GFP expression for age-matched CSF vs. non-age-matched CSF 
experiments. (H) qPCR of explants cultured as in (G) show that E10.5 CSF more 
favorably promotes Sox2 expression in E10.5 explants compared to E8.5 AF 
(E8.5 AF = 1.00; E10.5 CSF = 1.80 ± 0.29; n=3 of 4 pooled explants each, p < 
0.05, Mann-Whitney). See also Figure A2.S1.  
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Figure A2.3. Early AF and CSF undergo dynamic changes, and age-
matched AF supports olfactory placode development. (A) Total protein 
concentration of AF decreases from E8.5 – E14.5; total CSF protein 
concentration increases from E10.5-E14.5 (mean protein concentration [mg/ml] ± 
SEM: E8.5 AF = 1.99 ± 0.06; E10.5 AF = 1.73 ± 0.13; E10.5 CSF = 1.70 ± 0.14; 
E14.5 AF = 1.51 ± 0.05; E14.5 CSF = 2.73 ± 0.26; n = 4 for all except E10.5 
CSF, n=5; ANOVA; (*) p < 0.05 (***) p < 0.0001). (B) Silver stain of 1 µl AF or 
CSF suggests highest protein complexity in E8.5 AF. Asterisks denote 
representative proteins enriched in E8.5 AF (red) or E14.5 CSF (green). (C) 
Osmolality of CSF decreases from E8.5-E10.5, and then increases. Osmolality of 
AF decreases from E8.5-E14.5 (mean osmolality [mOsm/Kg] ± SEM: E8.5 AF = 
303.0 ± 3.0 (n=3); E10.5 AF = 296.8 ± 2.2 (n=5); E10.5 CSF = 293.4 ± 4.4 (n=5); 
E12.5 AF = 292.5 ± 2.5 (n=4); E12.5 CSF = 297.0 ± 5.3 (n=3); E14.5 AF = 293.7 
± 1.2; E14.5 CSF = 298.0 ± 1.5; n=3; ANOVA, p < 0.05). Osmolality of E14.5 
CSF is higher compared to E14.5 AF (t-test, (*) p < 0.05). (D) Schematic of E10.5 
olfactory epithelium dissections: pairs of bilateral olfactory epithelial explants 
(denoted by dashed lines) placed on porous membrane contacting the AF. (E) 
E10.5 olfactory epithelial explants grown on E8.5 or E10.5 AF. Sox2:EGFP 
shows age-matched fluid most favorably supports neural stem cell identity (n=4). 
(F) qPCR of E10.5 OE explants cultured as in (E) show E10.5 AF more favorably 
promotes Sox2 expression in E10.5 OE explants compared to E8.5 AF (E8.5 
AF=1.00; E10.5 AF = 1.78 ± 0.32; n=3 of 4 pooled explants each, p < 0.05, 
Mann-Whitney). 
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Figure A2.4. Mass spectrometry reveals dynamic changes in CSF proteome 
as it differentiates from E8.5 AF to E14.5 CSF. (A) Heatmap of normalized 
spectral counts reveals differential protein availability between E8.5 AF, E10.5 
CSF and E14.5 CSF. Unsupervised hierarchical clustering grouped the three 
biological replicates of each fluid together. Each replicate contains 30µg total 
CSF protein pooled from multiple embryos. Spectral counts were scaled such 
that for each protein, the sample with the highest spectral count is set as one. 
Grey indicates undetected protein (i.e. 0 spectral counts). Proteins with peptides 
detected in at least two samples were included in the heatmap. (B) Total of 961 
proteins were identified across all samples. Venn diagram depicts numbers of 
proteins exclusive to or shared between distinct fluid compartments. (C) 
Unsupervised clustering using GProX partitioned proteins into 6 clusters, 
revealing different temporal expression patterns for each cluster. Number of 
proteins in each cluster (n) is indicated above each graph. 33 proteins showed 
less than two-fold difference in availability between the fluids, and were not 
included in clustering. Membership indicates how well proteins fit into the general 
profile of cluster. (D) Functional annotation clustering of proteins in GProX 
clusters 1, 2 and 3 using DAVID. The top five enriched functional clusters are 
shown. (E) Proteins in GProX cluster 2 that are members of the axon guidance 
pathway were subjected to network analysis using GeneMania (Warde-Farley et 
al., 2010). Green nodes represent proteins members of cluster 2, whereas grey 
nodes represent related proteins. Lines connecting the nodes denote the 
relationship between the proteins. See also Table S1 and Figure S1.  
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Figure A2.5. Canonical signaling activities present in AF and nascent CSF. 
(A) Shh levels measured in E8.5 AF, E10.5 CSF, and E14.5 CSF by ELISA 
peaked in E10.5 CSF (mean Shh concentration [pg/ml] ± SEM: E8.5 AF = 31.13 
± 4.34; E10.5 CSF = 197.58 ± 12.71; E14.5 CSF = 70.68 ± 14.25). (B) P-SMAD 
1/5/8/-positive staining progenitor cells along ventricular surface  of E8.5 (left 
panel) and E10.5 (right panel) forebrain (arrows). Inset: high magnification 
image. Nuclei counterstained with Hoechst. (C) Bmp activity measured in E8.5 
AF, E10.5 CSF, and E14.5 CSF as luciferase signal in clonally derived Bmp-
sensitive cell line. Responses were compared to linear responses generated by 
pure Bmp4 (ng/ml) in the same cell line (data not shown). Overall Bmp activity 
decreases in nascent CSF (mean Bmp activity + SEM: E8.5 AF = 0.05 + 0.02; 
E10.5 CSF = 0.001 + 0.002; E14.5 CSF = 9.9x10-5 + 3.4x10-5; E8.5 AF vs. E10.5 
CSF, t-test, p < 0.05; E10.5 CSF vs. E14.5 CSF, t-test, p < 0.01; data represent 
duplicate runs of biological replicates, n=3, from E8.5 AF and E14.5 CSF and 
n=2 for E14.5 CSF). (D) Retinoic acid (RA) activity measured in E8.5 AF, E10.5 
CSF, and E14.5 CSF as luciferase signal in clonally derived RA-sensitive cell 
line. Responses were compared to linear responses generated by pure RA in the 
same cell line (data not shown). Overall RA activity increases in E14.5 CSF 
(mean RA activity + SEM: E8.5 AF = 12.3 + 2.0; E10.5 CSF = 15.3 + 3.4; E14.5 
CSF = 33.4 + 7.4; t-test, p < 0.01; n=3; data represent duplicate runs of biological 
replicates, n=3, at each age. (E) RA indicator mice at E8.5 (left panel) with open 
neural tube and E10.5 (right panel) with closed neural tube. Arrows: presumptive, 
developing forebrain. RA signaling is not detected in the forebrain neuroectoderm 
of the open neural tube at E8.5. Signaling in the somites and spinal cord reflects 
local RA production by the somites (Stavridis et al., 2010; Vermot et al., 2005). At 
E10.5, RA signaling activity in the forebrain and head is modest, confined to the 
ventro-lateral forebrain, eye and nose, all reflecting local neural crest 
mesenchyme sources of RA (Haskell and LaMantia, 2005; LaMantia et al., 
1993).   
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Figure A2.6. Nascent CSF promotes signaling and self-renewal in 
progenitor cells. (A) E10.5 forebrain shows P-STAT3 (red) activity in P-
Vimentin-positive (green) progenitor cells along ventricular surface. Nuclei 
counterstained with Hoechst. (B) Higher magnification images of E10.5 forebrain 
show LIFR (red) expression in P-Vimentin-positive (green) progenitor cells along 
ventricular surface. Nuclei counterstained with Hoechst. Scale bar, 20 µm. (C) 
Removal of N-linked glycans from E10.5 CSF with PNGase F reveals robust 
bands immunoreactive for LIF. (D) Intraventricular LIF injection (15 minutes; 
200ng/ml) at E10.5 stimulates P-STAT3 (red) signaling in P-Vimentin-positive 
(green) progenitor cells along ventricular surface. Nuclei counterstained with 
Hoechst. (E) Schematic depicting potential combinations of daughter cells in pair 
cell assay (P – progenitor; N – neuron; Tr – transient/intermediate cell type co-
expressing Sox2 and Tuj1). (F) LIF stimulates Sox2-positive self-renewal (P-P) of 
progenitor cells at expense of differentiating cells (P-N; Tr-Tr; identities of pairs of 
cells represented as mean ± SEM; P-P division: control = 23.3 ± 0.8; LIF = 35.9 ± 
1.6; P-N division: control = 18.8 ± 0.9; LIF = 11.6 ± 0.9; Tr-Tr division: control = 
38.0 ± 1.9; LIF = 28.8 ± 2.0; N-N division: control = 20.1 ± 2.5; LIF = 23.7 ± 0.6; 
n=3; p < 0.0001; ANOVA). (G) E10.5 CSF (20%) stimulates Sox2-positive self-
renewal (P-P) of progenitor cells at expense of differentiating cells (data 
presented as above in (F)). P-P division: control = 33.3 ± 2.5; CSF = 40.2 ± 2.2; 
P-N division: control = 18.2 ± 0.9; CSF = 23.4 ± 3.4; Tr-Tr division: control = 36.8 
± 2.1; CSF = 26.0 ± 0.4; N-N division: control = 12.8 ± 0.8; CSF = 12.2 ± 1.3; 
n=3; p < 0.05; ANOVA). (H) Interference with LIF signaling in E10.5 CSF (20%) 
decreases the proportion of P-P division. Data presented as fold change relative 
to Control IgG (anti-GATA6) (Control IgG = 1.0; LIF neutralization (NAb) = 0.62 ± 
0.19; LIFR block = 0.56 ± 0.13; Control vs. LIF NAb, p = n.s.; Control vs. LIFR 
block, p<0.05; n=3 with approximately 100 pairs counted per condition; Mann-
Whitney). (I) Silver staining shows distinct protein patterns in E10.5 CSF 
collected from lateral vs. fourth ventricles. Arrowheads denote protein bands 
differentially detected in lateral ventricle CSF (red) vs. fourth ventricle CSF (blue). 
See also Figure S2.  
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Figure A2.7. Mass spectrometry reveals decreasing complexity of AF as 
embryo develops from E8.5 to E14.5. (A) Heatmap of normalized spectral 
counts reveals differential protein availability in AF between E8.5, E10.5 and 
E14.5. Unsupervised hierarchical clustering grouped biological replicates of each 
fluid together (E8.5: n=3; E10.5: n=2; E14.5: n=2). Each replicate contains 30µg 
total AF protein pooled from multiple embryos. Spectral counts were scaled and 
analyzed as in Fig. 4A. (B) Total of 844 proteins identified across all AF samples 
are represented as in Fig. 4B. (C) Unsupervised clustering was performed and 
data are presented as in Fig. 4C. 38 proteins showed less than two-fold 
difference in availability between the ages, and were not included in the 
clustering. (D) Functional annotation clustering of proteins in GProX clusters 1, 2 
and 3 was performed and is presented as in Fig. 4D. (E) At E10.5, 264 and 14 
proteins are exclusive to CSF and AF respectively, and 240 proteins are common 
to both fluid compartments. (F) By E14.5, 131 and 110 proteins are exclusive to 
CSF and AF respectively, and 207 proteins are shared between the two fluid 
compartments. (G) Principal component analysis of protein spectral counts 
revealed greater degree of variance between fluid compartments than between 
biological replicates within each compartment. E8.5 AF and E14.5 CSF were the 
most distinct fluid compartments, whereas E10.5 CSF, E10.5 AF and E14.5 AF 
were more similar to each other. PC1 and PC2 explained 48.9% and 24.5% of 
the total variance respectively. Ellipses and lines indicate the 95% confidence 
interval. See also Table S2.  
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Figure A2.S1. The neuroepithelium remains intact following AF collection at 
E8.5. (A) Whole mount images show presumptive forebrain region in E8.5 
embryos that are not disrupted (left) and after AF collection (right). Note that the 
forebrain neuroectoderm (black arrows) remains intact after AF collection. Scale 
bar, 100 µm. (B) Apical membrane staining of β-catenin (green) shows that the 
ventricular surface remains intact following AF collection at E8.5. Nuclei 
counterstained with Hoechst. Scale bar, 10 µm. (C, D) E8.5 forebrain 
neuroectoderm shows stronger expression of two ribosomal protein subunits 
RPS12 and RPL11 (red), in P-Vimentin-positive (green) progenitor cells. Nuclei 
counterstained with Hoechst. Scale bar, 10 µm.   
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Figure A2.S2. Availability of receptors in differentiating cerebrospinal 
fluid. (A) Availability of TGFBR3 peaked at E10.5 CSF, and was not detected in 
E14.5 CSF (mean normalized spectral counts ± SEM: E8.5 AF = 1.225 ± 0.630; 
E10.5 CSF = 4.211 ± 0.243; E14.5 CSF = not detected). Circles represent 
individual samples, n=3 for all samples). (B) EGFR was detected in E8.5 AF but 
not in E10.5 CSF or E14.5 CSF (mean normalized spectral counts ± SEM: E8.5 
AF = 5.132 ± 1.107; E10.5 CSF = not detected; E14.5 CSF = not detected). (C) 
The availability of LIFR decreased from E8.5 AF to E10.5 CSF, and was not 
detected in E14.5 CSF by mass spectrometry (mean normalized spectral counts 
± SEM: E8.5 AF = 14.771 ± 1.249; E10.5 CSF = 7.829 ± 2.847; E14.5 CSF = not 
detected). (D) LIFR was most abundant in E8.5 AF by immunoblotting. The 
transmembrane isoform (122.57kDa) was detected in all three fluid 
compartments, whereas the soluble isoform (81.29kDa) was only detected in 
E8.5 AF under low exposure setting (left). Under long exposure (right), soluble 
LIFR isoform was also detected in E10.5 CSF but not in E14.5 CSF. (E) RT-PCR 
showed higher Lif expression in amniotic sac (AS) and yolk sac (YS) compared 
to neuroepithelium (NE). H2O as negative control; placenta (P) as positive 
control.  
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